Nothing Special   »   [go: up one dir, main page]

TWI724860B - Cured film forming composition, alignment material and retardation material - Google Patents

Cured film forming composition, alignment material and retardation material Download PDF

Info

Publication number
TWI724860B
TWI724860B TW109112027A TW109112027A TWI724860B TW I724860 B TWI724860 B TW I724860B TW 109112027 A TW109112027 A TW 109112027A TW 109112027 A TW109112027 A TW 109112027A TW I724860 B TWI724860 B TW I724860B
Authority
TW
Taiwan
Prior art keywords
group
component
cured film
mass
forming composition
Prior art date
Application number
TW109112027A
Other languages
Chinese (zh)
Other versions
TW202030263A (en
Inventor
伊藤潤
畑中真
大村浩之
湯川昇志郎
Original Assignee
日商日產化學工業股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 日商日產化學工業股份有限公司 filed Critical 日商日產化學工業股份有限公司
Publication of TW202030263A publication Critical patent/TW202030263A/en
Application granted granted Critical
Publication of TWI724860B publication Critical patent/TWI724860B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09DCOATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
    • C09D7/00Features of coating compositions, not provided for in group C09D5/00; Processes for incorporating ingredients in coating compositions
    • C09D7/40Additives
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09DCOATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
    • C09D201/00Coating compositions based on unspecified macromolecular compounds
    • C09D201/02Coating compositions based on unspecified macromolecular compounds characterised by the presence of specified groups, e.g. terminal or pendant functional groups
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09DCOATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
    • C09D133/00Coating compositions based on homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides, or nitriles thereof; Coating compositions based on derivatives of such polymers
    • C09D133/04Homopolymers or copolymers of esters
    • C09D133/14Homopolymers or copolymers of esters of esters containing halogen, nitrogen, sulfur or oxygen atoms in addition to the carboxy oxygen
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09DCOATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
    • C09D201/00Coating compositions based on unspecified macromolecular compounds
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/52Liquid crystal materials characterised by components which are not liquid crystals, e.g. additives with special physical aspect: solvents, solid particles
    • C09K19/54Additives having no specific mesophase characterised by their chemical composition
    • C09K19/56Aligning agents
    • GPHYSICS
    • G02OPTICS
    • G02BOPTICAL ELEMENTS, SYSTEMS OR APPARATUS
    • G02B5/00Optical elements other than lenses
    • G02B5/30Polarising elements
    • GPHYSICS
    • G02OPTICS
    • G02FOPTICAL DEVICES OR ARRANGEMENTS FOR THE CONTROL OF LIGHT BY MODIFICATION OF THE OPTICAL PROPERTIES OF THE MEDIA OF THE ELEMENTS INVOLVED THEREIN; NON-LINEAR OPTICS; FREQUENCY-CHANGING OF LIGHT; OPTICAL LOGIC ELEMENTS; OPTICAL ANALOGUE/DIGITAL CONVERTERS
    • G02F1/00Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics
    • G02F1/01Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour 
    • G02F1/13Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour  based on liquid crystals, e.g. single liquid crystal display cells
    • G02F1/133Constructional arrangements; Operation of liquid crystal cells; Circuit arrangements
    • G02F1/1333Constructional arrangements; Manufacturing methods
    • G02F1/1335Structural association of cells with optical devices, e.g. polarisers or reflectors
    • G02F1/13363Birefringent elements, e.g. for optical compensation
    • GPHYSICS
    • G02OPTICS
    • G02FOPTICAL DEVICES OR ARRANGEMENTS FOR THE CONTROL OF LIGHT BY MODIFICATION OF THE OPTICAL PROPERTIES OF THE MEDIA OF THE ELEMENTS INVOLVED THEREIN; NON-LINEAR OPTICS; FREQUENCY-CHANGING OF LIGHT; OPTICAL LOGIC ELEMENTS; OPTICAL ANALOGUE/DIGITAL CONVERTERS
    • G02F1/00Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics
    • G02F1/01Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour 
    • G02F1/13Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour  based on liquid crystals, e.g. single liquid crystal display cells
    • G02F1/133Constructional arrangements; Operation of liquid crystal cells; Circuit arrangements
    • G02F1/1333Constructional arrangements; Manufacturing methods
    • G02F1/1337Surface-induced orientation of the liquid crystal molecules, e.g. by alignment layers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Organic Chemistry (AREA)
  • Nonlinear Science (AREA)
  • Wood Science & Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Optics & Photonics (AREA)
  • General Physics & Mathematics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Mathematical Physics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Liquid Crystal (AREA)
  • Polarising Elements (AREA)
  • Graft Or Block Polymers (AREA)
  • Paints Or Removers (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)

Abstract

本發明提供一種使用於提供具備優良垂直配向性與密著性,且於樹脂薄膜上亦可在高感度下將聚合性液晶呈垂直地配向之配向材、與使用如此配向材的相位差材之硬化膜形成組成物。 The present invention provides an alignment material that has excellent vertical alignment and adhesion and can also align polymerizable liquid crystals vertically on a resin film with high sensitivity, and a phase difference material that uses such an alignment material. The cured film forms a composition.

本發明的硬化膜形成組成物的特徵為含有(A)具有垂直配向性基與可進行熱交聯的官能基之聚合物、(B)交聯劑、以及(C)密著促進劑及(D)具有熱交聯性基之聚合物中任一方或雙方者;以使用該組成物所得者為特徵之配向材、使用該組成物所得者為特徵之相位差材。 The cured film forming composition of the present invention is characterized by containing (A) a polymer having a vertical alignment group and a functional group that can be thermally crosslinked, (B) a crosslinking agent, and (C) an adhesion promoter and ( D) Either one or both of the polymers with thermally crosslinkable groups; the alignment material characterized by the use of the composition, and the retardation material characterized by the use of the composition.

Description

硬化膜形成組成物、配向材及相位差材 Cured film forming composition, alignment material and retardation material

本發明係關於適用於將液晶分子呈垂直地配向的垂直配向材之硬化膜形成組成物。特別為本發明係關於使用於欲改善液晶顯示裝置(liquid crystal display;LCD),具體為在製造改善具有正型介電異方性之液晶(△ε>0)所填充的IPS液晶顯示裝置(In-plane Switching LCD;面內配向開關LCD)之視野角特性所使用的+C板(正型C板)時有用的硬化膜形成組成物、配向材及相位差材。 The present invention relates to a cured film forming composition suitable for a vertical alignment material for vertically aligning liquid crystal molecules. In particular, the present invention relates to the use of liquid crystal display devices (LCD) to improve liquid crystal display (LCD), specifically in the manufacture of IPS liquid crystal display devices filled with liquid crystals (△ε>0) with positive dielectric anisotropy ( In-plane Switching LCD (In-plane Switching LCD; In-plane alignment switch LCD) is useful for curing film forming composition, alignment material and phase difference material when using +C plate (positive C plate) for viewing angle characteristics.

IPS-LCD因不會產生液晶分子之垂直方向傾斜,故藉由視野角之亮度變化/色變化較少為其特徵,但可舉出相對比與亮度、應答速度難以提高的弱點。例如於專利文獻1所揭示,在提案初期的IPS-LCD中,不使用視野角之補償薄膜,在如此不使用視野角之補償薄膜的IPS-LCD中,因傾斜角之暗狀態中會產生相對較大漏光,故有著顯示低對比值之缺點。 Since IPS-LCD does not cause the vertical tilt of the liquid crystal molecules, it is characterized by less brightness change/color change due to the viewing angle. However, there are weaknesses that it is difficult to improve the relative contrast, brightness, and response speed. For example, Patent Document 1 discloses that in the IPS-LCD at the initial stage of the proposal, the compensation film for the viewing angle is not used. In the IPS-LCD that does not use the compensation film for the viewing angle, relatively Larger light leakage, so it has the disadvantage of showing low contrast value.

專利文獻2中揭示使用+C板與+A板(正型A板)之IPS-LCD補償薄膜。本文獻中對於該所記載的液晶顯示元件,記載有關以下構成。 Patent Document 2 discloses an IPS-LCD compensation film using +C plate and +A plate (positive type A plate). The liquid crystal display element described in this document describes the following structure.

1)藉由可施加與液晶層面為平行的電場之電極,所供給的兩基板之間夾著具有水平配向之液晶層。 1) With electrodes that can apply an electric field parallel to the liquid crystal layer, a liquid crystal layer with horizontal alignment is sandwiched between the two supplied substrates.

2)一片以上的+A板與+C板被夾於兩偏光板之間。 2) More than one +A plate and +C plate are sandwiched between two polarizing plates.

3)+A板的主光軸為垂直於液晶層之主光軸。 3) The main optical axis of the +A plate is perpendicular to the main optical axis of the liquid crystal layer.

4)液晶層之相位差值RLC、+C板之相位差值R+C、+A板之相位差值R+A取決於滿足以下式子。 4) The liquid crystal layer retardation value R LC, + C plate retardation value of R + C, + A-plate retardation value of R + A satisfy the following expression depends.

RLC:R+C:R+A≒1:0.5:0.25 R LC :R +C :R +A ≒1: 0.5: 0.25

5)對於+A板與+C板之相位差值,並未顯示偏光板之保護薄膜的厚度方向之相位差值的關係(TAC、COP、PNB)。 5) Regarding the retardation value of the +A plate and the +C plate, the relationship of the retardation value (TAC, COP, PNB) in the thickness direction of the protective film of the polarizing plate is not shown.

又,以藉由始在傾斜角之暗狀態的漏光最小化,提供具有在正面及傾斜角之高對比特性、低色偏(Color Shift)的IPS-LCD為目的之具有+A板與+C板之IPS-LCD已被揭示(專利文獻3)。 In addition, it has a +A plate and +C for the purpose of providing an IPS-LCD with high contrast characteristics at the front and tilt angles and low color shift (Color Shift) by minimizing the light leakage in the dark state starting at the oblique angle. The panel IPS-LCD has been disclosed (Patent Document 3).

[先行技術文獻] [Advanced Technical Literature]

[專利文獻] [Patent Literature]

[專利文獻1]日本特開平2-256023號公報 [Patent Document 1] Japanese Patent Application Laid-Open No. 2-256023

[專利文獻2]日本特開平11-133408號公報 [Patent Document 2] Japanese Patent Application Laid-Open No. 11-133408

[專利文獻3]日本特開2009-122715號公報 [Patent Document 3] JP 2009-122715 A

[專利文獻4]日本特開2001-281669號公報 [Patent Document 4] Japanese Patent Application Publication No. 2001-281669

如過去所提案一般,+C板可補償偏光板之視野角較大時的漏光,故可作為IPS-LCD之光學補償薄膜而非常有用。然而,在藉由過去一般已知的延伸處理所進行的方法中,難使垂直配向(正型C板)性表現。 As proposed in the past, the +C plate can compensate for light leakage when the viewing angle of the polarizer is large, so it can be very useful as an optical compensation film for IPS-LCD. However, it is difficult to perform vertical alignment (positive C-plate) performance in the method performed by the generally known stretching process in the past.

又,使用過去所提案的聚醯亞胺之垂直配向膜,必須在膜作成時使用N-甲基-2-吡咯啶酮等聚醯亞胺之溶劑。因此對於玻璃基材而言並未成為問題,但基材為薄膜時,於配向膜形成時對於基材會有賦予損害之問題產生。其上使用聚醯亞胺的垂直配向膜中,在高溫下的燒成成為必要步驟,而有著薄膜基材無法耐高溫之問題。 In addition, to use the polyimide vertically aligned film proposed in the past, it is necessary to use a polyimide solvent such as N-methyl-2-pyrrolidone when forming the film. Therefore, it does not pose a problem for the glass substrate, but when the substrate is a thin film, there is a problem of imparting damage to the substrate when the alignment film is formed. In the vertical alignment film on which polyimide is used, firing at high temperature becomes a necessary step, and there is a problem that the film substrate cannot withstand high temperatures.

且,以具有長鏈烷基之矽烷偶合劑等對基材進行直接處理時,可形成垂直配向膜之方法亦被提案,但在於基材表面不羥基的情況下難以處理,有著基材受到限制的問題(專利文獻4)。 In addition, when the substrate is directly processed with a silane coupling agent with a long-chain alkyl group, a method that can form a vertical alignment film has also been proposed. However, it is difficult to process when the surface of the substrate is not hydroxyl, and the substrate is limited. Problem (Patent Document 4).

又,使用光配向技術製造3D顯示之圖型化相位差材時,過去為在玻璃基板上形成。然而,近年來配合製造成本減低之要求,在TAC(三乙醯纖維素)薄膜、COP(環烯烴聚合物)薄膜等為便宜樹脂薄膜下,要求藉由所謂卷對卷之方式進行生產。 In addition, when using photo-alignment technology to manufacture patterned phase difference materials for 3D display, they used to be formed on a glass substrate. However, in recent years, in response to the demand for reduction in manufacturing costs, TAC (triacetyl cellulose) films, COP (cycloolefin polymer) films, etc., are inexpensive resin films, requiring so-called roll-to-roll production.

然而,在如上述由過去材料所形成的光配向膜中,對樹脂薄膜之密著性較為弱,在樹脂薄膜上難製造 高信賴圖型化相位差材。 However, in the photo-alignment film formed of the past material as described above, the adhesion to the resin film is relatively weak, and it is difficult to manufacture on the resin film. High-reliability patterned phase difference material.

因此,具有優良密著性,且即使在TAC薄膜等樹脂薄膜上亦可形成高信賴之相位差材,可適用於光配向技術之配向材與使用於形成如此配向材之硬化膜形成組成物被期待著。 Therefore, it has excellent adhesion and can form highly reliable retardation materials even on resin films such as TAC films. It can be applied to the alignment materials of optical alignment technology and the cured film forming composition used to form such alignment materials. Look forward to.

本發明係以以上見解或檢討結果為基礎下所得者,該欲解決之課題為具有優良垂直配向性之同時,提供一種欲提供具備光學補償薄膜所要求的透明性或溶劑耐性,即使在樹脂薄膜上亦可在低溫短時間之燒成條件下穩定地將聚合性液晶呈垂直配向的配向材之硬化膜形成組成物。 The present invention is based on the above findings or the results of the review. The problem to be solved is to have excellent vertical alignment while providing a method for providing transparency or solvent resistance required for optical compensation films, even in resin films. The composition can also be formed into a cured film of an alignment material that stably aligns the polymerizable liquid crystal into a vertical alignment under the firing conditions at a low temperature and a short time.

而本發明之另外目的為提供一種自上述硬化膜形成組成物所得之具備優良垂直配向性之同時,具備耐溶劑性,即使在樹脂薄膜上亦可在低溫短時間之燒成條件下穩定地使聚合性液晶呈垂直配向的配向材與使用該配向材所形成之+C板上為有用的相位差材。 Another object of the present invention is to provide a cured film-forming composition obtained from the above-mentioned cured film forming composition, which has excellent vertical alignment and solvent resistance, and can be stably used on a resin film under low-temperature and short-time firing conditions. The alignment material in which the polymerizable liquid crystal is vertically aligned and the +C plate formed by using the alignment material are useful retardation materials.

本發明之其他目的及優點為可由下述記載而得知。 Other objects and advantages of the present invention can be understood from the following description.

本發明者們欲達成上述目的,經過重複詳細檢討之結果,發現藉由選擇將於側鏈具有長鏈烷基之丙烯酸共聚物作為基底之硬化膜形成材料,不管基材之種類亦可形成具有優良垂直配向性之硬化膜,故完成本發明。 In order to achieve the above-mentioned object, the inventors of the present invention, after repeated detailed reviews, found that by selecting an acrylic copolymer having a long-chain alkyl group in the side chain as the base material for the hardened film forming material, it is possible to form a hardened film regardless of the type of substrate A cured film with excellent vertical alignment, thus completing the present invention.

即,作為本發明之第1觀點為關於硬化膜形成組成物; That is, as the first viewpoint of the present invention, it relates to a cured film forming composition;

一種硬化膜形成組成物,其為含有 A cured film forming composition which contains

(A)具有垂直配向性基與可進行熱交聯之官能基的聚合物、 (A) Polymers with vertical alignment groups and functional groups that can be thermally crosslinked,

(B)交聯劑、以及(C)密著促進劑及(D)具有熱交聯性基之聚合物中任一方或雙方者,其特徵為前述垂直配向性基為下述式[1]所示基者。 Either or both of (B) a crosslinking agent, (C) an adhesion promoter, and (D) a polymer having a thermally crosslinkable group, characterized in that the aforementioned vertical alignment group is the following formula [1] The base shown.

Figure 109112027-A0101-12-0005-1
Figure 109112027-A0101-12-0005-1

(式[1]中, (In formula [1],

*表示鍵結位置, * Indicates the position of the bond,

Y1表示單鍵或鍵結基, Y 1 represents a single bond or a bonding group,

Y2表示單鍵、碳原子數1~15的伸烷基或-CH2-CH(OH)-CH2-,或選自苯環、環己烷環或雜環的2價環狀基,前述環狀基上之任意氫原子可由碳原子數1~3的烷基、碳原子數1~3的烷氧基、碳原子數1~3的含氟烷基、碳原子數1~3的含氟烷氧基或氟原子所取代, Y 2 represents a single bond, an alkylene group having 1 to 15 carbon atoms or -CH 2 -CH(OH)-CH 2 -, or a divalent cyclic group selected from a benzene ring, a cyclohexane ring or a heterocyclic ring, Any hydrogen atom on the aforementioned cyclic group can be an alkyl group with 1 to 3 carbon atoms, an alkoxy group with 1 to 3 carbon atoms, a fluorine-containing alkyl group with 1 to 3 carbon atoms, and one with 1 to 3 carbon atoms. Substituted by fluorine-containing alkoxy or fluorine atom,

Y3表示單鍵或碳原子數1~15的伸烷基, Y 3 represents a single bond or an alkylene group with 1 to 15 carbon atoms,

Y4表示單鍵,或選自苯環、環己烷環或雜環的2價環狀基、或碳原子數17~30之具有類固醇骨架之2價有 機基,前述環狀基上之任意氫原子可由碳原子數1~3的烷基、碳原子數1~3的烷氧基、碳原子數1~3的含氟烷基、碳原子數1~3的含氟烷氧基或氟原子所取代, Y 4 represents a single bond, or a divalent cyclic group selected from a benzene ring, a cyclohexane ring or a heterocyclic ring, or a divalent organic group having a steroid skeleton with 17 to 30 carbon atoms, any of the aforementioned cyclic groups The hydrogen atom can be an alkyl group with 1 to 3 carbon atoms, an alkoxy group with 1 to 3 carbon atoms, a fluorinated alkyl group with 1 to 3 carbon atoms, a fluorinated alkoxy group with 1 to 3 carbon atoms, or fluorine. Replaced by atoms,

Y5表示選自苯環、環己烷環或雜環的2價環狀基,這些環狀基上之任意氫原子可由碳原子數1~3的烷基、碳原子數1~3的烷氧基、碳原子數1~3的含氟烷基、碳原子數1~3的含氟烷氧基或氟原子所取代, Y 5 represents a divalent cyclic group selected from a benzene ring, a cyclohexane ring or a heterocyclic ring. Any hydrogen atom on these cyclic groups can be an alkyl group with 1 to 3 carbon atoms and an alkane with 1 to 3 carbon atoms. Substituted by oxy group, fluorine-containing alkyl group with 1 to 3 carbon atoms, fluorine-containing alkoxy group with 1 to 3 carbon atoms or fluorine atom,

n表示0~4的整數,n為2以上時,Y5彼此可相同或相異, n represents an integer from 0 to 4, and when n is 2 or more, Y 5 may be the same or different from each other,

Y6表示氫原子、碳原子數1~18烷基、碳原子數1~18的含氟烷基、碳原子數1~18的烷氧基或碳原子數1~18的含氟烷氧基, Y 6 represents a hydrogen atom, an alkyl group with 1 to 18 carbon atoms, a fluorinated alkyl group with 1 to 18 carbon atoms, an alkoxy group with 1 to 18 carbon atoms or a fluorinated alkoxy group with 1 to 18 carbon atoms ,

作為Y2及Y3的伸烷基、以及作為環狀基上的取代基或Y6的烷基、含氟烷基、烷氧基及含氟烷氧基可為直鏈狀、分支狀、或環狀中任一種或這些組合, The alkylene group as Y 2 and Y 3 , and the alkyl group, fluorine-containing alkyl group, alkoxy group, and fluorine-containing alkoxy group as the substituent on the cyclic group or Y 6 may be linear, branched, Or any one or a combination of these,

又,作為Y2及Y3的伸烷基、以及作為Y6的烷基、含氟烷基、烷氧基及含氟烷氧基中只要鍵結基彼此不相鄰,即可由1至3的鍵結基中斷, In addition, the alkylene group as Y 2 and Y 3 , and the alkyl group, fluorine-containing alkyl group, alkoxy group, and fluorine-containing alkoxy group as Y 6 can be from 1 to 3 as long as the bonding groups are not adjacent to each other. The bond base is interrupted,

且Y2、Y4或Y5表示2價環狀基,或Y4表示具有類固醇骨架之2價有機基,或Y2表示-CH2-CH(OH)-CH2-,或Y2或Y3表示伸烷基,或者Y6表示烷基或含氟烷基時,該2價環狀基、具有該類固醇骨架之2價有機基、該-CH2-CH(OH)-CH2-、該伸烷基、該烷基及該含氟烷基可介著鄰接於此等的基與鍵結基進行鍵結, And Y 2 , Y 4 or Y 5 represents a divalent cyclic group, or Y 4 represents a divalent organic group with a steroid skeleton, or Y 2 represents -CH 2 -CH(OH)-CH 2 -, or Y 2 or When Y 3 represents an alkylene group, or Y 6 represents an alkyl group or a fluorine-containing alkyl group, the divalent cyclic group, the divalent organic group having the steroid skeleton, the -CH 2 -CH(OH)-CH 2- , The alkylene group, the alkyl group and the fluorine-containing alkyl group may be bonded to the bonding group via the adjacent group,

而上述鍵結基表示選自由-O-、-CH2O-、-COO-、-OCO-、-NHCO-、-NH-CO-O-及-NH-CO-NH-所成群的基, The above-mentioned bonding group means a group selected from the group consisting of -O-, -CH 2 O-, -COO-, -OCO-, -NHCO-, -NH-CO-O- and -NH-CO-NH- ,

但,Y2至Y6各所示的碳原子數1~15的伸烷基、苯環、環己烷環、雜環、具有類固醇骨架之2價有機基、-CH2-CH(OH)-CH2-、碳原子數1~18的烷基、碳原子數1~18的含氟烷基、碳原子數1~18的烷氧基及碳原子數1~18的含氟烷氧基之碳原子數的合計為6~30)。 However, each of Y 2 to Y 6 represents an alkylene group having 1 to 15 carbon atoms, a benzene ring, a cyclohexane ring, a heterocyclic ring, a divalent organic group having a steroid skeleton, and -CH 2 -CH(OH) -CH 2 -, C1-C18 alkyl group, C1-C18 fluoroalkyl group, C1-C18 alkoxy group and C1-C18 fluoroalkoxy group The total number of carbon atoms is 6-30).

作為第2觀點係關於第1觀點所記載的硬化膜形成組成物,其中(A)成分的可進行熱交聯之官能基為羥基、羧基、胺基或烷氧基矽基。 The second aspect is the cured film forming composition described in the first aspect, wherein the thermally crosslinkable functional group of the component (A) is a hydroxyl group, a carboxyl group, an amino group, or an alkoxysilyl group.

作為第3觀點係關於第1觀點或第2觀點所記載的硬化膜形成組成物,其中(B)成分的交聯劑為具有羥甲基或烷氧基甲基之交聯劑。 The third aspect is the cured film forming composition described in the first aspect or the second aspect, wherein the crosslinking agent of the component (B) is a crosslinking agent having a methylol group or an alkoxymethyl group.

作為第4觀點係關於第1觀點至第3觀點中任一項所記載的硬化膜形成組成物,其中進一步含有(E)交聯觸媒。 As a fourth viewpoint, the cured film forming composition described in any one of the first viewpoint to the third viewpoint further contains (E) a crosslinking catalyst.

作為第5觀點係關於第1觀點至第4觀點中任一項所記載的硬化膜形成組成物,其中以(A)成分100質量份為基準下,含有1質量份~300質量份之(B)成分。 As a fifth viewpoint, the cured film forming composition described in any one of the first to fourth viewpoints contains 1 part by mass to 300 parts by mass based on 100 parts by mass of the (A) component. )ingredient.

作為第6觀點係關於第1觀點至第5觀點中任一項所記載的硬化膜形成組成物,其中對於(A)成分之聚合物及(B)成分之交聯劑的合計量100質量份而言,含有0.1質量份~100量部之(C)的成分及1質量份~400質量份之(D) 成分中任一方或雙方。 As a sixth viewpoint, the cured film forming composition described in any one of the first to fifth viewpoints, wherein the total amount of the polymer of the component (A) and the crosslinking agent of the component (B) is 100 parts by mass In terms, it contains 0.1 parts by mass to 100 parts of (C) and 1 part by mass to 400 parts by mass of (D) Either or both of the ingredients.

作為第7觀點係關於第4觀點至第6觀點中任一項所記載的硬化膜形成組成物,其中含有0.01質量份~20質量份之(E)成分。 As a seventh viewpoint, the cured film forming composition described in any one of the fourth viewpoint to the sixth viewpoint contains 0.01 parts by mass to 20 parts by mass of the (E) component.

作為第8觀點係關於一種配向材,其特徵為將第1觀點至第7觀點中任一項所記載的硬化膜形成組成物經硬化所得者。 The eighth viewpoint relates to an alignment material characterized by curing the cured film forming composition described in any one of the first to seventh viewpoints.

作為第9觀點係關於相位差材,其特徵為使用自第1觀點至第7觀點中任一項所記載的硬化膜形成組成物所得的硬化膜所形成者。 The ninth viewpoint relates to the retardation material, which is characterized by using a cured film obtained from the cured film forming composition described in any one of the first viewpoint to the seventh viewpoint.

依據本發明之第1態樣係可提供一種欲提供具備優良垂直配向性,即使在樹脂薄膜上亦可在低溫短時間之燒成條件下可穩定地將聚合性液晶呈垂直配向之配向材時的有用硬化膜形成組成物。 According to the first aspect of the present invention, it is possible to provide an alignment material with excellent vertical alignment properties that can stably align polymerizable liquid crystals in vertical alignment even on a resin film under low-temperature and short-time firing conditions. The useful cured film forming composition.

依據本發明之第2態樣係可提供一種具備優良垂直配向性,且在低溫短時間之燒成條件下可穩定地使聚合性液晶呈垂直配向的配向材。 According to the second aspect of the present invention, it is possible to provide an alignment material that has excellent vertical alignment properties and can stably align the polymerizable liquid crystals in a vertical alignment under the firing conditions at a low temperature and a short time.

依據本發明之第3態樣係可提供一種在樹脂薄膜上亦可高效率下形成,高透明且具有高溶劑耐性與基板(亦稱為基材)及液晶薄膜之密著性的相位差材。 According to the third aspect of the present invention, it is possible to provide a retardation material that can be formed on a resin film with high efficiency, is highly transparent and has high solvent resistance and adhesion to the substrate (also called base material) and liquid crystal film .

[實施發明之形態] [The form of implementing the invention]

<硬化膜形成組成物> <Cured film forming composition>

本發明之硬化膜形成組成物含有(A)具有垂直配向性基與可進行熱交聯之官能基的聚合物、(B)交聯劑、以及(C)密著促進劑及(D)具有熱交聯性基之聚合物中任一方或雙方者。本發明之硬化膜形成組成物除上述(A)成分、(B)成分、(C)成分及(D)成分以外,亦可進一步含有作為(E)成分之交聯觸媒。而不損害本發明之效果的範圍下,可含有其他添加劑。 The cured film forming composition of the present invention contains (A) a polymer having a vertical alignment group and a functional group that can be thermally crosslinked, (B) a crosslinking agent, and (C) an adhesion promoter and (D) having Either or both of the thermally crosslinkable polymers. In addition to the above-mentioned (A) component, (B) component, (C) component, and (D) component, the cured film forming composition of the present invention may further contain a crosslinking catalyst as the (E) component. Other additives may be contained within a range that does not impair the effects of the present invention.

以下詳細說明各成分。 Each component is explained in detail below.

<(A)成分> <(A) Ingredient>

於本發明之硬化膜形成組成物所含有的(A)成分為,作為側鏈具有垂直配向性基與可進行熱交聯之官能基(以下亦稱為熱交聯性基)的聚合物。 The (A) component contained in the cured film forming composition of the present invention is a polymer having a vertical alignment group and a thermally crosslinkable functional group (hereinafter also referred to as a thermally crosslinkable group) as a side chain.

本發明之(A)成分的聚合物並無特別限定,較佳為使用丙烯酸酯、甲基丙烯酸酯、苯乙烯、馬來醯亞胺等具有不飽和雙鍵之單體經聚合所得之共聚物。 The polymer of component (A) of the present invention is not particularly limited, but it is preferably a copolymer obtained by polymerizing monomers having unsaturated double bonds such as acrylate, methacrylate, styrene, maleimide, etc. .

即本發明之(A)成分的聚合物為於側鏈含有垂直配向性基與可進行熱交聯之官能基,例如僅為丙烯酸聚合物(以下僅將(A)成分之聚合物稱為特定共聚物),對於構成丙烯酸共聚物之高分子的主鏈之骨架及其他側鏈之種類等並無特別限定。 That is, the polymer of component (A) of the present invention contains a vertical alignment group and a functional group that can be thermally crosslinked in the side chain. For example, it is only an acrylic polymer (hereinafter, only the polymer of component (A) is referred to as specific Copolymer), there are no particular restrictions on the types of the backbone of the main chain and other side chains of the polymer constituting the acrylic copolymer.

(A)成分的聚合物之重量平均分子量以1,000 至200,000為佳,以2,000至150,000為較佳,以3,000至100,000為更佳。重量平均分子量若超過200,000之過大者時,對於溶劑之溶解性會降低使得處理性亦降低之情況產生,若重量平均分子量未達1,000之過小者時,於熱硬化時其硬化會不足而使溶劑耐性及耐熱性降低之情況產生。 (A) The weight average molecular weight of the polymer of the component is 1,000 It is preferably 200,000, more preferably 2,000 to 150,000, and more preferably 3,000 to 100,000. If the weight average molecular weight exceeds 200,000, the solubility to the solvent will decrease and the handling properties will be reduced. If the weight average molecular weight is less than 1,000, the hardening will be insufficient during thermal curing and the solvent will be reduced. The endurance and heat resistance are reduced.

(A)成分的聚合物,即作為於側鏈具有垂直配向性基等特定基的丙烯酸共聚物之合成方法,以後述之將具有垂直配向性基的單體進行聚合之方法、或將具有反應性基之丙烯酸聚合物與具有垂直配向性基之化合物在高分子反應進行鍵結的方法為簡便。 The polymer of component (A) is a method for synthesizing an acrylic copolymer having a specific group such as a vertical alignment group in the side chain. The method of polymerizing a monomer having a vertical alignment group described later, or a reaction The method of bonding the acrylic polymer of the free group and the compound having the vertical alignment group in the polymer reaction is simple.

其中亦以(A)成分之具有垂直配向性基與熱交聯性基之聚合物為藉由具有垂直配向性基之單體與具有熱交聯性基之單體進行共聚合後所得之共聚物,即可簡便地使用具有上述垂直配向性基或熱交聯性基之丙烯酸酯、甲基丙烯酸酯、苯乙烯、馬來醯亞胺等具有不飽和雙鍵之單體經聚合所得之共聚物。 Among them, the polymer having a vertical alignment group and a thermally crosslinkable group of component (A) is a copolymer obtained by copolymerizing a monomer having a vertical alignment group and a monomer having a thermally crosslinkable group. It is easy to use the above-mentioned vertical alignment group or thermally crosslinkable group of acrylate, methacrylate, styrene, maleimide and other monomers with unsaturated double bonds obtained by polymerization. Things.

對於本說明書,所謂垂直配向性基,例如表示含有碳原子數為6~20程度的烴基之基,具體係指後述式[1]所示基。 In this specification, the term "vertical alignment group" means, for example, a group containing a hydrocarbon group having about 6 to 20 carbon atoms, and specifically means a group represented by formula [1] described later.

因此,作為具有垂直配向性基之單體,例如可舉出具有碳原子數6~20程度的烴基之單體。作為碳原子數6~20的烴基,可舉出含有直鏈狀、分支狀或環狀之碳原子數6~20的烷基或芳香族基的碳原子數6~20的烴基。因 此,作為含有碳原子數6~20的烴基之單體的具體例子,其為丙烯酸的烷基酯、甲基丙烯酸的烷基酯、烷基乙烯基醚、2-烷基苯乙烯、3-烷基苯乙烯、4-烷基苯乙烯、N-烷基馬來醯亞胺,該烷基為碳原子數6~20者。 Therefore, as a monomer having a vertical alignment group, for example, a monomer having a hydrocarbon group with about 6 to 20 carbon atoms can be cited. Examples of the hydrocarbon group having 6 to 20 carbon atoms include a hydrocarbon group having 6 to 20 carbon atoms containing a linear, branched, or cyclic alkyl group or aromatic group having 6 to 20 carbon atoms. because Here, as specific examples of monomers containing a hydrocarbon group with 6 to 20 carbon atoms, they are acrylic acid alkyl ester, methacrylic acid alkyl ester, alkyl vinyl ether, 2-alkylstyrene, 3- Alkyl styrene, 4-alkyl styrene, N-alkyl maleimide, and the alkyl group has 6 to 20 carbon atoms.

垂直配向性基較為具體為下述式[1]所示基,即具有垂直配向性基之單體,更具體為含有下述式[1]所示基之丙烯酸酯、甲基丙烯酸酯、苯乙烯、馬來醯亞胺等具有不飽和雙鍵之單體。 The vertical alignment group is more specifically a group represented by the following formula [1], that is, a monomer having a vertical alignment group, and more specifically, an acrylate, methacrylate, benzene containing a group represented by the following formula [1] Monomers with unsaturated double bonds such as ethylene and maleimide.

Figure 109112027-A0101-12-0011-2
Figure 109112027-A0101-12-0011-2

(式中,*表示鍵結位置)。 (In the formula, * represents the bonding position).

式[1]中,Y1表示單鍵或鍵結基。 In formula [1], Y 1 represents a single bond or a bonding group.

式[1]中,Y2表示單鍵、碳原子數1~15的伸烷基或-CH2-CH(OH)-CH2-。 In the formula [1], Y 2 represents a single bond, an alkylene group having 1 to 15 carbon atoms, or -CH 2 -CH(OH)-CH 2 -.

又,作為Y2可舉出選自苯環、環己烷環或雜環的2價環狀基,這些環狀基上之任意氫原子可由碳原子數1~3的烷基、碳原子數1~3的烷氧基、碳原子數1~3的含氟烷基、碳原子數1~3的含氟烷氧基或氟原子所取代。 In addition, Y 2 includes a divalent cyclic group selected from a benzene ring, a cyclohexane ring, or a heterocyclic ring. Any hydrogen atom on these cyclic groups can be an alkyl group with 1 to 3 carbon atoms, and the number of carbon atoms. Substitution with 1 to 3 alkoxy groups, fluorinated alkyl groups with 1 to 3 carbon atoms, fluorinated alkoxy groups with 1 to 3 carbon atoms, or fluorine atoms.

作為上述雜環,可舉出吡咯環、咪唑環、噁唑環、噻唑環、吡唑環、吡啶環、嘧啶環、喹啉環、吡唑啉環、異喹啉環、咔唑環、嘌呤環、噻二唑環、噠嗪環、吡唑啉環、三嗪環、吡唑烷環、三唑環、吡嗪環、苯並咪 唑環、噌啉環、菲咯啉環、吲哚環、喹喔啉環、苯並噻唑環、吩噻嗪環、噁二唑環、吖啶環等,較佳為吡咯環、咪唑環、吡唑環、吡啶環、嘧啶環、吡唑啉環、咔唑環、噠嗪環、吡唑啉環、三嗪環、吡唑烷環、三唑環、吡嗪環、苯並咪唑環。 Examples of the heterocyclic ring include pyrrole ring, imidazole ring, oxazole ring, thiazole ring, pyrazole ring, pyridine ring, pyrimidine ring, quinoline ring, pyrazoline ring, isoquinoline ring, carbazole ring, and purine Ring, thiadiazole ring, pyridazine ring, pyrazoline ring, triazine ring, pyrazolidine ring, triazole ring, pyrazine ring, benzimid Azole ring, cinnoline ring, phenanthroline ring, indole ring, quinoxaline ring, benzothiazole ring, phenothiazine ring, oxadiazole ring, acridine ring, etc., preferably pyrrole ring, imidazole ring, Pyrazole ring, pyridine ring, pyrimidine ring, pyrazoline ring, carbazole ring, pyridazine ring, pyrazoline ring, triazine ring, pyrazolidine ring, triazole ring, pyrazine ring, benzimidazole ring.

作為上述取代基所舉出的烷基,可舉出甲基、乙基、n-丙基、異丙基、環丙基,作為上述烷氧基可舉出前述烷基作為具體例子所舉出的基上鍵結氧原子-O-之基。又作為上述含氟烷基、含氟烷氧基,可舉出前述烷基及烷氧基中任意氫原子由氟原子所取代的基。 The alkyl group mentioned as the above-mentioned substituent includes methyl, ethyl, n-propyl, isopropyl, and cyclopropyl. As the above-mentioned alkoxy group, the aforementioned alkyl group can be mentioned as specific examples. The oxygen atom -O- is bonded to the group. As the above-mentioned fluorine-containing alkyl group and fluorine-containing alkoxy group, any hydrogen atom in the aforementioned alkyl group and alkoxy group is substituted with a fluorine atom.

彼等中,由合成之容易度的觀點來看,Y2以苯環或環己烷環為佳。 Among them, from the viewpoint of ease of synthesis, Y 2 is preferably a benzene ring or a cyclohexane ring.

上述式[1]中,Y3表示單鍵或碳原子數1~15的伸烷基。 In the above formula [1], Y 3 represents a single bond or an alkylene group having 1 to 15 carbon atoms.

上述式[1]中,Y4表示單鍵,或表示選自苯環、環己烷環或雜環的2價環狀基,這些環狀基上之任意氫原子可由碳原子數1~3的烷基、碳原子數1~3的烷氧基、碳原子數1~3的含氟烷基、碳原子數1~3的含氟烷氧基或氟原子所取代。 In the above formula [1], Y 4 represents a single bond, or represents a divalent cyclic group selected from a benzene ring, a cyclohexane ring or a heterocyclic ring, and any hydrogen atom on these cyclic groups can be carbon atoms of 1 to 3 Is substituted with an alkyl group having 1 to 3 carbon atoms, a fluorinated alkyl group having 1 to 3 carbon atoms, a fluorinated alkoxy group having 1 to 3 carbon atoms, or a fluorine atom.

作為上述雜環以及作為取代基所舉出的烷基等可舉出前述Y2所舉者。 Examples of the above-mentioned heterocyclic ring and the alkyl group as the substituent include those listed for Y 2 described above.

且,作為Y4,可為選自碳原子數17~30且具有類固醇骨架之有機基的2價有機基。該較佳例為具有自選自膽固醇、雄固醇、β-膽固醇、表雄固醇、麥角固醇、 Estoril、11α-羥基甲基固醇、11α-黃體固醇、羊毛甾醇、Meratoranyl、甲基睪丸固醇、炔諾固醇、孕烯固醇、β-谷固醇、豆甾固醇、睪丸固醇、及乙酸膽固醇酯等的結構取出2個氫原子的結構之2價基。更具體,例如下述所示。 In addition, Y 4 may be a divalent organic group selected from organic groups having 17 to 30 carbon atoms and having a steroid skeleton. The preferred example is one having selected from cholesterol, androsterol, β-cholesterol, epiandrosterol, ergosterol, Estoril, 11α-hydroxymethyl sterol, 11α-progesterol, lanosterol, Meratoranyl, methyl ester The structure of testosterol, norethisterol, pregnasterol, β-sitosterol, stigmasterol, testosterol, and cholesteryl acetate is a divalent group in which two hydrogen atoms are taken out. More specifically, for example, it is as follows.

Figure 109112027-A0101-12-0013-3
Figure 109112027-A0101-12-0013-3

(式中,*表示與Y3及Y5(或Y6)之鍵結位置)。 (In the formula, * represents the bonding position with Y 3 and Y 5 (or Y 6 )).

彼等中,由合成容易度的觀點來看,Y4以苯環、環己烷環或碳原子數17~30之具有類固醇骨架的2價有機基者為佳。 Among them, from the viewpoint of ease of synthesis, Y 4 is preferably a benzene ring, a cyclohexane ring, or a divalent organic group having a steroid skeleton with 17 to 30 carbon atoms.

式[1]中,Y5表示選自苯環、環己烷環或雜環的2價環狀基,這些環狀基上之任意氫原子可由碳原子數1~3的烷基、碳原子數1~3的烷氧基、碳原子數1~3的含氟烷基、碳原子數1~3的含氟烷氧基或氟原子所取代。作為上述雜環以及取代基所舉出的烷基等可為前述的Y4中所舉出者。 In formula [1], Y 5 represents a divalent cyclic group selected from a benzene ring, a cyclohexane ring or a heterocyclic ring. Any hydrogen atom on these cyclic groups can be an alkyl group with 1 to 3 carbon atoms or carbon atoms It is substituted with alkoxy groups having 1 to 3, fluorinated alkyl groups having 1 to 3 carbon atoms, fluorinated alkoxy groups having 1 to 3 carbon atoms, or fluorine atoms. The alkyl group and the like exemplified as the heterocyclic ring and the substituent may be those exemplified in Y 4 described above.

這些之中,Y5以苯環或環己烷環為佳。 Among these, Y 5 is preferably a benzene ring or a cyclohexane ring.

又,式[1]中,n表示0~4的整數,n表示2以上時,Y5彼此可為相同基或相異基。其中亦由原料之獲得性或合成容易度之觀點來看,n以0~3為佳。較佳為0~2。 In addition, in formula [1], n represents an integer of 0 to 4, and when n represents 2 or more, Y 5 may be the same group or different groups. Among them, from the viewpoint of availability of raw materials or ease of synthesis, n is preferably 0~3. Preferably it is 0~2.

式[1]中,Y6表示氫原子、碳原子數1~18的烷基、碳原子數1~18的含氟烷基、碳原子數1~18的烷氧基或碳原子數1~18的含氟烷氧基。 In formula [1], Y 6 represents a hydrogen atom, an alkyl group having 1 to 18 carbon atoms, a fluorinated alkyl group having 1 to 18 carbon atoms, an alkoxy group having 1 to 18 carbon atoms, or a carbon number of 1~ 18 fluorine-containing alkoxy group.

其中Y6亦以碳原子數1~18的烷基、碳原子數1~10的含氟烷基、碳原子數1~18的烷氧基或碳原子數1~10的含氟烷氧基者為佳。較佳為Y6為碳原子數1~12的烷基或碳原子數1~12的烷氧基。特佳為Y6為碳原子數1~9的烷基或碳原子數1~9的烷氧基。 Among them, Y 6 is also an alkyl group with 1 to 18 carbon atoms, a fluorinated alkyl group with 1 to 10 carbon atoms, an alkoxy group with 1 to 18 carbon atoms or a fluorinated alkoxy group with 1 to 10 carbon atoms. The one is better. Preferably, Y 6 is an alkyl group having 1 to 12 carbon atoms or an alkoxy group having 1 to 12 carbon atoms. It is particularly preferable that Y 6 is an alkyl group having 1 to 9 carbon atoms or an alkoxy group having 1 to 9 carbon atoms.

且,Y4為具有類固醇骨架之2價有機基時,Y6以氫原子為佳。 In addition, when Y 4 is a divalent organic group having a steroid skeleton, Y 6 is preferably a hydrogen atom.

上述式[1]中之定義中所舉出的伸烷基、烷基、含氟烷基、烷氧基或含氟烷氧基可為直鏈狀、分支狀、或環狀中任一種或亦可為這些組合。 The alkylene group, alkyl group, fluorine-containing alkyl group, alkoxy group or fluorine-containing alkoxy group mentioned in the definition in the above formula [1] may be any of linear, branched, or cyclic, or It can also be a combination of these.

例如上述烷基,例如可舉出甲基、乙基、n-丙基、異丙基、n-丁基、異丁基、sec-丁基、tert-丁基、n-戊基、1-甲基-n-丁基、2-甲基-n-丁基、3-甲基-n-丁基、1,1-二甲基-n-丙基、1,2-二甲基-n-丙基、2,2-二甲基-n-丙基、1-乙基-n-丙基、n-己基、1-甲基-n-戊基、2-甲基-n-戊基、3-甲基-n-戊基、4-甲基-n-戊基、1,1-二甲基-n-丁基、1,2-二甲基-n-丁基、1,3-二甲基-n-丁基、2,2-二甲基-n-丁基、2,3-二甲基-n-丁基、3,3-二甲基-n-丁基、1-乙基-n-丁基、2-乙基-n-丁基、1,1,2-三甲基-n-丙基、1,2,2-三甲基-n-丙基、1-乙基-1-甲基-n-丙基、1-乙基-2-甲基-n-丙基、n-庚基、1-甲基-n-己基、2-甲基-n-己基、3-甲基-n-己基、1,1-二甲基-n-戊基、1,2-二甲基-n-戊基、1,3-二甲基-n-戊基、2,2-二甲基-n-戊基、2,3-二甲基-n-戊基、3,3-二甲基-n-戊基、1-乙基-n-戊基、2-乙基-n-戊基、3-乙基-n-戊基、1-甲基-1-乙基-n-丁基、1-甲基-2-乙基-n-丁基、1-乙基-2-甲基-n-丁基、2-甲基-2-乙基-n-丁基、2-乙基-3-甲基-n-丁基、n-辛基、1-甲基-n-庚基、2-甲基-n-庚基、3-甲基-n-庚基、1,1-二甲基-n-己基、1,2-二甲基-n-己基、1,3-二甲基-n-己基、2,2-二甲基-n-己基、2,3-二甲基-n-己基、3,3-二甲基-n-己基、1-乙基-n-己基、2-乙基-n-己基、3-乙基-n-己基、1-甲基-1-乙基-n-戊基、1-甲基-2-乙基-n-戊基、1-甲基-3-乙基-n-戊基、2-甲基-2-乙基-n-戊基、2-甲基-3-乙基-n-戊基、3-甲基-3-乙基-n-戊基、n-壬基、n-癸基、n-十一烷基、n-十二烷基、n-十三烷基、n-十四烷基、n-十五 烷基等。 For example, the above-mentioned alkyl groups include, for example, methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, sec-butyl, tert-butyl, n-pentyl, 1- Methyl-n-butyl, 2-methyl-n-butyl, 3-methyl-n-butyl, 1,1-dimethyl-n-propyl, 1,2-dimethyl-n -Propyl, 2,2-Dimethyl-n-propyl, 1-ethyl-n-propyl, n-hexyl, 1-methyl-n-pentyl, 2-methyl-n-pentyl , 3-methyl-n-pentyl, 4-methyl-n-pentyl, 1,1-dimethyl-n-butyl, 1,2-dimethyl-n-butyl, 1,3 -Dimethyl-n-butyl, 2,2-dimethyl-n-butyl, 2,3-dimethyl-n-butyl, 3,3-dimethyl-n-butyl, 1 -Ethyl-n-butyl, 2-ethyl-n-butyl, 1,1,2-trimethyl-n-propyl, 1,2,2-trimethyl-n-propyl, 1 -Ethyl-1-methyl-n-propyl, 1-ethyl-2-methyl-n-propyl, n-heptyl, 1-methyl-n-hexyl, 2-methyl-n- Hexyl, 3-methyl-n-hexyl, 1,1-dimethyl-n-pentyl, 1,2-dimethyl-n-pentyl, 1,3-dimethyl-n-pentyl, 2,2-Dimethyl-n-pentyl, 2,3-dimethyl-n-pentyl, 3,3-dimethyl-n-pentyl, 1-ethyl-n-pentyl, 2 -Ethyl-n-pentyl, 3-ethyl-n-pentyl, 1-methyl-1-ethyl-n-butyl, 1-methyl-2-ethyl-n-butyl, 1 -Ethyl-2-methyl-n-butyl, 2-methyl-2-ethyl-n-butyl, 2-ethyl-3-methyl-n-butyl, n-octyl, 1 -Methyl-n-heptyl, 2-methyl-n-heptyl, 3-methyl-n-heptyl, 1,1-dimethyl-n-hexyl, 1,2-dimethyl-n -Hexyl, 1,3-dimethyl-n-hexyl, 2,2-dimethyl-n-hexyl, 2,3-dimethyl-n-hexyl, 3,3-dimethyl-n-hexyl , 1-ethyl-n-hexyl, 2-ethyl-n-hexyl, 3-ethyl-n-hexyl, 1-methyl-1-ethyl-n-pentyl, 1-methyl-2- Ethyl-n-pentyl, 1-methyl-3-ethyl-n-pentyl, 2-methyl-2-ethyl-n-pentyl, 2-methyl-3-ethyl-n- Pentyl, 3-methyl-3-ethyl-n-pentyl, n-nonyl, n-decyl, n-undecyl, n-dodecyl, n-tridecyl, n -Tetradecyl group, n-fiveteen Alkyl and so on.

作為上述伸烷基,可舉出自前述烷基除去1個任意氫原子的二價基。 As said alkylene group, the divalent group which removed one arbitrary hydrogen atom from the said alkyl group is mentioned.

作為上述烷氧基,可舉出作為前述烷基之具體例子所舉出的基上鍵結氧原子-O-之基。 Examples of the above-mentioned alkoxy group include a group in which an oxygen atom -O- is bonded to the group mentioned as a specific example of the aforementioned alkyl group.

又,作為上述含氟烷基、含氟烷氧基,可舉出前述烷基及烷氧基中之任意氫原子可由氟原子所取代的基。 In addition, as the above-mentioned fluorine-containing alkyl group and fluorine-containing alkoxy group, any hydrogen atom in the aforementioned alkyl group and alkoxy group may be substituted with a fluorine atom.

作為上述Y2及Y3的伸烷基,以及作為環狀基上之取代基或Y6的烷基、含氟烷基、烷氧基及含氟烷氧基可為直鏈狀、分支狀、或環狀中任一種或這些組合。 As the above-mentioned Y 2 and Y 3 alkylene, the group as well as cyclic alkyl substituent or Y 6, fluorine-containing alkyl, alkoxy and fluorine-containing group may be linear, branched , Or any one of cyclic or a combination of these.

又,作為Y2及Y3的伸烷基、以及作為Y6的烷基、含氟烷基、烷氧基及含氟烷氧基只要鍵結基彼此不相鄰,即可由1至3的鍵結基中斷。 In addition, the alkylene group as Y 2 and Y 3 , and the alkyl group, fluorine-containing alkyl group, alkoxy group, and fluorine-containing alkoxy group as Y 6 can be from 1 to 3 as long as the bonding groups are not adjacent to each other. The bond base is interrupted.

且Y2、Y4或Y5表示2價環狀基、Y4表示具有類固醇骨架之2價有機基、Y2表示-CH2-CH(OH)-CH2-、Y2或Y3表示伸烷基、或者Y6表示烷基或含氟烷基時,該2價環狀基、具有該類固醇骨架之2價有機基、該-CH2-CH(OH)-CH2-、該伸烷基、該烷基及該含氟烷基可介著彼此所鄰接的基與鍵結基進行鍵結。 And Y 2 , Y 4 or Y 5 represents a divalent cyclic group, Y 4 represents a divalent organic group with a steroid skeleton, Y 2 represents -CH 2 -CH(OH)-CH 2 -, Y 2 or Y 3 represents When an alkylene group or Y 6 represents an alkyl group or a fluorine-containing alkyl group, the divalent cyclic group, the divalent organic group having the steroid skeleton, the -CH 2 -CH(OH)-CH 2 -, the The alkyl group, the alkyl group, and the fluorine-containing alkyl group may be bonded via a group adjacent to each other and a bonding group.

又,上述鍵結基表示選自由-O-、-CH2O-、-COO-、-OCO-、-NHCO-、-NH-CO-O-及-NH-CO-NH-所成群之基。 In addition, the above-mentioned bonding group means selected from the group consisting of -O-, -CH 2 O-, -COO-, -OCO-, -NHCO-, -NH-CO-O- and -NH-CO-NH- base.

且,Y2至Y6各所表示之碳原子數1~15的伸烷基、苯環、環己烷環、雜環、具有類固醇骨架之2價有 機基、-CH2-CH(OH)-CH2-、碳原子數1~18的烷基、碳原子數1~18的含氟烷基、碳原子數1~18的烷氧基及碳原子數1~18的含氟烷氧基之碳原子數合計為6~30,例如為6~20。 In addition, each of Y 2 to Y 6 represents an alkylene group having 1 to 15 carbon atoms, a benzene ring, a cyclohexane ring, a heterocyclic ring, a divalent organic group having a steroid skeleton, and -CH 2 -CH(OH)- CH 2 -, an alkyl group with 1 to 18 carbon atoms, a fluorinated alkyl group with 1 to 18 carbon atoms, an alkoxy group with 1 to 18 carbon atoms, and a fluorinated alkoxy group with 1 to 18 carbon atoms The total number of carbon atoms is 6-30, for example, 6-20.

彼等中,若考慮到垂直配向性與聚合性液晶之塗佈性時,垂直配向性基以含有碳原子數7~18,特別為含有8~15的烷基之基為佳。 Among them, when considering the vertical alignment properties and the coating properties of the polymerizable liquid crystal, the vertical alignment groups preferably contain 7-18 carbon atoms, especially those containing 8-15 alkyl groups.

作為較佳垂直配向性基,例如可舉出碳原子數6~20程度的烴基。作為碳原子數6~20的烴基,可舉出直鏈狀、分支狀或環狀之含有碳原子數6~20的烷基或芳香族基的碳原子數6~20的烴基。 As a preferable vertical alignment group, for example, a hydrocarbon group having about 6 to 20 carbon atoms is mentioned. Examples of the hydrocarbon group having 6 to 20 carbon atoms include linear, branched or cyclic hydrocarbon groups containing 6 to 20 carbon atoms or aromatic groups having 6 to 20 carbon atoms.

作為垂直配向性基,例如上述Y1至Y4為單鍵,Y3為單鍵或碳原子數1~15的伸烷基,n為0,Y6為碳原子數1~18的烷基之基可舉出,其中亦以式[1]所示基為碳原子數合計為6~20之烷基的垂直配向性基(a-1)為佳。作為如此烷基之具體例子,前述烷基之中,可舉出碳原子數之合計為6~20之烷基。 As the vertical alignment group, for example, the aforementioned Y 1 to Y 4 are single bonds, Y 3 is a single bond or an alkylene group having 1 to 15 carbon atoms, n is 0, and Y 6 is an alkyl group having 1 to 18 carbon atoms. Examples of the group include a vertical alignment group (a-1) in which the group represented by the formula [1] is an alkyl group with a total of 6 to 20 carbon atoms. As a specific example of such an alkyl group, among the aforementioned alkyl groups, an alkyl group having 6 to 20 carbon atoms in total can be mentioned.

作為垂直配向性基,上述以外,例如以上述Y1至Y4為單鍵,n為2至3,Y5為選自苯環及環己烷環的基,Y6為碳原子數1~18的烷基之垂直配向性基(a-2)為佳。作為如此基(a-2),以下述(a-2-1)~(a-2-6)等為佳。 As the vertical alignment group, in addition to the above, for example, the above Y 1 to Y 4 are single bonds, n is 2 to 3, Y 5 is a group selected from a benzene ring and a cyclohexane ring, and Y 6 is a carbon number of 1 to The vertical alignment group (a-2) of the alkyl group of 18 is preferable. As such a group (a-2), the following (a-2-1) to (a-2-6), etc. are preferable.

Figure 109112027-A0101-12-0017-4
Figure 109112027-A0101-12-0017-4

(式中,Y6為碳原子數1~18的烷基。又*表示鍵結位置)。 (In the formula, Y 6 is an alkyl group having 1 to 18 carbon atoms. Also * represents the bonding position).

作為垂直配向性基,上述以外,例如以上述Y1至Y3為單鍵,Y4為類固醇骨架,n為0,Y6為氫原子之垂直配向性基(a-3)為佳。作為如此基(a-3),例如可舉出下述式所示垂直配向性基(a-3-1)~(a-3-8)。 As the vertical alignment group, in addition to the above, for example, the above Y 1 to Y 3 are single bonds, Y 4 is a steroid skeleton, n is 0, and Y 6 is a vertical alignment group (a-3) of a hydrogen atom. Examples of such groups (a-3) include vertical alignment groups (a-3-1) to (a-3-8) represented by the following formulae.

Figure 109112027-A0101-12-0018-5
Figure 109112027-A0101-12-0018-5

(式中,*表示鍵結位置)。 (In the formula, * represents the bonding position).

作為熱交聯性基,可舉出羥基、羧基、胺 基、封閉型異氰酸酯基、乙烯基、烯丙基、丙烯酸基、甲基丙烯酸基、烷氧基矽基。在低溫短時間下可形成熱硬化膜之觀點來看,作為較佳熱交聯性基有羥基、羧基、胺基、烷氧基矽基。 Examples of thermally crosslinkable groups include hydroxyl, carboxyl, and amine Groups, blocked isocyanate groups, vinyl groups, allyl groups, acrylic groups, methacrylic groups, alkoxysilyl groups. From the viewpoint that a thermally cured film can be formed at a low temperature in a short time, the preferred thermally crosslinkable group includes a hydroxyl group, a carboxyl group, an amino group, and an alkoxysilyl group.

作為熱交聯性基之具有上述羥基、羧基、胺基、烷氧基矽基的單體,例如可舉出2-羥基乙基丙烯酸酯、2-羥基乙基甲基丙烯酸酯、2-羥基丙基丙烯酸酯、2-羥基丙基甲基丙烯酸酯、4-羥基丁基丙烯酸酯、4-羥基丁基甲基丙烯酸酯、2,3-二羥基丙基丙烯酸酯、2,3-二羥基丙基甲基丙烯酸酯、二乙二醇單丙烯酸酯、二乙二醇單甲基丙烯酸酯、己內酯2-(丙烯醯氧基)乙基酯、己內酯2-(甲基丙烯醯氧)乙基酯、聚(乙二醇)乙基醚丙烯酸酯、聚(乙二醇)乙基醚甲基丙烯酸酯、5-丙烯醯氧基-6-羥基降冰片烯-2-羧酸-6-內酯及5-甲基丙烯醯氧-6-羥基降冰片烯-2-羧酸-6-內酯等具有羥基之單體;丙烯酸、甲基丙烯酸、巴豆酸、單-(2-(丙烯醯氧基)乙基)鄰苯二甲酸酯、單-(2-(甲基丙烯醯氧)乙基)鄰苯二甲酸酯、N-(羧基苯基)馬來醯亞胺、N-(羧基苯基)丙烯醯基及N-(羧基苯基)甲基丙烯醯基等具有羧基之單體;羥基苯乙烯、N-(羥基苯基)丙烯醯基、N-(羥基苯基)甲基丙烯醯基及N-(羥基苯基)馬來醯亞胺等具有酚性羥基之單體;胺基乙基丙烯酸酯、胺基乙基甲基丙烯酸酯、胺基丙基丙烯酸酯及胺基丙基甲基丙烯酸酯等具有胺基之單體;以及丙烯醯氧基丙基三甲氧基矽烷、甲基丙烯醯氧丙基三甲氧基矽烷、丙烯醯氧基丙基三 乙氧基矽烷及甲基丙烯醯氧丙基三乙氧基矽烷等具有烷氧基矽基之單體等。 Examples of monomers having the above-mentioned hydroxyl, carboxyl, amino, and alkoxysilyl groups as thermally crosslinkable groups include 2-hydroxyethyl acrylate, 2-hydroxyethyl methacrylate, and 2-hydroxy Propyl acrylate, 2-hydroxypropyl methacrylate, 4-hydroxybutyl acrylate, 4-hydroxybutyl methacrylate, 2,3-dihydroxypropyl acrylate, 2,3-dihydroxypropyl Methacrylate, diethylene glycol monoacrylate, diethylene glycol monomethacrylate, caprolactone 2-(acryloxy) ethyl ester, caprolactone 2-(methacryloxy) Ethyl ester, poly(ethylene glycol) ethyl ether acrylate, poly(ethylene glycol) ethyl ether methacrylate, 5-propenoxy-6-hydroxynorbornene-2-carboxylic acid-6 -Lactone and 5-methacryloyloxy-6-hydroxynorbornene-2-carboxylic acid-6-lactone and other monomers having hydroxyl groups; acrylic acid, methacrylic acid, crotonic acid, mono-(2-( Acrylonyloxy)ethyl)phthalate, mono-(2-(methacryloxy)ethyl)phthalate, N-(carboxyphenyl)maleimide, Monomers with carboxyl groups such as N-(carboxyphenyl)acryloyl and N-(carboxyphenyl)methacryloyl; hydroxystyrene, N-(hydroxyphenyl)acryloyl, N-(hydroxybenzene) Monomers with phenolic hydroxyl groups such as methacrylic acid group and N-(hydroxyphenyl) maleimide; amino ethyl acrylate, amino ethyl methacrylate, amino propyl acrylic acid Ester and aminopropyl methacrylate and other monomers with amine groups; and acryloxypropyl trimethoxysilane, methacryloxypropyl trimethoxysilane, acryloxypropyl trimethoxysilane Monomers with alkoxysilyl groups such as ethoxysilane and methacryloxypropyl triethoxysilane.

又,不損害本發明之效果的範圍下,於本發明中在得到含有垂直配向性基與熱交聯性基之丙烯酸聚合物(特定共聚物)時,具有上述垂直配向性基之單體、以及熱交聯性基(較佳為選自羥基、羧基、胺基、烷氧基矽基的至少一個取代基)的單體以外,可併用可與這些單體進行共聚合的不具有上述特定官能基(垂直配向性基及熱交聯性基)之其他單體。 In addition, within the range that does not impair the effect of the present invention, when obtaining an acrylic polymer (specific copolymer) containing a vertical alignment group and a thermally crosslinkable group in the present invention, the monomer having the above vertical alignment group, In addition to monomers with thermally crosslinkable groups (preferably at least one substituent selected from hydroxyl, carboxyl, amine, and alkoxysilyl groups), those that can be copolymerized with these monomers that do not have the above-mentioned specific Other monomers for functional groups (vertical alignment groups and thermally crosslinkable groups).

作為如此其他單體之具體例子,可舉出丙烯酸酯化合物、甲基丙烯酸酯化合物、馬來醯亞胺化合物、丙烯醯基化合物、丙烯腈、馬來酸酐、苯乙烯化合物及乙烯基化合物等。 Specific examples of such other monomers include acrylate compounds, methacrylate compounds, maleimide compounds, acryl-based compounds, acrylonitrile, maleic anhydride, styrene compounds, and vinyl compounds.

以下可舉出其他的單體之具體例子,但並未限定於此等。 Specific examples of other monomers can be given below, but they are not limited to these.

作為前述丙烯酸酯化合物,例如可舉出甲基丙烯酸酯、乙基丙烯酸酯、異丙基丙烯酸酯、苯甲基丙烯酸酯、萘丙烯酸酯、蒽基丙烯酸酯、蒽基甲基丙烯酸酯、苯基丙烯酸酯、縮水甘油基丙烯酸酯、2,2,2-三氟乙基丙烯酸酯、tert-丁基丙烯酸酯、環己基丙烯酸酯、異冰片基丙烯酸酯、2-甲氧基乙基丙烯酸酯、甲氧基三乙二醇丙烯酸酯、2-乙氧基乙基丙烯酸酯、四氫糠基丙烯酸酯、3-甲氧基丁基丙烯酸酯等。 Examples of the acrylate compound include methacrylate, ethacrylate, isopropyl acrylate, benzyl methacrylate, naphthalene acrylate, anthracenyl acrylate, anthryl methacrylate, and phenyl methacrylate. Acrylate, glycidyl acrylate, 2,2,2-trifluoroethyl acrylate, tert-butyl acrylate, cyclohexyl acrylate, isobornyl acrylate, 2-methoxyethyl acrylate, Methoxytriethylene glycol acrylate, 2-ethoxyethyl acrylate, tetrahydrofurfuryl acrylate, 3-methoxybutyl acrylate, etc.

作為前述甲基丙烯酸酯化合物,例如可舉出 甲基甲基丙烯酸酯、乙基甲基丙烯酸酯、異丙基甲基丙烯酸酯、苯甲基甲基丙烯酸酯、萘甲基丙烯酸酯、蒽基甲基丙烯酸酯、蒽基甲基甲基丙烯酸酯、苯基甲基丙烯酸酯、縮水甘油基甲基丙烯酸酯、2,2,2-三氟乙基甲基丙烯酸酯、tert-丁基甲基丙烯酸酯、環己基甲基丙烯酸酯、異冰片基甲基丙烯酸酯、2-甲氧基乙基甲基丙烯酸酯、甲氧基三乙二醇甲基丙烯酸酯、2-乙氧基乙基甲基丙烯酸酯、四氫糠基甲基丙烯酸酯、3-甲氧基丁基甲基丙烯酸酯、γ-丁內酯甲基丙烯酸酯等。 As the aforementioned methacrylate compound, for example, Methmethacrylate, Ethyl Methacrylate, Isopropyl Methacrylate, Benzyl Methacrylate, Naphthalene Methacrylate, Anthryl Methacrylate, Anthryl Methacrylate Ester, phenyl methacrylate, glycidyl methacrylate, 2,2,2-trifluoroethyl methacrylate, tert-butyl methacrylate, cyclohexyl methacrylate, isobornyl methylacrylate Methyl acrylate, 2-methoxyethyl methacrylate, methoxytriethylene glycol methacrylate, 2-ethoxyethyl methacrylate, tetrahydrofurfuryl methacrylate, 3 -Methoxybutyl methacrylate, γ-butyrolactone methacrylate, etc.

作為前述馬來醯亞胺化合物,例如可舉出馬來醯亞胺、N-甲基馬來醯亞胺、N-乙基馬來醯亞胺等。 As said maleimide compound, maleimide, N-methylmaleimide, N-ethylmaleimide, etc. are mentioned, for example.

作為前述苯乙烯化合物,例如可舉出苯乙烯、甲基苯乙烯、氯苯乙烯、溴苯乙烯等。 As said styrene compound, styrene, methylstyrene, chlorostyrene, bromostyrene, etc. are mentioned, for example.

作為前述乙烯基化合物,例如可舉出甲基乙烯基醚、苯甲基乙烯基醚、乙烯基萘、乙烯基咔唑、烯丙基縮水甘油基醚、3-乙烯基-7-六聯環[4.1.0]庚烷、1,2-環氧基-5-己烯及1,7-辛二烯單環氧化物等。 Examples of the aforementioned vinyl compound include methyl vinyl ether, benzyl vinyl ether, vinyl naphthalene, vinyl carbazole, allyl glycidyl ether, and 3-vinyl-7-hexaring. [4.1.0] Heptane, 1,2-epoxy-5-hexene and 1,7-octadiene monoepoxide, etc.

如前述所示,作為(A)成分之聚合物,即特定共聚物(具有垂直配向性基與熱交聯性基之丙烯酸共聚物)之合成方法,選自具有垂直配向性基之單體的至少一種單體與選自具有熱交聯性基之單體的至少一種單體依所需與其他單體進行共聚合之方法為簡便。 As shown above, the polymer as the component (A), that is, a specific copolymer (acrylic copolymer with a vertical alignment group and a thermally crosslinkable group) is selected from monomers with a vertical alignment group. The method of copolymerizing at least one monomer and at least one monomer selected from monomers having a thermally crosslinkable group with other monomers as required is simple.

欲得到特定共聚物所使用的各單體之使用量,以全單體合計量為基準下,具有3至90莫耳%之垂 直配向性基的單體、具有3至90莫耳%之熱交聯性基(羥基、羧基、胺基、烷氧基矽基)的單體、不具有0至94莫耳%之上述特定官能基的其他單體(但,這些單體之合計為100莫耳%)為佳。 The usage amount of each monomer used to obtain a specific copolymer, based on the total amount of all monomers, has a sag of 3 to 90 mol% Monomers with straight alignment groups, monomers with 3 to 90 mol% of thermally crosslinkable groups (hydroxyl, carboxyl, amine, alkoxysilyl), without 0 to 94 mol% of the above specific Other monomers of functional groups (however, the total of these monomers is 100 mol%) is preferable.

具有垂直配向性基之單體的含有量若比3莫耳%少時,難賦予良好垂直液晶配向性。具有垂直配向性基之單體的含有量比90莫耳%多時,聚合性液晶之塗佈性會惡化,難形成均勻相位差薄膜。 If the content of the monomer having a vertical alignment group is less than 3 mol%, it is difficult to impart good vertical liquid crystal alignment. When the content of the monomer having a vertical alignment group is more than 90 mol%, the coatability of the polymerizable liquid crystal will deteriorate and it is difficult to form a uniform retardation film.

又,具有熱交聯性基(較佳為選自羥基、羧基、胺基及烷氧基矽基的至少一種取代基)之單體的含有量若比3莫耳%少時,難賦予充分熱硬化性,難維持良好垂直液晶配向性。 In addition, if the content of the monomer having a thermally crosslinkable group (preferably at least one substituent selected from a hydroxyl group, a carboxyl group, an amino group, and an alkoxysilyl group) is less than 3 mol%, it is difficult to provide sufficient It is difficult to maintain good vertical liquid crystal alignment due to thermosetting properties.

欲得到使用於本發明之特定共聚物的方法並無特別限定,例如將具有垂直配向性基之單體與具有熱交聯性基之單體,而配合所需將不具有上述特定官能基之單體於與聚合起始劑等共存之溶劑中,在50至110℃之溫度下進行聚合反應而得到。此時,所使用的溶劑僅可溶解具有垂直配向性基之單體與具有熱交聯性基之單體、而配合需要所使用的不具有上述特定官能基之單體、及聚合起始劑等者即可並無特別限定。作為其具體例子,可使用後述<溶劑>中所列舉者。 The method for obtaining the specific copolymer used in the present invention is not particularly limited. For example, a monomer having a vertical alignment group and a monomer having a thermally crosslinkable group are combined, and the combination required will not have the above specific functional group. The monomer is obtained by polymerizing the monomer in a solvent coexisting with a polymerization initiator and the like at a temperature of 50 to 110°C. At this time, the solvent used can only dissolve monomers with vertical alignment groups and monomers with thermally crosslinkable groups, and the monomers that do not have the above-mentioned specific functional groups and polymerization initiators that need to be used It is not particularly limited as long as they are the same. As specific examples thereof, those listed in the below-mentioned <solvent> can be used.

藉由前述方法所得之特定共聚物,通常為溶解於溶劑之溶液狀態。如後述,將所得之特定共聚物溶液可直接作為(A)成分(之溶液)使用。 The specific copolymer obtained by the aforementioned method is usually in the state of a solution dissolved in a solvent. As described later, the obtained specific copolymer solution can be used as it is (A) component (solution).

又,將以上述方法所得之特定共聚物的溶液,投入於攪拌下之二乙基醚或水等中使其再沉澱,將所生成之沉澱物經過濾‧洗淨後,在常壓或減壓下,進行常溫乾燥或加熱乾燥後可成為特定共聚物之粉體。藉由前述操作,可除去與特定共聚物共存之聚合起始劑及未反應的單體,其結果可得到經純化的特定共聚物之粉體。經一次操作後未充分純化時,將所得之粉體於溶劑中再溶解,並重複進行上述操作即可。 In addition, the solution of the specific copolymer obtained by the above method is poured into diethyl ether or water under stirring to re-precipitate, and the resulting precipitate is filtered and washed, and then placed under normal pressure or reduced After pressing, drying at room temperature or heating and drying, it can become a powder of a specific copolymer. Through the foregoing operation, the polymerization initiator and unreacted monomer coexisting with the specific copolymer can be removed, and as a result, a purified powder of the specific copolymer can be obtained. If it is not sufficiently purified after one operation, redissolve the obtained powder in a solvent and repeat the above operation.

對於本發明,可在特定共聚物在粉體形態下,或者將經純化的粉末於後述溶劑中再溶解的溶液形態下使用。 In the present invention, the specific copolymer can be used in the form of a powder or in the form of a solution in which the purified powder is re-dissolved in the solvent described below.

又,對於本發明,(A)成分之特定共聚物可為複數種特定共聚物之混合物。 In addition, in the present invention, the specific copolymer of the component (A) may be a mixture of a plurality of specific copolymers.

<(B)成分> <(B) Ingredient>

本發明之硬化膜形成組成物中之(B)成分為交聯劑。 The (B) component in the cured film forming composition of the present invention is a crosslinking agent.

(B)成分之交聯劑為具有與前述(A)成分之可進行熱交聯的官能基可形成交聯的基,例如具有羥甲基或烷氧基甲基之交聯劑為佳。 The crosslinking agent of the component (B) has a group capable of forming a crosslink with the thermally crosslinkable functional group of the component (A), for example, a crosslinking agent having a methylol group or an alkoxymethyl group is preferred.

作為具有這些基之化合物,例如可舉出烷氧基甲基化乙二醇脲、烷氧基甲基化苯並胍胺及烷氧基甲基化三聚氰胺等羥甲基化合物。 Examples of compounds having these groups include methylol compounds such as alkoxymethylated glycol urea, alkoxymethylated benzoguanamine, and alkoxymethylated melamine.

作為烷氧基甲基化乙二醇脲之具體例子,例如可舉出1,3,4,6-肆(甲氧基甲基)乙二醇脲、1,3,4,6-肆(丁氧基甲基)乙二醇脲、1,3,4,6-肆(羥基甲基)乙二醇脲、1,3- 雙(羥基甲基)尿素、1,1,3,3-肆(丁氧基甲基)尿素、1,1,3,3-肆(甲氧基甲基)尿素、1,3-雙(羥基甲基)-4,5-二羥基-2-咪唑啉酮、及1,3-雙(甲氧基甲基)-4,5-二甲氧基-2-咪唑啉酮等。作為市售品,可舉出日本氰特工業(股)(舊Mitsui Cytec(股))製乙二醇脲化合物(商品名:Cymel(註冊商標)1170、Powder link(註冊商標)1174)等化合物、甲基化尿素樹脂(商品名:UFR(註冊商標)65)、丁基化尿素樹脂(商品名:UFR(註冊商標)300、U-VAN10S60、U-VAN10R、U-VAN11HV)、DIC(股)(舊 大日本油墨化學工業(股))製尿素/甲醛系樹脂(高縮合型、商品名:BECKAMINE(註冊商標)J-300S、同P-955、同N)等。 As a specific example of alkoxymethylated glycol urea, for example, 1,3,4,6-four (methoxymethyl) glycol urea, 1,3,4,6-four ( Butoxymethyl) glycol urea, 1,3,4,6-four (hydroxymethyl) glycol urea, 1,3- Bis (hydroxymethyl) urea, 1,1,3,3-four (butoxymethyl) urea, 1,1,3,3-four (methoxymethyl) urea, 1,3-bis( Hydroxymethyl)-4,5-dihydroxy-2-imidazolinone, 1,3-bis(methoxymethyl)-4,5-dimethoxy-2-imidazolinone, etc. As commercially available products, compounds such as ethylene glycol urea compounds (trade names: Cymel (registered trademark) 1170, Powder link (registered trademark) 1174) manufactured by Nihon Cytec Industry Co., Ltd. (formerly Mitsui Cytec Co., Ltd.) can be mentioned. , Methylated urea resin (trade name: UFR (registered trademark) 65), butylated urea resin (trade name: UFR (registered trademark) 300, U-VAN10S60, U-VAN10R, U-VAN11HV), DIC (stock ) (Old Dainippon Ink Chemical Industry Co., Ltd.) Urea/formaldehyde resin (high condensation type, trade name: BECKAMINE (registered trademark) J-300S, same as P-955, same as N), etc.

作為烷氧基甲基化苯並胍胺之具體例子,可舉出四甲氧基甲基苯並胍胺等。作為市售品,可舉出日本氰特工業(股)(舊 Mitsui Cytec(股))製(商品名:Cymel(註冊商標)1123)、(股)三和化學製(商品名:NIKALAC(註冊商標)BX-4000、同BX-37、同BL-60、同BX-55H)等。 As a specific example of alkoxymethylated benzoguanamine, tetramethoxymethyl benzoguanamine etc. are mentioned. Commercially available products include Nihon Cytec Industries Co., Ltd. (formerly Mitsui Cytec Co., Ltd.) (trade name: Cymel (registered trademark) 1123), and Sanwa Chemical Co., Ltd. (trade name: NIKALAC (registered) Trademark) BX-4000, same as BX-37, same as BL-60, same as BX-55H) etc.

作為烷氧基甲基化三聚氰胺之具體例子,例如可舉出六甲氧基甲基三聚氰胺等。作為市售品,可舉出日本氰特工業(股)(舊 Mitsui Cytec(股))製甲氧基甲基型三聚氰胺化合物(商品名:Cymel(註冊商標)300、同301、同303、同350)、丁氧基甲基型三聚氰胺化合物(商品名:Mycoat(註冊商標)506、同508)、(股)三和化學製甲氧基甲基型三聚氰胺化合物(商品名:NIKALAC(註冊商標)MW-30、同MW-22、同MW-11、同MS-001、同MX- 002、同MX-730、同MX-750、同MX-035)、丁氧基甲基型三聚氰胺化合物(商品名:NIKALAC(註冊商標)MX-45、同MX-410、同MX-302)等。 As a specific example of alkoxymethylated melamine, hexamethoxymethyl melamine etc. are mentioned, for example. As commercially available products, methoxymethyl melamine compounds (trade name: Cymel (registered trademark) 300, the same 301, the same 303, the same 350), butoxymethyl melamine compound (trade name: Mycoat (registered trademark) 506, the same as 508), (stock) Sanwa Chemical's methoxymethyl melamine compound (trade name: NIKALAC (registered trademark) MW-30, same MW-22, same MW-11, same MS-001, same MX- 002, the same MX-730, the same MX-750, the same MX-035), butoxymethyl melamine compound (trade name: NIKALAC (registered trademark) MX-45, the same MX-410, the same MX-302), etc. .

又,亦可為如此胺基之氫原子由羥甲基或烷氧基甲基所取代之三聚氰胺化合物、尿素化合物、乙二醇脲化合物及苯並胍胺化合物經縮合後所得之化合物。例如可舉出如美國專利第6323310號所記載的由三聚氰胺化合物及苯並胍胺化合物所製造之高分子量的化合物。作為前述三聚氰胺化合物之市售品,可舉出商品名:Cymel(註冊商標)303等,作為前述苯並胍胺化合物之市售品,可舉出商品名:Cymel(註冊商標)1123(以上為日本氰特工業(股)(舊 Mitsui Cytec(股))製)等。 In addition, it may also be a compound obtained by condensation of a melamine compound, a urea compound, a glycol urea compound, and a benzoguanamine compound in which the hydrogen atom of the amino group is replaced by a methylol group or an alkoxymethyl group. For example, a high molecular weight compound produced from a melamine compound and a benzoguanamine compound as described in U.S. Patent No. 6,323,310 can be mentioned. Commercial products of the aforementioned melamine compound include trade name: Cymel (registered trademark) 303, etc., and commercial products of the aforementioned benzoguanamine compound include trade name: Cymel (registered trademark) 1123 (the above are Japan Cytec Industry Co., Ltd. (formerly manufactured by Mitsui Cytec Co., Ltd.), etc.

且作為(B)成分的交聯劑亦可使用下述聚合物,該聚合物為使用以N-羥基甲基丙烯醯基、N-甲氧基甲基甲基丙烯醯基、N-乙氧基甲基丙烯醯基、N-丁氧基甲基甲基丙烯醯基等羥基甲基(即羥甲基)或烷氧基甲基進行取代的丙烯醯基化合物或甲基丙烯醯基化合物所製造的聚合物。 In addition, as the crosslinking agent of component (B), the following polymers can also be used. The polymer is based on N-hydroxymethacryloyl, N-methoxymethylmethacryloyl, and N-ethoxy Methacrylic acid group, N-butoxymethyl methacrylic acid group and other hydroxymethyl (i.e. hydroxymethyl) or alkoxymethyl substituted acryloyl compounds or methacryloyl compounds Manufactured polymers.

作為如此聚合物,例如可舉出聚(N-丁氧基甲基丙烯醯基)、N-丁氧基甲基丙烯醯基與苯乙烯之共聚物、N-羥基甲基甲基丙烯醯基與甲基甲基丙烯酸酯之共聚物、N-乙氧基甲基甲基丙烯醯基與苯甲基甲基丙烯酸酯之共聚物、及N-丁氧基甲基丙烯醯基與苯甲基甲基丙烯酸酯與2-羥基丙基甲基丙烯酸酯之共聚物等。如此聚合物之 重量平均分子量(聚苯乙烯換算值)為1,000~500,000,以2,000~200,000為佳,較佳為3,000~150,000,更佳為3,000~50,000。 Examples of such polymers include poly(N-butoxymethacryloyl), copolymers of N-butoxymethacryloyl and styrene, and N-hydroxymethylmethacryloyl Copolymer with methacrylate, copolymer of N-ethoxymethylmethacrylic acid and benzyl methacrylate, and N-butoxymethacrylic acid and benzyl Copolymers of methacrylate and 2-hydroxypropyl methacrylate, etc. Of such a polymer The weight average molecular weight (polystyrene conversion value) is 1,000 to 500,000, preferably 2,000 to 200,000, preferably 3,000 to 150,000, and more preferably 3,000 to 50,000.

如此交聯劑可單獨或組合2種以上使用。又,作為(B)成分之交聯劑亦為後述(C)成分所例示的作為單位結構,亦可使用具有N-烷氧基甲基與含有C=C雙鍵之聚合性基的聚合物(特定共聚物2)。 Such a crosslinking agent can be used individually or in combination of 2 or more types. In addition, the crosslinking agent as the component (B) is also the unit structure exemplified in the component (C) described later, and a polymer having an N-alkoxymethyl group and a polymerizable group containing a C=C double bond can also be used (Specific copolymer 2).

本發明之硬化膜形成組成物中之(B)成分的交聯劑之含有量依據(A)成分之聚合物100質量份為準,以1質量份~300質量份為佳,較佳為5質量份~200質量份。交聯劑的含有量過少時,自硬化膜形成組成物所得之硬化膜的溶劑耐性會降低,使得垂直配向性降低。另一方面,若含有量過大時,垂直配向性及保存安定性會降低。 The content of the crosslinking agent of component (B) in the cured film forming composition of the present invention is based on 100 parts by mass of the polymer of component (A), preferably 1 part by mass to 300 parts by mass, preferably 5 Parts by mass ~ 200 parts by mass. When the content of the crosslinking agent is too small, the solvent resistance of the cured film obtained from the cured film forming composition will decrease, resulting in a decrease in vertical alignment. On the other hand, if the content is too large, the vertical alignment and storage stability will decrease.

<(C)成分> <(C) Ingredient>

本發明之硬化膜形成組成物含有(C)成分:密著促進劑與後述(D)成分:具有熱交聯性基之聚合物中任一方或者雙方。 The cured film forming composition of the present invention contains either or both of the component (C): an adhesion promoter and the component (D) described later: a polymer having a thermally crosslinkable group.

本發明之(C)成分為可提升所形成之硬化膜的接著性之成分(以下亦稱為密著提升成分)。 The (C) component of the present invention is a component that can improve the adhesiveness of the formed cured film (hereinafter also referred to as an adhesion promoting component).

且如後述,使用作為前述(B)成分之特定共聚物2時,(C)成分可與(B)成分相同。 And when using the specific copolymer 2 which is the said (B) component as mentioned later, (C) component may be the same as (B) component.

將自含有(C)成分之本實施形態的硬化膜形成組成物所形成的硬化膜作為配向材使用時,可提高配向材 與聚合性液晶之層的密著性,聚合性液晶之聚合性官能基與配向材之交聯反應部位可藉由共價鍵進行連接。其結果於本實施形態之配向材上層合經硬化的聚合性液晶所成的本實施形態之相位差材即使在高溫高濕之條件下,亦可維持強密著性,顯示對於剝離等之高耐久性。 When the cured film formed from the cured film forming composition of the present embodiment containing the component (C) is used as an alignment material, the alignment material can be improved The adhesion to the layer of the polymerizable liquid crystal, the crosslinking reaction site of the polymerizable functional group of the polymerizable liquid crystal and the alignment material can be connected by a covalent bond. As a result, the retardation material of the present embodiment formed by laminating the hardened polymerizable liquid crystal on the alignment material of the present embodiment can maintain strong adhesion even under the conditions of high temperature and high humidity, showing high resistance to peeling, etc. Durability.

作為(C)成分,以選自羥基及N-烷氧基甲基的基與具有聚合性基之單體及聚合物為佳。 As the (C) component, monomers and polymers selected from the group consisting of a hydroxyl group and an N-alkoxymethyl group, and a polymerizable group are preferred.

作為如此(C)成分,可舉出具有羥基與(甲基)丙烯酸基之化合物、具有N-烷氧基甲基之(甲基)丙烯酸基的化合物、具有N-烷氧基甲基與(甲基)丙烯酸基之聚合物等。以下表示各具體例子。 As such (C) component, a compound having a hydroxyl group and a (meth)acrylic group, a compound having a (meth)acrylic group of an N-alkoxymethyl group, and a compound having an N-alkoxymethyl group and ( Meth) acrylic-based polymers, etc. Specific examples are shown below.

作為(C)成分之一例子,可舉出含有羥基之多官能丙烯酸酯(以下亦稱為含有羥基之多官能丙烯酸酯)。 As an example of (C) component, the polyfunctional acrylate containing a hydroxyl group (hereinafter also referred to as a polyfunctional acrylate containing a hydroxyl group) is mentioned.

作為(C)成分之例子的含有羥基之多官能丙烯酸酯,例如可舉出季戊四醇三丙烯酸酯及二季戊四醇五丙烯酸酯等。 (C) Examples of the hydroxyl group-containing polyfunctional acrylate as an example of the component include, for example, pentaerythritol triacrylate, dipentaerythritol pentaacrylate, and the like.

作為(C)成分之一例子,可舉出具有1個丙烯酸基、與1個以上的羥基之化合物。如此可舉出具有1個丙烯酸基與1個以上的羥基之化合物的較佳例。且,(C)成分之化合物並未限定為以下化合物例。 As an example of (C) component, the compound which has 1 acrylic group and 1 or more hydroxyl groups is mentioned. In this way, preferred examples of compounds having one acrylic group and one or more hydroxyl groups can be given. In addition, the compound of the component (C) is not limited to the following compound examples.

Figure 109112027-A0101-12-0028-6
Figure 109112027-A0101-12-0028-6

(上述式中,R11表示氫原子或甲基,m表示1~10的整數)。 (In the above formula, R 11 represents a hydrogen atom or a methyl group, and m represents an integer of 1 to 10).

又,作為(C)成分的化合物,可舉出具有至少1個於1分子中含有C=C雙鍵之聚合性基與至少1個N-烷氧基甲基之化合物。 Moreover, as a compound of (C)component, the compound which has at least 1 polymerizable group containing a C=C double bond in 1 molecule, and at least 1 N-alkoxymethyl group is mentioned.

作為含有C=C雙鍵之聚合性基,可舉出丙烯酸基、甲基丙烯酸基、乙烯基、烯丙基、馬來醯亞胺基等。 Examples of the polymerizable group containing a C=C double bond include an acrylic group, a methacrylic group, a vinyl group, an allyl group, and a maleimide group.

有關N-烷氧基甲基之N,即作為氮原子,可舉出醯胺之氮原子、硫醯胺之氮原子、脲之氮原子、硫脲之氮原子、胺基甲酸酯之氮原子、含氮雜環之氮原子的鄰接位置上所鍵結的氮原子等。因此,作為N-烷氧基甲基,可舉出於選自醯胺之氮原子、硫醯胺之氮原子、脲之氮原子、硫脲之氮原子、胺基甲酸酯之氮原子、含氮雜環 之氮原子的鄰接位置上所鍵結的氮原子等的氮原子上鍵結烷氧基甲基之結構。 Regarding the N of N-alkoxymethyl group, that is, as the nitrogen atom, it can include the nitrogen atom of amide, the nitrogen atom of thioamide, the nitrogen atom of urea, the nitrogen atom of thiourea, the nitrogen of urethane The nitrogen atom, the nitrogen atom bonded to the adjacent position of the nitrogen atom of the nitrogen-containing heterocyclic ring, etc. Therefore, as the N-alkoxymethyl group, it can be selected from the nitrogen atom of amide, the nitrogen atom of thioamide, the nitrogen atom of urea, the nitrogen atom of thiourea, the nitrogen atom of urethane, Nitrogen-containing heterocycle A structure in which an alkoxymethyl group is bonded to a nitrogen atom such as a nitrogen atom adjacent to the nitrogen atom.

作為(C)成分,僅為具有上述基者即可,例如較佳可舉出下述式(X1)所示化合物。 As the (C) component, it is only necessary to have the above-mentioned group. For example, a compound represented by the following formula (X1) is preferably used.

Figure 109112027-A0101-12-0029-7
Figure 109112027-A0101-12-0029-7

(式中,R1表示氫原子或甲基,R2表示氫原子、或者直鏈或分支之碳原子數1至10的烷基)。 (In the formula, R 1 represents a hydrogen atom or a methyl group, and R 2 represents a hydrogen atom or a linear or branched alkyl group having 1 to 10 carbon atoms).

作為上述碳原子數1至10的烷基,例如可舉出甲基、乙基、n-丙基、異丙基、n-丁基、異丁基、sec-丁基、tert-丁基、n-戊基、1-甲基-n-丁基、2-甲基-n-丁基、3-甲基-n-丁基、1,1-二甲基-n-丙基、1,2-二甲基-n-丙基、2,2-二甲基-n-丙基、1-乙基-n-丙基、n-己基、1-甲基-n-戊基、2-甲基-n-戊基、3-甲基-n-戊基、4-甲基-n-戊基、1,1-二甲基-n-丁基、1,2-二甲基-n-丁基、1,3-二甲基-n-丁基、2,2-二甲基-n-丁基、2,3-二甲基-n-丁基、3,3-二甲基-n-丁基、1-乙基-n-丁基、2-乙基-n-丁基、1,1,2-三甲基-n-丙基、1,2,2-三甲基-n-丙基、1-乙基-1-甲基-n-丙基、1-乙基-2-甲基-n-丙基、n-庚基、1-甲基-n-己基、2-甲基-n-己基、3-甲基-n-己基、1,1-二甲基-n-戊基、1,2-二 甲基-n-戊基、1,3-二甲基-n-戊基、2,2-二甲基-n-戊基、2,3-二甲基-n-戊基、3,3-二甲基-n-戊基、1-乙基-n-戊基、2-乙基-n-戊基、3-乙基-n-戊基、1-甲基-1-乙基-n-丁基、1-甲基-2-乙基-n-丁基、1-乙基-2-甲基-n-丁基、2-甲基-2-乙基-n-丁基、2-乙基-3-甲基-n-丁基、n-辛基、1-甲基-n-庚基、2-甲基-n-庚基、3-甲基-n-庚基、1,1-二甲基-n-己基、1,2-二甲基-n-己基、1,3-二甲基-n-己基、2,2-二甲基-n-己基、2,3-二甲基-n-己基、3,3-二甲基-n-己基、1-乙基-n-己基、2-乙基-n-己基、3-乙基-n-己基、1-甲基-1-乙基-n-戊基、1-甲基-2-乙基-n-戊基、1-甲基-3-乙基-n-戊基、2-甲基-2-乙基-n-戊基、2-甲基-3-乙基-n-戊基、3-甲基-3-乙基-n-戊基、n-壬基、n-癸基等。 Examples of the alkyl group having 1 to 10 carbon atoms include methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, sec-butyl, tert-butyl, n-pentyl, 1-methyl-n-butyl, 2-methyl-n-butyl, 3-methyl-n-butyl, 1,1-dimethyl-n-propyl, 1, 2-dimethyl-n-propyl, 2,2-dimethyl-n-propyl, 1-ethyl-n-propyl, n-hexyl, 1-methyl-n-pentyl, 2- Methyl-n-pentyl, 3-methyl-n-pentyl, 4-methyl-n-pentyl, 1,1-dimethyl-n-butyl, 1,2-dimethyl-n -Butyl, 1,3-dimethyl-n-butyl, 2,2-dimethyl-n-butyl, 2,3-dimethyl-n-butyl, 3,3-dimethyl -n-butyl, 1-ethyl-n-butyl, 2-ethyl-n-butyl, 1,1,2-trimethyl-n-propyl, 1,2,2-trimethyl -n-propyl, 1-ethyl-1-methyl-n-propyl, 1-ethyl-2-methyl-n-propyl, n-heptyl, 1-methyl-n-hexyl, 2-methyl-n-hexyl, 3-methyl-n-hexyl, 1,1-dimethyl-n-pentyl, 1,2-di Methyl-n-pentyl, 1,3-dimethyl-n-pentyl, 2,2-dimethyl-n-pentyl, 2,3-dimethyl-n-pentyl, 3,3 -Dimethyl-n-pentyl, 1-ethyl-n-pentyl, 2-ethyl-n-pentyl, 3-ethyl-n-pentyl, 1-methyl-1-ethyl- n-butyl, 1-methyl-2-ethyl-n-butyl, 1-ethyl-2-methyl-n-butyl, 2-methyl-2-ethyl-n-butyl, 2-ethyl-3-methyl-n-butyl, n-octyl, 1-methyl-n-heptyl, 2-methyl-n-heptyl, 3-methyl-n-heptyl, 1,1-dimethyl-n-hexyl, 1,2-dimethyl-n-hexyl, 1,3-dimethyl-n-hexyl, 2,2-dimethyl-n-hexyl, 2, 3-dimethyl-n-hexyl, 3,3-dimethyl-n-hexyl, 1-ethyl-n-hexyl, 2-ethyl-n-hexyl, 3-ethyl-n-hexyl, 1 -Methyl-1-ethyl-n-pentyl, 1-methyl-2-ethyl-n-pentyl, 1-methyl-3-ethyl-n-pentyl, 2-methyl-2 -Ethyl-n-pentyl, 2-methyl-3-ethyl-n-pentyl, 3-methyl-3-ethyl-n-pentyl, n-nonyl, n-decyl, etc.

作為上述式(X1)所示化合物的具體例子,可舉出N-羥基甲基(甲基)丙烯醯基、N-甲氧基甲基(甲基)丙烯醯基、N-乙氧基甲基(甲基)丙烯醯基、N-丁氧基甲基(甲基)丙烯醯基等由羥基甲基或烷氧基甲基所取代之丙烯醯基化合物或甲基丙烯醯基化合物。且所謂(甲基)丙烯醯基表示甲基丙烯醯基與丙烯醯基之雙方。 As specific examples of the compound represented by the above formula (X1), N-hydroxymethyl (meth)acryloyl, N-methoxymethyl (meth)acryloyl, N-ethoxymethyl Acrylic compounds or methacrylic compounds substituted with hydroxymethyl or alkoxymethyl, such as methacrylic acid group and N-butoxymethyl(meth)acrylic acid group. In addition, the (meth)acryloyl group means both a methacryloyl group and an acrylic group.

作為具有含有(C)成分之含有C=C雙鍵的聚合性基與N-烷氧基甲基之化合物的另一態樣,例如較佳可舉出下述式(X2)所示化合物。 As another aspect of the compound having a C=C double bond-containing polymerizable group containing the component (C) and an N-alkoxymethyl group, for example, a compound represented by the following formula (X2) is preferably used.

Figure 109112027-A0101-12-0031-8
Figure 109112027-A0101-12-0031-8

式中,R51表示氫原子或甲基。R52及R53各獨立表示含有直鏈或分支的碳原子數2至20的伸烷基、碳原子數5至6的脂肪族環基、或者碳原子數5至6的脂肪族環之脂肪族基,於結構中可含有醚鍵。R54表示含有直鏈或分支之碳原子數1至20的烷基、碳原子數5至6的脂肪族環基、或者碳原子數5至6的脂肪族環之脂肪族基,這些基之一個伸甲基或未相鄰的複數個伸甲基可取代為醚鍵。Z表示>NCOO-、或-OCON<(其中「-」表示結合鍵為1個之意思。又「>」「<」表示結合鍵為2個的意思,且表示任一個結合鍵上鍵結烷氧基甲基)。R為2以上9以下之自然數。 In the formula, R 51 represents a hydrogen atom or a methyl group. R 52 and R 53 each independently represent a straight chain or branched alkylene group having 2 to 20 carbon atoms, aliphatic cyclic group having 5 to 6 carbon atoms, or aliphatic ring having 5 to 6 carbon atoms The group group may contain ether bonds in the structure. R 54 represents an aliphatic group containing a linear or branched alkyl group having 1 to 20 carbon atoms, an aliphatic ring group having 5 to 6 carbon atoms, or an aliphatic ring having 5 to 6 carbon atoms, one of these groups One methylene group or a plurality of non-adjacent methylene groups may be substituted with ether linkages. Z means >NCOO-, or -OCON< (where "-" means that there is one bond. Also, ">" and "<" mean that there are two bonds, and it means that any one of the bonds is bound to an alkane. Oxymethyl). R is a natural number of 2 or more and 9 or less.

作為R53及R54的定義中之碳原子數2至20的伸烷基之具體例子,可舉出自碳原子數2至20的烷基進一步取出1至8個氫原子之2價至9價基。 As a specific example of the alkylene group having 2 to 20 carbon atoms in the definition of R 53 and R 54 , there can be exemplified the divalent to 9 of the alkyl group having 2 to 20 carbon atoms and 1 to 8 hydrogen atoms. Price base.

作為該碳原子數2至20的烷基之具體例子,可舉出乙基、n-丙基、i-丙基、n-丁基、i-丁基、s-丁基、t-丁基、n-戊基、1-甲基-n-丁基、2-甲基-n-丁基、3-甲基-n-丁基、1,1-二甲基-n-丙基、n-己基、1-甲基-n-戊基、2-甲基-n-戊基、1,1-二甲基-n-丁基、1-乙基-n-丁基、1,1,2-三甲基-n-丙基、n-庚基、n-辛基、n-壬基、n-癸基、n-十 一烷基、n-十二烷基、n-十三烷基、n-十四烷基、n-十五烷基、n-十六烷基、n-十七烷基、n-十八烷基、n-十九烷基、n-二十烷基、環戊基、環己基、這些一種或複數種以碳原子數至20的範圍進行鍵結的基、與這些基之一的伸甲基或未相鄰的複數個伸甲基取代為醚鍵之基等皆為可舉出的例子。 Specific examples of the alkyl group having 2 to 20 carbon atoms include ethyl, n-propyl, i-propyl, n-butyl, i-butyl, s-butyl, t-butyl , N-pentyl, 1-methyl-n-butyl, 2-methyl-n-butyl, 3-methyl-n-butyl, 1,1-dimethyl-n-propyl, n -Hexyl, 1-methyl-n-pentyl, 2-methyl-n-pentyl, 1,1-dimethyl-n-butyl, 1-ethyl-n-butyl, 1,1, 2-Trimethyl-n-propyl, n-heptyl, n-octyl, n-nonyl, n-decyl, n-decyl Monoalkyl, n-dodecyl, n-tridecyl, n-tetradecyl, n-pentadecyl, n-hexadecyl, n-heptadecyl, n-octadecyl Alkyl, n-nonadecyl, n-eicosyl, cyclopentyl, cyclohexyl, one or more of these groups bonded in the range of carbon atoms to 20, and the extension of one of these groups Methyl groups or groups in which a plurality of non-adjacent methyl groups are substituted with ether bonds are all examples.

其中,以碳原子數2至10的伸烷基為佳,R53為伸乙基,R54為戊烷基時,由原料之獲得性等觀點來看為特佳。 Among them, an alkylene group having 2 to 10 carbon atoms is preferred, when R 53 is an ethylidene group, and R 54 is a pentyl group, it is particularly preferred from the viewpoint of availability of raw materials.

作為R52定義中之碳原子數1至20的烷基之具體例子,可舉出R53及R54定義中之碳原子數2至20的烷基之具體例子及甲基。彼等中,以碳原子數1至6的烷基為佳,以甲基、乙基、n-丙基或n-丁基為特佳。 Specific examples of the alkyl group having 1 to 20 carbon atoms in the definition of R 52 include specific examples of the alkyl group having 2 to 20 carbon atoms in the definition of R 53 and R 54 and methyl group. Among them, an alkyl group having 1 to 6 carbon atoms is preferred, and a methyl group, an ethyl group, an n-propyl group or an n-butyl group is particularly preferred.

作為r,可舉出2以上9以下的自然數,但其中亦以2至6為佳。 Examples of r include natural numbers of 2 or more and 9 or less, but among them, 2 to 6 are also preferred.

化合物(X2)係由下述反應流程所示製造方法所得。即,將具有下述式(X2-1)所示丙烯酸基或甲基丙烯酸基之胺基甲酸酯化合物(以下亦稱為化合物(X2-1))加入三甲基矽基氯化物與對甲醛(一般以化學式(CH2O)n所示)在溶劑中進行反應而合成下述式(X2-2)所示中間體,對該反應液加入R52-OH所示醇使其反應後而製造。 Compound (X2) is obtained by the production method shown in the following reaction scheme. That is, a urethane compound having an acrylic or methacrylic group represented by the following formula (X2-1) (hereinafter also referred to as compound (X2-1)) is added to trimethylsilyl chloride and Formaldehyde (generally represented by the chemical formula (CH 2 O) n) is reacted in a solvent to synthesize the intermediate represented by the following formula (X2-2), and the alcohol represented by R 52 -OH is added to the reaction solution to react And manufacturing.

Figure 109112027-A0101-12-0033-9
Figure 109112027-A0101-12-0033-9

式中,R51、R52、R53、R54、Z及r表示前述意思,X表示-NHCOO-或-OCONH-。 In the formula, R 51 , R 52 , R 53 , R 54 , Z and r represent the aforementioned meanings, and X represents -NHCOO- or -OCONH-.

對於化合物(X2-1)的三甲基矽基氯化物與對甲醛之使用量並無特別限定,欲使反應終結,對於分子中之1個胺基甲酸酯鍵,以使用三甲基矽基氯化物1.0至6.0當量倍、對甲醛1.0至3.0當量倍時為佳,三甲基矽基氯化物之使用當量比對甲醛之使用當量多時為佳。 There are no particular restrictions on the amount of trimethylsilyl chloride and formaldehyde used in compound (X2-1). To terminate the reaction, use trimethylsilyl for one urethane bond in the molecule. 1.0 to 6.0 equivalent times of base chloride and 1.0 to 3.0 equivalent times of formaldehyde are preferred, and the use equivalent of trimethylsilyl chloride is better than that of formaldehyde.

作為反應溶劑,若對反應為惰性者即可,並無特別限定,例如可舉出己烷、環己烷、苯、甲苯等的烴類;二氯甲烷、四氯化碳素、氯仿、1,2-二氯乙烷等鹵素系烴類;二乙基醚、二異丙基醚、1,4-二噁烷、四氫呋喃等醚類;乙腈、丙腈等腈類;N,N-二甲基甲醯胺、N,N-二甲基乙醯胺、N-甲基-2-吡咯啶酮、1,3-二甲基-2-咪唑啉酮等含氮非質子性極性溶劑;吡啶、甲基吡啶等吡啶類等。這些溶劑可單獨使用,亦可混合這些2種類以上使用。較佳為二氯甲烷、氯仿,更佳為二氯甲烷。 The reaction solvent is not particularly limited as long as it is inert to the reaction. Examples include hydrocarbons such as hexane, cyclohexane, benzene, and toluene; dichloromethane, carbon tetrachloride, chloroform, and , 2-Dichloroethane and other halogen-based hydrocarbons; diethyl ether, diisopropyl ether, 1,4-dioxane, tetrahydrofuran and other ethers; acetonitrile, propionitrile and other nitriles; N,N-di Methylformamide, N,N-dimethylacetamide, N-methyl-2-pyrrolidone, 1,3-dimethyl-2-imidazolinone and other nitrogen-containing aprotic polar solvents; Pyridines such as pyridine and picoline. These solvents may be used alone, or two or more of these solvents may be mixed and used. Dichloromethane and chloroform are preferred, and dichloromethane is more preferred.

上述溶劑的使用量(反應濃度)並無特別限定,可不使用溶劑下實施反應,又使用溶劑時對於化合物(X2- 1)可使用0.1至100質量倍的溶劑。較佳為1至30質量倍,更佳為2至20質量倍。 The use amount (reaction concentration) of the above-mentioned solvent is not particularly limited, and the reaction can be carried out without using a solvent, and when a solvent is used, the compound (X2- 1) 0.1 to 100 times the mass of the solvent can be used. It is preferably 1 to 30 times by mass, more preferably 2 to 20 times by mass.

反應溫度並無特別限定,例如-90至200℃,較佳為-20至100℃,更佳為-10至50℃。 The reaction temperature is not particularly limited, for example -90 to 200°C, preferably -20 to 100°C, more preferably -10 to 50°C.

反應時間一般為0.05至200小時,較佳為0.5至100小時。 The reaction time is generally 0.05 to 200 hours, preferably 0.5 to 100 hours.

反應可在常壓或加壓下進行,又可分為數批次方式或連續方式進行。 The reaction can be carried out under normal pressure or under pressure, and can be divided into batches or continuous methods.

進行反應時,可添加聚合禁止劑。作為如此聚合禁止劑,可使用BHT(2,6-二-第三丁基-對-甲酚)或氫醌、對-甲氧基酚等,僅為阻礙丙烯酸基、甲基丙烯酸基之聚合者亦可並無特別限定。 During the reaction, a polymerization inhibitor can be added. As such a polymerization inhibitor, BHT (2,6-di-tert-butyl-p-cresol), hydroquinone, p-methoxyphenol, etc. can be used, which only hinder the polymerization of acrylic and methacrylic groups. There may also be no particular limitation.

添加聚合禁止劑時的添加量並無特別限定,對於化合物(X2-1)之總使用量(質量)而言為0.0001至10wt%,較佳為0.01至1wt%。本說明書中wt%表示質量%。 The addition amount when adding the polymerization inhibitor is not particularly limited, and the total usage (mass) of the compound (X2-1) is 0.0001 to 10 wt%, preferably 0.01 to 1 wt%. In this specification, wt% means mass%.

對於於中間體(X2-2)使醇進行反應的步驟,欲抑制酸性條件下的水解可加入鹼。作為鹼的例子,可舉出吡啶、甲基吡啶等吡啶類或三甲基胺、三乙基胺、二異丙基乙基胺、三丁基胺等第3級胺等。較佳為三乙基胺、二異丙基乙基胺,更佳為三乙基胺。添加鹼時的添加量,並無特別限定,對於反應時所使用的三甲基矽基氯化物之添加量而言僅使用0.01至2.0當量倍使用即可,較佳為0.5至1.0當量。 For the step of reacting the alcohol with the intermediate (X2-2), a base can be added to suppress hydrolysis under acidic conditions. Examples of the base include pyridines such as pyridine and picoline, or tertiary amines such as trimethylamine, triethylamine, diisopropylethylamine, and tributylamine. Preferred are triethylamine and diisopropylethylamine, and more preferred is triethylamine. The addition amount when adding the base is not particularly limited. For the addition amount of the trimethylsilyl chloride used in the reaction, it is only necessary to use 0.01 to 2.0 equivalent times, preferably 0.5 to 1.0 equivalent.

又,自化合物(X2-1)得到中間體(X2-2)後,無須分離中間體(X2-2),亦可添加醇進行反應。 Moreover, after obtaining the intermediate (X2-2) from the compound (X2-1), it is not necessary to isolate the intermediate (X2-2), and an alcohol may be added to perform the reaction.

化合物(X2-1)的合成法並無特別限定,但可藉由使(甲基)丙烯醯氧基烷基異氰酸酯與多元醇化合物進行反應,或使羥基烷基(甲基)丙烯酸酯化合物與聚異氰酸酯化合物進行反應而製造。 The method for synthesizing compound (X2-1) is not particularly limited, but it can be achieved by reacting (meth)acryloxyalkyl isocyanate with a polyol compound, or by reacting a hydroxyalkyl (meth)acrylate compound with The polyisocyanate compound is produced by reacting.

作為(甲基)丙烯醯氧基烷基異氰酸酯之具體例子,例如可舉出2-甲基丙烯醯氧乙基異氰酸酯(昭和電工(股)製,商品名:Karenz MOI[註冊商標])、2-丙烯醯氧基乙基異氰酸酯(昭和電工(股)製,商品名:Karenz AOI[註冊商標])等。 As a specific example of (meth)acryloxyalkyl isocyanate, for example, 2-methacryloxyethyl isocyanate (manufactured by Showa Denko Co., Ltd., trade name: Karenz MOI [registered trademark]), 2 -Acrylic oxyethyl isocyanate (manufactured by Showa Denko Co., Ltd., trade name: Karenz AOI [registered trademark]), etc.

作為多元醇化合物之具體例子,可舉出乙二醇、丙二醇、1,4-丁二醇、1,3-丁二醇、1,5-戊烷二醇、新戊二醇、3-甲基-1,5-戊烷二醇、1,6-已二醇、1,4-環己烷二甲醇等之二醇化合物、甘油、三羥甲基丙烷等之三醇化合物、季戊四醇、二季戊四醇、二甘油等。 Specific examples of polyol compounds include ethylene glycol, propylene glycol, 1,4-butanediol, 1,3-butanediol, 1,5-pentanediol, neopentyl glycol, 3-methyl Diol compounds such as 1,5-pentanediol, 1,6-hexanediol, 1,4-cyclohexanedimethanol, triol compounds such as glycerol, trimethylolpropane, pentaerythritol, di Pentaerythritol, diglycerol, etc.

作為羥基烷基(甲基)丙烯酸酯化合物之具體例子,可舉出2-羥基乙基丙烯酸酯、2-羥基乙基甲基丙烯酸酯、2-羥基丙基丙烯酸酯、2-羥基丙基甲基丙烯酸酯、4-羥基丁基丙烯酸酯、4-羥基丁基甲基丙烯酸酯、二乙二醇單丙烯酸酯、二乙二醇單甲基丙烯酸酯、聚(乙二醇)乙基醚丙烯酸酯、聚(乙二醇)乙基醚甲基丙烯酸酯等具有羥基之單體等。 Specific examples of hydroxyalkyl (meth)acrylate compounds include 2-hydroxyethyl acrylate, 2-hydroxyethyl methacrylate, 2-hydroxypropyl acrylate, and 2-hydroxypropyl acrylate. Base acrylate, 4-hydroxybutyl acrylate, 4-hydroxybutyl methacrylate, diethylene glycol monoacrylate, diethylene glycol monomethacrylate, poly(ethylene glycol) ethyl ether acrylate, Monomers having hydroxyl groups such as poly(ethylene glycol) ethyl ether methacrylate.

作為聚異氰酸酯化合物之具體例子,可舉出 六伸甲基二異氰酸酯、2,4,4-三甲基六伸甲基二異氰酸酯、二聚物酸二異氰酸酯等脂肪族二異氰酸酯、異佛爾酮二異氰酸酯、4,4’-伸甲基雙(環己基異氰酸酯)、ω,ω’-二異氰酸酯二甲基環己烷等脂環族二異氰酸酯、賴胺酸酯三異氰酸酯、1,6,11-十一烷三異氰酸酯、1,8-二異氰酸酯-4-異氰酸酯甲基辛烷、1,3,6-六伸甲基三異氰酸酯、聯環庚烷三異氰酸酯等三異氰酸酯等。 As a specific example of the polyisocyanate compound, one can cite Aliphatic diisocyanates such as hexamethylene diisocyanate, 2,4,4-trimethylhexamethylene diisocyanate, dimer acid diisocyanate, isophorone diisocyanate, 4,4'-methylidene Alicyclic diisocyanates such as bis(cyclohexyl isocyanate), ω,ω'-diisocyanate dimethylcyclohexane, lysine triisocyanate, 1,6,11-undecane triisocyanate, 1,8- Triisocyanates such as diisocyanate-4-isocyanate methyl octane, 1,3,6-hexamethylene triisocyanate, bicycloheptane triisocyanate, etc.

這些(甲基)丙烯醯氧基烷基異氰酸酯化合物、多元醇化合物、羥基烷基(甲基)丙烯酸酯化合物及聚異氰酸酯化合物為一般被販賣的商品,又可藉由公知方法進行合成。 These (meth)acryloxyalkyl isocyanate compounds, polyol compounds, hydroxyalkyl (meth)acrylate compounds, and polyisocyanate compounds are generally sold products, and they can be synthesized by known methods.

又,作為(C)成分的一例子,作為單位結構,可舉出具有N-烷氧基甲基與含有C=C雙鍵之聚合性基的聚合物(以下亦稱為特定共聚物2)。此為如前述所示可作為(B)成分之交聯劑使用,即此時(C)成分與(B)成分可為相同。 In addition, as an example of the component (C), as a unit structure, a polymer having an N-alkoxymethyl group and a C=C double bond-containing polymerizable group (hereinafter also referred to as specific copolymer 2) . This is the crosslinking agent that can be used as the component (B) as described above, that is, the component (C) and the component (B) may be the same at this time.

上述特定共聚物可為以下兩種聚合物,其中一聚合物為含有以下重複單位結構,該重複單位結構為含有N-烷氧基甲基及含有C=C雙鍵之聚合性基雙方基的重複單位結構,另一聚合物為含有以下兩種重複單位結構,其中一個為含有N-烷氧基甲基之重複單位結構,另一個為包含具有C=C雙鍵之聚合性基的重複單位者;又亦可為含有至少一種以下兩種重複單位結構的聚合物,其中一重複單位結構為含有N-烷氧基甲基及含有C=C雙鍵之聚合性基 雙方基者,另一重複單位結構為含有具有N-烷氧基甲基之重複單位結構及含有C=C雙鍵之聚合性基的重複單位。彼等中,作為特定共聚物2,可適用含有以下重複單位結構之聚合物,該重複單位結構為含有N-烷氧基甲基者與含有具有C=C雙鍵之聚合性基的重複單位者。 The above-mentioned specific copolymer can be the following two kinds of polymers. One of the polymers contains the following repeating unit structure. The repeating unit structure is a two-group containing N-alkoxymethyl group and a polymerizable group containing a C=C double bond Repeating unit structure, the other polymer contains the following two repeating unit structures, one of which is a repeating unit structure containing N-alkoxymethyl group, and the other is a repeating unit containing a polymerizable group with a C=C double bond It can also be a polymer containing at least one of the following two repeating unit structures, one of which is a polymerizable group containing N-alkoxymethyl groups and C=C double bonds In the case of both groups, the other repeating unit structure is a repeating unit containing a repeating unit structure having an N-alkoxymethyl group and a polymerizable group containing a C=C double bond. Among them, as the specific copolymer 2, a polymer containing the following repeating unit structure is applicable. The repeating unit structure is a repeating unit containing an N-alkoxymethyl group and a polymerizable group having a C=C double bond By.

以下對於(C)成分之一例的特定共聚物2(亦稱為(C)成分之聚合物)做說明。 The specific copolymer 2 (also referred to as the polymer of the (C) component) as an example of the (C) component will be described below.

作為N-烷氧基甲基的N,即氮原子,可舉出醯胺之氮原子、硫醯胺之氮原子、脲之氮原子、硫脲之氮原子、胺基甲酸酯之氮原子、含氮雜環之氮原子的鄰接位置上所鍵結的氮原子等。因此,作為N-烷氧基甲基可舉出選自醯胺之氮原子、硫醯胺之氮原子、脲之氮原子、硫脲之氮原子、胺基甲酸酯之氮原子、含氮雜環之氮原子的鄰接位置上所鍵結的氮原子等氮原子上鍵結烷氧基甲基之結構。 As the N of the N-alkoxymethyl group, the nitrogen atom includes the nitrogen atom of amide, the nitrogen atom of thioamide, the nitrogen atom of urea, the nitrogen atom of thiourea, and the nitrogen atom of carbamate. , The nitrogen atom bonded to the adjacent position of the nitrogen atom of the nitrogen-containing heterocyclic ring, etc. Therefore, the N-alkoxymethyl group may be selected from the group consisting of nitrogen atom of amide, nitrogen atom of thioamide, nitrogen atom of urea, nitrogen atom of thiourea, nitrogen atom of urethane, nitrogen-containing A structure in which an alkoxymethyl group is bonded to a nitrogen atom such as a nitrogen atom bonded to a nitrogen atom adjacent to the nitrogen atom of the heterocyclic ring.

作為賦予N-烷氧基甲基的單體(以下亦稱為特定單體X1),僅具有上述基者即可,例如較佳為可舉出上述式(X1)所示化合物(式中之R2表示直鏈或分支的碳原子數1至10的烷基之化合物)。 The N-alkoxymethyl group-imparting monomer (hereinafter also referred to as the specific monomer X1) may only have the above-mentioned groups. For example, the compound represented by the above-mentioned formula (X1) (in the formula R 2 represents a compound of a linear or branched alkyl group having 1 to 10 carbon atoms).

作為含有C=C雙鍵之聚合性基,可舉出丙烯酸基、甲基丙烯酸基、乙烯基、烯丙基、馬來醯亞胺基等。 Examples of the polymerizable group containing a C=C double bond include an acrylic group, a methacrylic group, a vinyl group, an allyl group, and a maleimide group.

上述含有C=C雙鍵之聚合性基為於聚合物的主骨架之側鏈上插入而得,即作為具有含有C=C雙鍵之 聚合性基的特定側鏈,於(C)成分的聚合物之側鏈上插入而得。 The above-mentioned polymerizable group containing C=C double bond is obtained by inserting into the side chain of the main skeleton of the polymer, that is, as having C=C double bond The specific side chain of the polymerizable group is inserted into the side chain of the polymer of the component (C).

(C)成分之含有C=C雙鍵之聚合性基的特定側鏈中該碳原子數為3~16,以於末端具有不飽和鍵者為佳,以下述式(b2)所示特定側鏈者為特佳。式(b2)所示特定側鏈,例如為如式(b2-1)所示,其為鍵結於丙烯酸聚合物之酯鍵部分者。 (C) The number of carbon atoms in the specific side chain of the polymerizable group containing the C=C double bond of the component is 3-16, preferably having an unsaturated bond at the end, and the specific side represented by the following formula (b2) The chain is especially good. The specific side chain represented by the formula (b2) is, for example, as represented by the formula (b2-1), which is bonded to the ester bond portion of the acrylic polymer.

Figure 109112027-A0101-12-0038-10
Figure 109112027-A0101-12-0038-10

式(b2)中,R61中碳原子數為1~14,選自由脂肪族基、含有環式結構之脂肪族基及芳香族基所成群的有機基、或選自該群的複數有機基的組合所成的有機基。R61亦可含有酯鍵、醚鍵、醯胺鍵或胺基甲酸酯鍵等。 In formula (b2), the number of carbon atoms in R 61 is 1 to 14, selected from the group consisting of aliphatic groups, cyclic structure-containing aliphatic groups and aromatic groups, or plural organic groups selected from the group An organic base formed by a combination of bases. R 61 may also contain an ester bond, ether bond, amide bond, or urethane bond.

對於式(b2)所示特定側鏈,R62為氫原子或甲基,特別R62以氫原子之特定側鏈為佳。較佳為末端為丙烯醯基、甲基丙烯醯基或乙烯基苯基之特定側鏈。 For the specific side chain represented by the formula (b2), R 62 is a hydrogen atom or a methyl group, and it is particularly preferable that R 62 is a specific side chain of a hydrogen atom. Preferably, it is a specific side chain whose terminal is an acryloyl group, a methacryloyl group or a vinyl phenyl group.

式(b2-1)中,R63為氫原子或甲基。 In the formula (b2-1), R 63 is a hydrogen atom or a methyl group.

欲得到具有如上述特定側鏈之聚合物的方法 並無特別限定。 To obtain a polymer with specific side chains as described above It is not particularly limited.

若要舉出一例子,藉由預先聚合自由基等聚合方法,生成具有後述之特定官能基的丙烯酸聚合物(以下亦稱為具有特定官能基之聚合物)(且,具有該特定官能基的丙烯酸共聚物中可如後述已導入N-烷氧基甲基)。其次,藉由該特定官能基與於末端具有不飽和鍵(C=C雙鍵)之化合物(以下稱為特定化合物)進行反應後生成特定側鏈後,導入含有C=C雙鍵之聚合性基,可得到(C)成分之聚合物。 To give an example, an acrylic polymer having a specific functional group described later (hereinafter also referred to as a polymer having a specific functional group) is produced by a polymerization method such as prepolymerization of free radicals (and, a polymer having the specific functional group) (N-alkoxymethyl) can be introduced into the acrylic copolymer as described later. Secondly, after the specific functional group reacts with a compound having an unsaturated bond (C=C double bond) at the end (hereinafter referred to as a specific compound) to form a specific side chain, the polymerizability containing the C=C double bond is introduced Base, the polymer of component (C) can be obtained.

其中,所謂特定官能基表示羧基、縮水甘油基、羥基、具有活性氫之胺基、酚性羥基或者異氰酸酯基等官能基、或選自這些的複數種官能基。 Here, the specific functional group means a functional group such as a carboxyl group, a glycidyl group, a hydroxyl group, an amine group having active hydrogen, a phenolic hydroxyl group, or an isocyanate group, or a plurality of functional groups selected from these.

對於生成上述特定側鏈之反應,特定官能基與特定化合物所具有官能基(生成特性側鏈)即反應之相關基的較佳組合為,羧基與環氧基、羥基與異氰酸酯基、酚性羥基與環氧基、羧基與異氰酸酯基、胺基與異氰酸酯基、或羥基與酸氯化物等。且較佳組合為羧基與縮水甘油基甲基丙烯酸酯、或羥基與異氰酸酯乙基甲基丙烯酸酯。 For the reaction to generate the above-mentioned specific side chain, the preferred combination of the specific functional group and the functional group of the specific compound (generating the characteristic side chain), that is, the relevant group of the reaction, is a carboxyl group and an epoxy group, a hydroxyl group and an isocyanate group, and a phenolic hydroxyl group. With epoxy groups, carboxyl groups and isocyanate groups, amine groups and isocyanate groups, or hydroxyl groups and acid chlorides. And the preferred combination is carboxyl group and glycidyl methacrylate, or hydroxyl group and isocyanate ethyl methacrylate.

又,對於生成上述特定側鏈之反應所使用的具有特定官能基的聚合物係以具有N-烷氧基甲基與特定官能基之聚合物為佳。即,較佳為具有前述特定官能基之聚合物為,使賦予N-烷氧基甲基之單體的特定單體X1、及具有用於與在末端具有不飽和鍵(C=C雙鍵)之化合物的特定化合物進行反應的官能基(特定官能基)」之單體,即具有羧基、縮水甘油基、羥基、具有活性氫之胺基、酚性 羥基或異氰酸酯基等單體(以下亦稱為特定單體X3)作為必須成分所得之共聚物,又該數平均分子量以2,000~25,000者為為佳。其中,使用於聚合的具有特定官能基的單體可單獨使用,若在聚合中不起反應則可組合複數種併用。 In addition, the polymer having a specific functional group used in the reaction for generating the specific side chain is preferably a polymer having an N-alkoxymethyl group and a specific functional group. That is, it is preferable that the polymer having the aforementioned specific functional group is such that the specific monomer X1, which is a monomer imparting an N-alkoxymethyl group, and has an unsaturated bond (C=C double bond) at the end ) Is the functional group (specific functional group) of the compound that reacts with the specific compound "monomers with carboxyl group, glycidyl group, hydroxyl group, amine group with active hydrogen, phenolic A copolymer obtained by using monomers such as a hydroxyl group or an isocyanate group (hereinafter also referred to as a specific monomer X3) as an essential component, and the number average molecular weight is preferably 2,000-25,000. Among them, the monomer having a specific functional group used in the polymerization can be used alone, and if it does not react during the polymerization, a plurality of types can be combined and used.

以下可舉出欲得到具有特定官能基之聚合物所必要的單體,即可舉出特定單體X3之具體例子。但並未限定於此等。 The monomers necessary to obtain a polymer having a specific functional group are listed below, and specific examples of the specific monomer X3 can be cited. But it is not limited to this.

作為具有羧基之單體,例如可舉出丙烯酸、甲基丙烯酸、巴豆酸、單-(2-(丙烯醯氧基)乙基)鄰苯二甲酸酯、單-(2-(甲基丙烯醯氧)乙基)鄰苯二甲酸酯、N-(羧基苯基)馬來醯亞胺、N-(羧基苯基)甲基丙烯醯基及N-(羧基苯基)丙烯醯基等。 As the monomer having a carboxyl group, for example, acrylic acid, methacrylic acid, crotonic acid, mono-(2-(acryloyloxy)ethyl)phthalate, mono-(2-(methacrylic acid) ((Oxy)ethyl)phthalate, N-(carboxyphenyl)maleimide, N-(carboxyphenyl)methacryloyl and N-(carboxyphenyl)acryloyl, etc. .

作為具有縮水甘油基之單體,例如可舉出縮水甘油基甲基丙烯酸酯、縮水甘油基丙烯酸酯、烯丙基縮水甘油基醚、3-乙烯基-7-六聯環[4.1.0]庚烷、1,2-環氧基-5-己烯及1,7-辛二烯單環氧化物等。 Examples of monomers having a glycidyl group include glycidyl methacrylate, glycidyl acrylate, allyl glycidyl ether, and 3-vinyl-7-hexaring [4.1.0] Heptane, 1,2-epoxy-5-hexene and 1,7-octadiene monoepoxide, etc.

作為具有羥基之單體,例如可舉出2-羥基乙基丙烯酸酯、2-羥基乙基甲基丙烯酸酯、2-羥基丙基丙烯酸酯、2-羥基丙基甲基丙烯酸酯、4-羥基丁基丙烯酸酯、4-羥基丁基甲基丙烯酸酯、2,3-二羥基丙基丙烯酸酯、2,3-二羥基丙基甲基丙烯酸酯、二乙二醇單丙烯酸酯、二乙二醇單甲基丙烯酸酯、己內酯2-(丙烯醯氧基)乙基酯、己內酯2-(甲基丙烯醯氧)乙基酯、聚(乙二醇)乙基醚丙烯 酸酯、聚(乙二醇)乙基醚甲基丙烯酸酯、5-丙烯醯氧基-6-羥基降冰片烯-2-羧酸-6-內酯及5-甲基丙烯醯氧-6-羥基降冰片烯-2-羧酸-6-內酯等。 Examples of monomers having a hydroxyl group include 2-hydroxyethyl acrylate, 2-hydroxyethyl methacrylate, 2-hydroxypropyl acrylate, 2-hydroxypropyl methacrylate, and 4-hydroxyethyl methacrylate. Butyl acrylate, 4-hydroxybutyl methacrylate, 2,3-dihydroxypropyl acrylate, 2,3-dihydroxypropyl methacrylate, diethylene glycol monoacrylate, diethylene glycol mono Methacrylate, caprolactone 2-(acryloxy) ethyl ester, caprolactone 2-(methacryloxy) ethyl ester, poly(ethylene glycol) ethyl ether propylene Ester, poly(ethylene glycol) ethyl ether methacrylate, 5-propenoxy-6-hydroxynorbornene-2-carboxylic acid-6-lactone and 5-methacryloxy-6 -Hydroxynorbornene-2-carboxylic acid-6-lactone and the like.

作為具有胺基之單體,例如可舉出2-胺基乙基丙烯酸酯及2-胺基甲基甲基丙烯酸酯等。 Examples of monomers having an amino group include 2-aminoethyl acrylate, 2-aminomethyl methacrylate, and the like.

作為具有酚性羥基之單體,例如可舉出羥基苯乙烯、N-(羥基苯基)丙烯醯基、N-(羥基苯基)甲基丙烯醯基及N-(羥基苯基)馬來醯亞胺等。 Examples of monomers having a phenolic hydroxyl group include hydroxystyrene, N-(hydroxyphenyl)acryloyl, N-(hydroxyphenyl)methacryloyl, and N-(hydroxyphenyl)maleic group. Diimines and so on.

作為具有異氰酸酯基之單體,例如可舉出丙烯醯基乙基異氰酸酯、甲基丙烯醯基乙基異氰酸酯及m-四甲基二甲苯異氰酸酯等。 Examples of the monomer having an isocyanate group include acryloyl ethyl isocyanate, methacryloyl ethyl isocyanate, m-tetramethyl xylene isocyanate, and the like.

如上述,對於藉由與前述特定官能基之反應而得的前述式(b2)所示特定側鏈,作為R61的具體例子,可舉出下述式(B-1)~式(B-11)等。 As described above, for the specific side chain represented by the formula (b2) obtained by the reaction with the specific functional group , specific examples of R 61 include the following formulas (B-1) to (B- 11) etc.

Figure 109112027-A0101-12-0041-11
Figure 109112027-A0101-12-0041-11

(式中,*表示R62與所鍵結的形成雙鍵的碳原子之鍵結處數目)。 (In the formula, * represents the number of bonding places between R 62 and the carbon atom forming a double bond).

又,對於本發明,得到(C)成分之聚合物時,特定單體X1可與特定單體X3以外的該單體進行共聚合,可併用不具有前述(A)成分之可進行熱交聯之官能基(即羥基、羧基、胺基、烷氧基矽基等)的單體。 Furthermore, in the present invention, when obtaining the polymer of the component (C), the specific monomer X1 can be copolymerized with the monomer other than the specific monomer X3, and it can be used in combination without the component (A), which can be thermally crosslinked. The functional group (ie, hydroxyl, carboxyl, amine, alkoxysilyl, etc.) monomers.

作為如此單體之具體例子,可舉出特定單體X1、以及具有與特定單體X3相異結構之丙烯酸酯化合物或甲基丙烯酸酯化合物、馬來醯亞胺化合物、丙烯醯基化合物、丙烯腈、馬來酸酐、苯乙烯化合物及乙烯基化合物等(以下亦稱為單體X4)。 As specific examples of such monomers, specific monomers X1, and acrylate compounds or methacrylate compounds having a structure different from that of specific monomer X3, maleimide compounds, acryl-based compounds, propylene Nitriles, maleic anhydride, styrene compounds, vinyl compounds, etc. (hereinafter also referred to as monomer X4).

以下雖舉出前述單體X4之具體例子,但未限定於此等。 Although specific examples of the aforementioned monomer X4 are given below, it is not limited to these.

作為前述單體X4的例子之丙烯酸酯化合物,例如可舉出甲基丙烯酸酯、乙基丙烯酸酯、n-丙基丙烯酸酯、異丙基丙烯酸酯、n-丁基丙烯酸酯、異丁基丙烯酸酯、t-丁基丙烯酸酯、苯甲基丙烯酸酯、萘丙烯酸酯、蒽基丙烯酸酯、蒽基甲基丙烯酸酯、苯基丙烯酸酯、縮水甘油基丙烯酸酯、2,2,2-三氟乙基丙烯酸酯、環己基丙烯酸酯、異冰片基丙烯酸酯、2-甲氧基乙基丙烯酸酯、甲氧基三乙二醇丙烯酸酯、2-乙氧基乙基丙烯酸酯、四氫糠基丙烯酸酯、3-甲氧基丁基丙烯酸酯、2-甲基-2-金剛烷基丙烯酸酯、2-丙基-2-金剛烷基丙烯酸酯、8-甲基-8-三環癸基丙烯酸酯及8-乙基-8-三環癸基丙烯酸酯等。 Examples of acrylate compounds as examples of the aforementioned monomer X4 include methacrylate, ethacrylate, n-propyl acrylate, isopropyl acrylate, n-butyl acrylate, and isobutyl acrylate. Esters, t-butyl acrylate, benzyl acrylate, naphthalene acrylate, anthracenyl acrylate, anthryl methacrylate, phenyl acrylate, glycidyl acrylate, 2,2,2-trifluoro Ethyl acrylate, cyclohexyl acrylate, isobornyl acrylate, 2-methoxyethyl acrylate, methoxytriethylene glycol acrylate, 2-ethoxyethyl acrylate, tetrahydrofurfuryl Acrylate, 3-methoxybutyl acrylate, 2-methyl-2-adamantyl acrylate, 2-propyl-2-adamantyl acrylate, 8-methyl-8-tricyclodecyl Acrylate and 8-ethyl-8-tricyclodecyl acrylate, etc.

作為前述單體X4之例子的甲基丙烯酸酯化合物,例如可舉出甲基甲基丙烯酸酯、乙基甲基丙烯酸酯、n-丙基甲基丙烯酸酯、異丙基甲基丙烯酸酯、n-丁基甲基丙烯酸酯、異丁基甲基丙烯酸酯、t-丁基甲基丙烯酸酯、苯甲基甲基丙烯酸酯、萘甲基丙烯酸酯、蒽基甲基丙烯酸酯、蒽基甲基甲基丙烯酸酯、苯基甲基丙烯酸酯、縮水甘油基甲基丙烯酸酯、2,2,2-三氟乙基甲基丙烯酸酯、環己基甲基丙烯酸酯、異冰片基甲基丙烯酸酯、2-甲氧基乙基甲基丙烯酸酯、甲氧基三乙二醇甲基丙烯酸酯、2-乙氧基乙基甲基丙烯酸酯、四氫糠基甲基丙烯酸酯、3-甲氧基丁基甲基丙烯酸酯、2-甲基-2-金剛烷基甲基丙烯酸酯、γ-丁內酯甲基丙烯酸酯、2-丙基-2-金剛烷基甲基丙烯酸酯、8-甲基-8-三環癸基甲基丙烯酸酯及8-乙基-8-三環癸基甲基丙烯酸酯等。 The methacrylate compound as an example of the aforementioned monomer X4 includes, for example, methacrylate, ethyl methacrylate, n-propyl methacrylate, isopropyl methacrylate, n -Butyl methacrylate, isobutyl methacrylate, t-butyl methacrylate, benzyl methacrylate, naphthalene methacrylate, anthryl methacrylate, anthryl methacrylate, benzene Methyl methacrylate, glycidyl methacrylate, 2,2,2-trifluoroethyl methacrylate, cyclohexyl methacrylate, isobornyl methacrylate, 2-methoxyethyl Methyl methacrylate, methoxytriethylene glycol methacrylate, 2-ethoxyethyl methacrylate, tetrahydrofurfuryl methacrylate, 3-methoxybutyl methacrylate, 2 -Methyl-2-adamantyl methacrylate, γ-butyrolactone methacrylate, 2-propyl-2-adamantyl methacrylate, 8-methyl-8-tricyclodecyl Methacrylate and 8-ethyl-8-tricyclodecyl methacrylate, etc.

作為前述單體X4的例子之乙烯基化合物,例如可舉出甲基乙烯基醚、苯甲基乙烯基醚、乙烯基萘、乙烯基咔唑、烯丙基縮水甘油基醚、3-乙烯基-7-六聯環[4.1.0]庚烷、1,2-環氧基-5-己烯及1,7-辛二烯單環氧化物等。 Examples of vinyl compounds as examples of the aforementioned monomer X4 include methyl vinyl ether, benzyl vinyl ether, vinyl naphthalene, vinyl carbazole, allyl glycidyl ether, 3-vinyl -7-hexacyclo[4.1.0]heptane, 1,2-epoxy-5-hexene and 1,7-octadiene monoepoxide, etc.

作為前述單體X4的例子之苯乙烯化合物,例如可舉出苯乙烯、甲基苯乙烯、氯苯乙烯、溴苯乙烯等。 Examples of styrene compounds that are examples of the aforementioned monomer X4 include styrene, methylstyrene, chlorostyrene, and bromostyrene.

作為前述單體X4的例子之馬來醯亞胺化合物,例如可舉出馬來醯亞胺、N-甲基馬來醯亞胺、N-苯基馬來醯亞胺、及N-環己基馬來醯亞胺等。 Examples of the maleimide compound as an example of the aforementioned monomer X4 include maleimide, N-methylmaleimide, N-phenylmaleimide, and N-cyclohexylimine. Leimine and so on.

(C)成分之聚合物中,N-烷氧基甲基的存在比例對於該聚合物之全重複單位100莫耳而言,以40莫耳%~90莫耳%為佳,以50莫耳%~85莫耳%為更佳。 In the polymer of component (C), the proportion of N-alkoxymethyl is 40 mol%~90 mol% for the total repeating unit of the polymer 100 mol, and 50 mol% %~85mol% is better.

即,欲得到(C)成分之特定共聚物2而使用的特定單體X1(賦予N-烷氧基甲基之單體)的使用量,以欲得到(C)成分的特定共聚物2所使用的全單體合計量為基準,以40莫耳%~90莫耳%為佳,以50莫耳%~85莫耳%為更佳。 That is, the amount of the specific monomer X1 (N-alkoxymethyl-imparting monomer) used to obtain the specific copolymer 2 of the component (C) is determined by the specific copolymer 2 of the component (C). The total amount of all monomers used is the basis, preferably 40 mol%~90 mol%, and more preferably 50 mol%~85 mol%.

合計若未達40莫耳%時,有時藉由與(A)成分之熱交聯的硬化會有不充分的情況,若比90莫耳%大時,對與液晶層之密著性有著壞影響的情況會產生。 If the total is less than 40 mol%, the curing by thermal cross-linking with component (A) may be insufficient. If it is greater than 90 mol%, it will have an effect on the adhesion to the liquid crystal layer. A bad influence situation will occur.

(C)成分的聚合物中含有C=C雙鍵之聚合性基的存在比例對於該聚合物的全重複單位100莫耳而言,以10莫耳%~60莫耳%為佳,以15莫耳%~50莫耳%為更佳。 (C) The proportion of polymerizable groups containing C=C double bonds in the polymer of the component is 10 mol% to 60 mol% for the total repeating unit of the polymer 100 mol, preferably 15 mol% Moear%~50mol% is better.

即,欲使用於得到(C)成分之特定共聚物2的特定單體X3(具有欲與於末端具有不飽和鍵(C=C雙鍵)之化合物的特定化合物進行反應的官能基(特定官能基)之單體)的使用量,以,欲得到(C)成分之特定共聚物2時所使用的全單體合計量為基準下以10莫耳%~60莫耳%為佳,以15莫耳%~50莫耳%為更佳。 That is, to be used to obtain the specific monomer X3 of the specific copolymer 2 of the component (C) (having a functional group (specific functional group) to react with a specific compound of a compound having an unsaturated bond (C=C double bond) at the end The usage amount of the monomer) is preferably 10 mol% to 60 mol% based on the total amount of all monomers used when the specific copolymer 2 of component (C) is to be obtained, and 15 Moear%~50mol% is better.

合計若未達10莫耳%時,與液晶層之密著性會有不充分的情況產生,比60莫耳%大時,藉由與(A)成分之熱交聯的硬化會有不充分的情況產生。 If the total is less than 10 mol%, the adhesion to the liquid crystal layer may be insufficient. If it is greater than 60 mol%, the curing by thermal cross-linking with the component (A) may be insufficient. The situation arises.

欲得到(C)成分的例子之特定共聚物2的方法並無特別限定,例如於可共存特定單體X1、特定單體X3、依所需之此以外的單體(例如單體X4)與聚合起始劑等之溶劑中,在50℃~110℃的溫度下藉由聚合反應得到。此時,所使用的溶劑僅為可溶解上述特定單體X1、特定單體X3、依所需使用之此以外的單體及聚合起始劑等者即可並無特別限定。作為具體例子,如後述[溶劑]之項所記載。 The method for obtaining the specific copolymer 2 as an example of the component (C) is not particularly limited. For example, the specific monomer X1, the specific monomer X3, and other monomers (for example, the monomer X4) and the It can be obtained by polymerization reaction at a temperature of 50°C to 110°C in a solvent such as a polymerization initiator. At this time, the solvent to be used is only one that can dissolve the above-mentioned specific monomer X1, specific monomer X3, other monomers and polymerization initiators used as needed, and is not particularly limited. As a specific example, it is as described in the item of [solvent] mentioned later.

藉由以上方法所得之(C)成分的例子之丙烯酸聚合物,一般為溶解於溶劑之溶液狀態,本發明中可作為(C)成分的溶液而直接使用。 The acrylic polymer as an example of the component (C) obtained by the above method is generally in the state of a solution dissolved in a solvent, and can be used directly as a solution of the component (C) in the present invention.

又,將以上述方法所得之(C)成分的例子之丙烯酸聚合物的溶液投入於攪拌下之二乙基醚或水等中使其再沉澱,將生成的沉澱物經過濾‧洗淨後,在常壓或減壓下,進行常溫乾燥或加熱乾燥,可使其成為(C)成分的特定共聚物2之粉體。藉由上述操作,可除去與(C)成分之特定共聚物2共存的聚合起始劑及未反應的單體,其結果,可得到經純化的(C)成分之例子的特定共聚物2之粉體。若一次操作無法充分純化時,將所得之粉體再溶解於溶劑中,重複進行上述操作即可。 In addition, the acrylic polymer solution, which is an example of component (C) obtained by the above method, is poured into diethyl ether or water under stirring to re-precipitate, and the resulting precipitate is filtered and washed, It can be made into the powder of the specific copolymer 2 of the component (C) by performing room temperature drying or heat drying under normal pressure or reduced pressure. By the above operation, the polymerization initiator and unreacted monomer coexisting with the specific copolymer 2 of the component (C) can be removed. As a result, a purified specific copolymer 2 of the example of the component (C) can be obtained Powder. If it is not possible to purify sufficiently in one operation, dissolve the obtained powder in the solvent again and repeat the above operation.

對於形成本發明之光學薄膜中之表面硬化膜的組成物,(C)成分的特定共聚物2可以粉體形態、或將經純化的粉末再溶解於後述溶劑的溶液形態下使用。 For the composition forming the surface cured film in the optical film of the present invention, the specific copolymer 2 of the component (C) can be used in the form of a powder or a solution in which the purified powder is re-dissolved in the solvent described below.

又,對於形成本發明之光學薄膜中之表面硬 化膜的組成物,(C)成分的特定共聚物2可為複數種混合物。 In addition, for the hard surface of the optical film of the present invention In the composition of the chemical film, the specific copolymer 2 of the component (C) may be a mixture of plural kinds.

如此聚合物的重量平均分子量為1,000~500,000,以2,000~200,000為佳,較佳為3,000~150,000,更佳為3,000~50,000。 The weight average molecular weight of such a polymer is 1,000 to 500,000, preferably 2,000 to 200,000, preferably 3,000 to 150,000, and more preferably 3,000 to 50,000.

本發明之實施形態的硬化膜形成組成物中之(C)成分的含有量對於(A)成分之聚合物及(B)成分的交聯劑之合計量100質量份而言,以0.1質量份~100質量份為佳,更佳為5質量份~70質量份。若使(C)成分的含有量在0.1質量份以上時,於所形成的硬化膜可賦予充分密著性。然而,若比100質量份多時,液晶配向性容易降低。 The content of the (C) component in the cured film forming composition of the embodiment of the present invention is 0.1 parts by mass relative to 100 parts by mass of the total amount of the polymer of the component (A) and the crosslinking agent of the (B) component ~100 parts by mass is better, more preferably 5 parts by mass to 70 parts by mass. When the content of the component (C) is 0.1 parts by mass or more, sufficient adhesiveness can be imparted to the cured film formed. However, if it is more than 100 parts by mass, the liquid crystal alignment tends to decrease.

且,(B)成分為上述特定共聚物2,且(C)成分與(B)成分為相同(同一化合物)時,(C)成分的配合量視為(B)成分之配合量(此時調配上將(C)成分的配合量視為0)。 And, when the component (B) is the above-mentioned specific copolymer 2, and the component (C) and the component (B) are the same (the same compound), the compounding quantity of the component (C) is regarded as the compounding quantity of the component (B) (in this case Regarding the blending, the blending amount of the component (C) is regarded as 0).

又,對於本實施形態之硬化膜形成組成物,(C)成分可為(C)成分之化合物的複數種混合物。 In addition, in the cured film forming composition of the present embodiment, the component (C) may be a mixture of plural kinds of compounds of the component (C).

<(D)成分> <(D) Ingredients>

本發明之硬化膜形成組成物為含有前述(C)成分:密著促進劑與(D)成分:具有熱交聯性基之聚合物中任一方或者雙方。 The cured film forming composition of the present invention contains either or both of the aforementioned (C) component: adhesion promoter and (D) component: a polymer having a thermally crosslinkable group.

作為本發明之(D)成分的聚合物(以下亦稱為特定聚合物),例如可舉出丙烯酸聚合物、聚醯胺酸、聚醯亞胺、聚乙烯醇、聚酯、聚酯聚羧酸、聚醚多元醇、聚酯多元 醇、聚碳酸酯多元醇、聚己內酯多元醇、聚伸烷基亞胺、聚烯丙基胺、纖維素類(纖維素或其衍生物)、酚酚醛清漆樹脂、三聚氰胺甲醛樹脂等具有直鏈結構或分支結構之聚合物、環糊精類等環狀聚合物等。 As the polymer of the component (D) of the present invention (hereinafter also referred to as a specific polymer), for example, acrylic polymer, polyamide acid, polyimide, polyvinyl alcohol, polyester, polyester polycarboxylate Acid, polyether polyol, polyester polyol Alcohol, polycarbonate polyol, polycaprolactone polyol, polyalkyleneimine, polyallylamine, cellulose (cellulose or its derivatives), phenol novolak resin, melamine formaldehyde resin, etc. Linear or branched polymers, cyclic polymers such as cyclodextrins, etc.

作為(D)成分之特定聚合物,較佳可舉出丙烯酸聚合物、羥基烷基環糊精類、纖維素類、聚醚多元醇、聚酯多元醇、聚碳酸酯多元醇以及聚己內酯多元醇。 The specific polymer of (D) component preferably includes acrylic polymers, hydroxyalkyl cyclodextrins, celluloses, polyether polyols, polyester polyols, polycarbonate polyols, and polycaprolactone. Ester polyol.

作為(D)成分的特定聚合物之較佳一例的丙烯酸聚合物,其為丙烯酸、甲基丙烯酸、苯乙烯、乙烯基化合物等具有不飽和雙鍵之單體經聚合所得之聚合物,僅為可藉由將含有具有下述特定官能基D的單體之單體或該混合物進行聚合而得之聚合物即可,對於構成丙烯酸聚合物之高分子的主鏈之骨架及側鏈種類等並無特別限定。 The acrylic polymer, which is a preferable example of the specific polymer of the component (D), is a polymer obtained by polymerizing monomers having unsaturated double bonds such as acrylic acid, methacrylic acid, styrene, and vinyl compounds. It is only The polymer can be obtained by polymerizing a monomer or a mixture containing a monomer having the following specific functional group D. The main chain skeleton and side chain types of the polymer constituting the acrylic polymer are combined There is no particular limitation.

作為具有特定官能基D之單體,可舉出具有聚乙二醇酯基之單體、具有碳原子數2~5的羥基烷基酯基之單體、具有酚性羥基之單體、具有羧基之單體、具有胺基之單體、具有烷氧基矽基之單體、具有乙醯乙醯氧基之單體、具有醯胺基之單體等。 Examples of monomers having a specific functional group D include monomers having polyethylene glycol ester groups, monomers having hydroxyalkyl ester groups with 2 to 5 carbon atoms, monomers having phenolic hydroxyl groups, and monomers having phenolic hydroxyl groups. Monomers with carboxyl groups, monomers with amine groups, monomers with alkoxysilyl groups, monomers with acetyl acetoxy groups, monomers with amide groups, etc.

作為具有上述聚乙二醇酯基之單體,可舉出H-(OCH2CH2)p-OH之單丙烯酸酯或單甲基丙烯酸酯。該p值為2~50,較佳為2~10。 Examples of the monomer having the above-mentioned polyethylene glycol ester group include the monoacrylate or monomethacrylate of H-(OCH 2 CH 2 )p-OH. The p value is 2-50, preferably 2-10.

作為具有上述碳原子數2~5的羥基烷基酯基之單體,例如可舉出2-羥基乙基甲基丙烯酸酯、2-羥基乙基丙烯酸酯、2-羥基丙基甲基丙烯酸酯、2-羥基丙基丙烯 酸酯、4-羥基丁基丙烯酸酯、4-羥基丁基甲基丙烯酸酯。 Examples of monomers having the above-mentioned hydroxyalkyl ester group having 2 to 5 carbon atoms include 2-hydroxyethyl methacrylate, 2-hydroxyethyl acrylate, and 2-hydroxypropyl methacrylate. , 2-Hydroxypropyl propylene Acid ester, 4-hydroxybutyl acrylate, 4-hydroxybutyl methacrylate.

作為具有上述酚性羥基之單體,例如可舉出p-羥基苯乙烯、m-羥基苯乙烯、o-羥基苯乙烯。 Examples of the monomer having the above-mentioned phenolic hydroxyl group include p-hydroxystyrene, m-hydroxystyrene, and o-hydroxystyrene.

作為具有上述羧基之單體,例如可舉出丙烯酸、甲基丙烯酸、乙烯基安息香酸。 Examples of the monomer having the above-mentioned carboxyl group include acrylic acid, methacrylic acid, and vinyl benzoic acid.

作為上述於側鏈具有胺基之單體,例如可舉出2-胺基乙基丙烯酸酯、2-胺基乙基甲基丙烯酸酯、胺基丙基丙烯酸酯及胺基丙基甲基丙烯酸酯。 Examples of the monomer having an amino group in the side chain include 2-aminoethyl acrylate, 2-aminoethyl methacrylate, aminopropyl acrylate, and aminopropyl methacrylate. ester.

作為上述於側鏈具有烷氧基矽基的單體,例如可舉出3-丙烯醯氧基丙基三甲氧基矽烷、3-丙烯醯氧基丙基三乙氧基矽烷、3-甲基丙烯醯氧基丙基三甲氧基矽烷、3-甲基丙烯醯氧基丙基三甲氧基矽烷、乙烯基三甲氧基矽烷、乙烯基三乙氧基矽烷、烯丙基三甲氧基矽烷及烯丙基三乙氧基矽烷等。 As the monomer having an alkoxysilyl group on the side chain, for example, 3-propenyloxypropyltrimethoxysilane, 3-propenyloxypropyltriethoxysilane, 3-methyl Acrylic oxypropyl trimethoxy silane, 3-methacryloxy propyl trimethoxy silane, vinyl trimethoxy silane, vinyl triethoxy silane, allyl trimethoxy silane and alkene Propyl triethoxysilane and so on.

作為上述於側鏈具有乙醯乙醯氧基的單體,例如可舉出2-乙醯乙醯氧基乙基丙烯酸酯、2-乙醯乙醯氧基乙基甲基丙烯酸酯等。 Examples of the monomer having an acetylacetoxy group in the side chain include 2-acetylacetoxyethyl acrylate, 2-acetylacetoxyethyl methacrylate, and the like.

又,對於本實施形態,合成(D)成分之例子的丙烯酸聚合物時,以不損害本發明之效果下,不具有上述特定官能基D之單體,例如可併用不具有羥基、羧基、醯胺基、胺基、烷氧基矽基及乙醯乙醯氧基中任一種的單體。 In addition, in this embodiment, when synthesizing the acrylic polymer as an example of component (D), in order not to impair the effects of the present invention, monomers that do not have the above-mentioned specific functional group D, for example, can be used in combination without a hydroxyl group, a carboxyl group, or a glutamate. A monomer of any one of amine group, amine group, alkoxysilyl group and acetyl acetoxy group.

作為如此單體之具體例子,可舉出丙烯酸酯化合物、甲基丙烯酸酯化合物、馬來醯亞胺化合物、丙烯 腈、馬來酸酐、苯乙烯化合物及乙烯基化合物等。 As specific examples of such monomers, acrylate compounds, methacrylate compounds, maleimide compounds, acrylic Nitriles, maleic anhydride, styrene compounds and vinyl compounds, etc.

作為丙烯酸酯化合物,例如可舉出甲基丙烯酸酯、乙基丙烯酸酯、異丙基丙烯酸酯、苯甲基丙烯酸酯、萘丙烯酸酯、蒽基丙烯酸酯、蒽基甲基丙烯酸酯、苯基丙烯酸酯、2,2,2-三氟乙基丙烯酸酯、tert-丁基丙烯酸酯、環己基丙烯酸酯、異冰片基丙烯酸酯、2-甲氧基乙基丙烯酸酯、甲氧基三乙二醇丙烯酸酯、2-乙氧基乙基丙烯酸酯、四氫糠基丙烯酸酯、3-甲氧基丁基丙烯酸酯、2-甲基-2-金剛烷基丙烯酸酯、2-丙基-2-金剛烷基丙烯酸酯、8-甲基-8-三環癸基丙烯酸酯及8-乙基-8-三環癸基丙烯酸酯等。 Examples of acrylate compounds include methacrylate, ethacrylate, isopropyl acrylate, benzyl methacrylate, naphthalene acrylate, anthracenyl acrylate, anthryl methacrylate, and phenyl acrylate. Esters, 2,2,2-trifluoroethyl acrylate, tert-butyl acrylate, cyclohexyl acrylate, isobornyl acrylate, 2-methoxyethyl acrylate, methoxytriethylene glycol Acrylate, 2-ethoxyethyl acrylate, tetrahydrofurfuryl acrylate, 3-methoxybutyl acrylate, 2-methyl-2-adamantyl acrylate, 2-propyl-2- Adamantyl acrylate, 8-methyl-8-tricyclodecyl acrylate, 8-ethyl-8-tricyclodecyl acrylate, etc.

作為甲基丙烯酸酯化合物,例如可舉出甲基甲基丙烯酸酯、乙基甲基丙烯酸酯、異丙基甲基丙烯酸酯、苯甲基甲基丙烯酸酯、萘甲基丙烯酸酯、蒽基甲基丙烯酸酯、蒽基甲基甲基丙烯酸酯、苯基甲基丙烯酸酯、2,2,2-三氟乙基甲基丙烯酸酯、tert-丁基甲基丙烯酸酯、環己基甲基丙烯酸酯、異冰片基甲基丙烯酸酯、2-甲氧基乙基甲基丙烯酸酯、甲氧基三乙二醇甲基丙烯酸酯、2-乙氧基乙基甲基丙烯酸酯、四氫糠基甲基丙烯酸酯、3-甲氧基丁基甲基丙烯酸酯、2-甲基-2-金剛烷基甲基丙烯酸酯、2-丙基-2-金剛烷基甲基丙烯酸酯、8-甲基-8-三環癸基甲基丙烯酸酯及8-乙基-8-三環癸基甲基丙烯酸酯等。 As the methacrylate compound, for example, methacrylate, ethyl methacrylate, isopropyl methacrylate, benzyl methacrylate, naphthalene methacrylate, anthrylmethyl Methyl acrylate, anthryl methyl methacrylate, phenyl methacrylate, 2,2,2-trifluoroethyl methacrylate, tert-butyl methacrylate, cyclohexyl methacrylate, iso Bornyl methacrylate, 2-methoxyethyl methacrylate, methoxytriethylene glycol methacrylate, 2-ethoxyethyl methacrylate, tetrahydrofurfuryl methacrylate Ester, 3-methoxybutyl methacrylate, 2-methyl-2-adamantyl methacrylate, 2-propyl-2-adamantyl methacrylate, 8-methyl-8-tri Cyclodecyl methacrylate and 8-ethyl-8-tricyclodecyl methacrylate, etc.

作為馬來醯亞胺化合物,例如可舉出馬來醯亞胺、N-甲基馬來醯亞胺、N-苯基馬來醯亞胺、及N-環 己基馬來醯亞胺等。 Examples of the maleimide compound include maleimide, N-methylmaleimide, N-phenylmaleimide, and N-ring Hexyl maleimide and so on.

作為苯乙烯化合物,例如可舉出苯乙烯、甲基苯乙烯、氯苯乙烯、溴苯乙烯等。 Examples of styrene compounds include styrene, methylstyrene, chlorostyrene, bromostyrene, and the like.

作為乙烯基化合物,例如可舉出乙烯基醚、甲基乙烯基醚、苯甲基乙烯基醚、2-羥基乙基乙烯基醚、苯基乙烯基醚及丙基乙烯基醚等。 Examples of vinyl compounds include vinyl ether, methyl vinyl ether, benzyl vinyl ether, 2-hydroxyethyl vinyl ether, phenyl vinyl ether, and propyl vinyl ether.

欲得到(D)成分之例子的丙烯酸聚合物時所使用的具有特定官能基D之單體的使用量,以欲得到(D)成分之丙烯酸聚合物時所使用的全單體合計量為基準,以2莫耳%~98莫耳%者為佳。具有特定官能基D之單體若過小時,所得之硬化膜的液晶配向性會有容易不充分,過大時與(A)成分之相溶性容易降低。 The usage amount of the monomer having the specific functional group D used when obtaining the acrylic polymer of the example of the component (D) is based on the total amount of all monomers used when obtaining the acrylic polymer of the component (D) , Preferably 2 mol%~98 mol%. If the monomer having the specific functional group D is too small, the liquid crystal alignment of the cured film obtained will tend to be insufficient, and if it is too large, the compatibility with the component (A) will tend to decrease.

欲得到(D)成分的例子的丙烯酸聚合物之方法並無特別限定,例如於共存含有具有特定官能基D之單體的單體、依所需不具有特定官能基D之單體、與聚合起始劑等於溶劑中,在50℃~110℃的溫度下藉由聚合反應而得。此時,所使用的溶劑僅可溶解具有特定官能基D之單體與依所需使用的不具有特定官能基D之單體及聚合起始劑等者即可,並無特別限定。作為具體例子,如後述[溶劑]項所記載。 The method for obtaining the acrylic polymer as an example of the component (D) is not particularly limited. For example, in the coexistence of a monomer containing a monomer having a specific functional group D, a monomer that does not have a specific functional group D as required, and polymerization The initiator is equal to the solvent and is obtained by polymerization at a temperature of 50°C to 110°C. At this time, the solvent used can only dissolve the monomer having the specific functional group D, the monomer without the specific functional group D and the polymerization initiator used as needed, and is not particularly limited. As a specific example, it is as described in the item of [solvent] mentioned later.

藉由以上方法所得之(D)成分的例子之丙烯酸聚合物一般為溶解於溶劑之溶液狀態。 The acrylic polymer as an example of the component (D) obtained by the above method is generally in the state of a solution dissolved in a solvent.

又,將以上述方法所得之(D)成分的例子之丙烯酸聚合物的溶液,投入於攪拌下的二乙基醚或水等使其 再沉澱,將所生成之沉澱物經過濾‧洗淨後,在常壓或減壓下,進行常溫乾燥或加熱乾燥,可成為(D)成分的例子之丙烯酸聚合物的粉體。藉由上述操作,可除去與(D)成分的例子之丙烯酸聚合物共存之聚合起始劑及未反應的單體,其結果,得到經純化之(B)成分的例子之丙烯酸聚合物的粉體。若無法一次操作下充分純化時,將所得之粉體於溶劑中再溶解,重複上述操作即可。 In addition, the acrylic polymer solution, which is an example of the component (D) obtained by the above method, is poured into diethyl ether or water under stirring to make After re-precipitation, the resulting precipitate is filtered and washed, dried at room temperature or heated under normal pressure or reduced pressure, and can become acrylic polymer powder as an example of component (D). By the above operation, the polymerization initiator and unreacted monomers coexisting with the acrylic polymer of the example of the component (D) can be removed. As a result, a purified powder of the acrylic polymer of the example of the (B) component can be obtained. body. If it is not possible to fully purify in one operation, re-dissolve the obtained powder in a solvent and repeat the above operation.

(D)成分的較佳例子之丙烯酸聚合物的重量平均分子量以3,000~200,000為佳,以4,000~150,000為較佳,以5,000~100,000為更佳。重量平均分子量若超過200,000的過大者時,對於溶劑之溶解性會降低而使處理性降低之情況會產生,若重量平均分子量未達3,000而過小者時,於熱硬化時之硬化變得不足而有降低溶劑耐性及耐熱性之情況產生。且,重量平均分子量為藉由凝膠滲透層析法(GPC),作為標準試料使用聚苯乙烯所得之值。以下對於本說明書亦為相同。 (D) The weight average molecular weight of the acrylic polymer of the preferred example of the component is preferably 3,000 to 200,000, preferably 4,000 to 150,000, and more preferably 5,000 to 100,000. If the weight average molecular weight exceeds 200,000, the solubility to the solvent will be reduced and the handling properties will decrease. If the weight average molecular weight is less than 3,000 but too small, the curing during thermal curing becomes insufficient. There are cases where solvent resistance and heat resistance are reduced. In addition, the weight average molecular weight is a value obtained by gel permeation chromatography (GPC) using polystyrene as a standard sample. The following is the same for this manual.

其次,作為(D)成分的特定聚合物之較佳一例子的聚醚多元醇,可舉出於聚乙二醇、聚丙二醇、丙二醇或雙酚A、三乙二醇、山梨醇等多元醇加成環氧丙烷或聚乙二醇、聚丙二醇等者。作為聚醚多元醇之具體例子,可舉出(股)ADEKA製Adeka聚醚P系列、G系列、EDP系列、BPX系列、FC系列、CM系列、日油(股)製Uniox(註冊商標)HC-40、HC-60、ST-30E、ST-40E、G-450、G-750、Uniol(註冊商標)TG-330、TG-1000、TG-3000、TG- 4000、HS-1600D、DA-400、DA-700、DB-400、非離子(註冊商標)LT-221、ST-221、OT-221等。 Next, as a preferable example of the specific polymer of the component (D), polyether polyols include polyols such as polyethylene glycol, polypropylene glycol, propylene glycol, or bisphenol A, triethylene glycol, and sorbitol. Adding propylene oxide, polyethylene glycol, polypropylene glycol, etc. Specific examples of polyether polyols include Adeka polyether P series, G series, EDP series, BPX series, FC series, CM series, and Uniox (registered trademark) HC manufactured by ADEKA. -40, HC-60, ST-30E, ST-40E, G-450, G-750, Uniol (registered trademark) TG-330, TG-1000, TG-3000, TG- 4000, HS-1600D, DA-400, DA-700, DB-400, non-ionic (registered trademark) LT-221, ST-221, OT-221, etc.

作為(D)成分的特定聚合物之較佳一例子的聚酯多元醇,可舉出於己二酸、癸二酸、異鄰苯二甲酸等多價羧酸使乙二醇、丙二醇、丁二醇、聚乙二醇、聚丙二醇等二醇進行反應者。作為聚酯多元醇之具體例子,可舉出DIC(股)製POLYLITE(註冊商標)OD-X-286、OD-X-102、OD-X-355、OD-X-2330、OD-X-240、OD-X-668、OD-X-2108、OD-X-2376、OD-X-2044、OD-X-688、OD-X-2068、OD-X-2547、OD-X-2420、OD-X-2523、OD-X-2555、OD-X-2560、(股)Kuraray製多元醇P-510、P-1010、P-2010、P-3010、P-4010、P-5010、P-6010、F-510、F-1010、F-2010、F-3010、P-1011、P-2011、P-2013、P-2030、N-2010、PNNA-2016等。 As a preferred example of the specific polymer of the component (D), polyester polyols include polyvalent carboxylic acids such as adipic acid, sebacic acid, and isophthalic acid, ethylene glycol, propylene glycol, butane Diol, polyethylene glycol, polypropylene glycol and other glycols are reacted. Specific examples of polyester polyols include POLYLITE (registered trademark) OD-X-286, OD-X-102, OD-X-355, OD-X-2330, OD-X- 240, OD-X-668, OD-X-2108, OD-X-2376, OD-X-2044, OD-X-688, OD-X-2068, OD-X-2547, OD-X-2420, OD-X-2523, OD-X-2555, OD-X-2560, (stock) Kuraray polyol P-510, P-1010, P-2010, P-3010, P-4010, P-5010, P -6010, F-510, F-1010, F-2010, F-3010, P-1011, P-2011, P-2013, P-2030, N-2010, PNNA-2016, etc.

作為(D)成分的特定聚合物之較佳一例子的聚己內酯多元醇,將三羥甲基丙烷或乙二醇等多元醇作為起始劑,使ε-己內酯進行開環聚合者可舉出。作為聚己內酯多元醇之具體例子,可舉出DIC(股)製POLYLITE(註冊商標)OD-X-2155、OD-X-640、OD-X-2568、(股)大賽璐製PLACCEL(註冊商標)205、L205AL、205U、208、210、212、L212AL、220、230、240、303、305、308、312、320等。 The polycaprolactone polyol, which is a preferable example of the specific polymer of the component (D), uses a polyol such as trimethylolpropane or ethylene glycol as an initiator to carry out ring-opening polymerization of ε-caprolactone Those can be cited. Specific examples of polycaprolactone polyols include POLYLITE (registered trademark) OD-X-2155, OD-X-640, OD-X-2568, PLACCEL manufactured by DIC (Stock) Registered trademark) 205, L205AL, 205U, 208, 210, 212, L212AL, 220, 230, 240, 303, 305, 308, 312, 320, etc.

作為(D)成分的特定聚合物之較佳一例子的聚碳酸酯多元醇,可舉出三羥甲基丙烷或乙二醇等多元醇與 碳酸二乙基、碳酸二苯基、伸乙基碳酸酯等進行反應者。作為聚碳酸酯多元醇之具體例子,可舉出(股)大賽璐製PLACCEL(註冊商標)CD205、CD205PL、CD210、CD220、(股)Kuraray製C-590、C-1050、C-2050、C-2090、C-3090等。 As a preferable example of the specific polymer of the component (D), polycarbonate polyols include polyols such as trimethylolpropane or ethylene glycol and Reactors such as diethyl carbonate, diphenyl carbonate, and ethylene carbonate. Specific examples of polycarbonate polyols include PLACCEL (registered trademark) CD205, CD205PL, CD210, CD220 manufactured by Daicel Corporation, and C-590, C-1050, C-2050, C-2050 manufactured by Kuraray -2090, C-3090, etc.

作為(D)成分的特定聚合物之較佳一例子的纖維素,可舉出羥基乙基纖維素、羥基丙基纖維素等羥基烷基纖維素類、羥基乙基甲基纖維素、羥基丙基甲基纖維素、羥基乙基乙基纖維素等羥基烷基烷基纖維素類及纖維素等,例如以羥基乙基纖維素、羥基丙基纖維素等羥基烷基纖維素類為佳。 As a preferable example of the specific polymer of the component (D), cellulose includes hydroxyalkyl celluloses such as hydroxyethyl cellulose and hydroxypropyl cellulose, hydroxyethyl methyl cellulose, and hydroxypropyl cellulose. Hydroxyalkylalkylcelluloses, such as hydroxymethylcellulose and hydroxyethylethylcellulose, and cellulose, etc., for example, hydroxyalkylcelluloses such as hydroxyethylcellulose and hydroxypropylcellulose are preferred.

作為(D)成分的特定聚合物之較佳一例子的環糊精,可舉出α-環糊精、β-環糊精及γ環糊精等環糊精、甲基-α-環糊精、甲基-β-環糊精以及甲基-γ-環糊精等甲基化環糊精、羥基甲基-α-環糊精、羥基甲基-β-環糊精、羥基甲基-γ-環糊精、2-羥基乙基-α-環糊精、2-羥基乙基-β-環糊精、2-羥基乙基-γ-環糊精、2-羥基丙基-α-環糊精、2-羥基丙基-β-環糊精、2-羥基丙基-γ-環糊精、3-羥基丙基-α-環糊精、3-羥基丙基-β-環糊精、3-羥基丙基-γ-環糊精、2,3-二羥基丙基-α-環糊精、2,3-二羥基丙基-β-環糊精、2,3-二羥基丙基-γ-環糊精等羥基烷基環糊精等。 Cyclodextrin as a preferred example of the specific polymer of the component (D) includes cyclodextrins such as α-cyclodextrin, β-cyclodextrin, and γ-cyclodextrin, and methyl-α-cyclodextrin. Methylated cyclodextrin, methyl-β-cyclodextrin and methyl-γ-cyclodextrin, hydroxymethyl-α-cyclodextrin, hydroxymethyl-β-cyclodextrin, hydroxymethyl -γ-cyclodextrin, 2-hydroxyethyl-α-cyclodextrin, 2-hydroxyethyl-β-cyclodextrin, 2-hydroxyethyl-γ-cyclodextrin, 2-hydroxypropyl-α -Cyclodextrin, 2-hydroxypropyl-β-cyclodextrin, 2-hydroxypropyl-γ-cyclodextrin, 3-hydroxypropyl-α-cyclodextrin, 3-hydroxypropyl-β-ring Dextrin, 3-hydroxypropyl-γ-cyclodextrin, 2,3-dihydroxypropyl-α-cyclodextrin, 2,3-dihydroxypropyl-β-cyclodextrin, 2,3-di Hydroxyalkyl cyclodextrins such as hydroxypropyl-γ-cyclodextrin and the like.

作為(D)成分的特定聚合物之較佳一例子的三聚氰胺甲醛樹脂,如將三聚氰胺與甲醛經聚縮合而得之樹脂的下述式所示者。 The melamine formaldehyde resin which is a preferable example of the specific polymer of the component (D) is represented by the following formula of a resin obtained by polycondensing melamine and formaldehyde.

Figure 109112027-A0101-12-0054-12
Figure 109112027-A0101-12-0054-12

上述式中,R21表示氫原子或碳原子數1~4的烷基,q表示重複單位之數目的自然數。 In the above formula, R 21 represents a hydrogen atom or an alkyl group having 1 to 4 carbon atoms, and q represents a natural number of the number of repeating units.

(D)成分之三聚氰胺甲醛樹脂由保存安定性之觀點來看,於三聚氰胺與甲醛之聚縮合時所生成的羥甲基經烷基化者為佳。 (D) The melamine formaldehyde resin of the component, from the viewpoint of storage stability, the methylol formed during the polycondensation of melamine and formaldehyde is preferably alkylated.

欲得到(D)成分之三聚氰胺甲醛樹脂的方法並無特別限定,一般為混合三聚氰胺與甲醛,使用碳酸鈉或氨等使其成為弱鹼性後,藉由60℃~100℃之加熱使其合成。且藉由與醇進行反應可使羥甲基進行烷氧基化。 The method for obtaining the melamine-formaldehyde resin of component (D) is not particularly limited. Generally, it is to mix melamine and formaldehyde, use sodium carbonate or ammonia to make it weakly alkaline, and then heat it at 60°C to 100°C to synthesize it. . And by reacting with alcohol, hydroxymethyl can be alkoxylated.

(D)成分之三聚氰胺甲醛樹脂的重量平均分子量以250~5,000為佳,以300~4,000為較佳,以350~3,500為更佳。重量平均分子量若超過5,000之過大者時,對於溶劑的溶解性會降低且處理性會有降低之情況產生,若重量平均分子量未達250之過小者時,於熱硬化時會有硬化不足,且溶劑耐性及耐熱性之提高效果亦無法充分表現的情況會產生。 (D) The weight average molecular weight of the melamine formaldehyde resin of the component is preferably 250 to 5,000, preferably 300 to 4,000, and more preferably 350 to 3,500. If the weight average molecular weight exceeds 5,000, the solubility to the solvent will be reduced and the handling properties will be reduced. If the weight average molecular weight is less than 250, there will be insufficient curing during thermal curing, and There may be cases where the effect of improving solvent resistance and heat resistance cannot be fully expressed.

對於本發明之實施形態,(D)成分的三聚氰胺 甲醛樹脂可在液體形態,或者將經純化的液體於後述溶劑再溶解的溶液形態下使用。 For the embodiment of the present invention, the melamine of component (D) The formaldehyde resin can be used in a liquid form or in a solution form in which a purified liquid is re-dissolved in a solvent described below.

作為(D)成分的特定聚合物之較佳一例子的酚酚醛清漆樹脂,例如可舉出酚-甲醛聚縮合物等。 As a phenol novolak resin which is a preferable example of the specific polymer of (D) component, a phenol-formaldehyde polycondensate etc. are mentioned, for example.

對於本實施形態之硬化膜形成組成物,(D)成分的聚合物可在粉體形態下或將經純化的粉末於後述溶劑進行再溶解的溶液形態下使用。 Regarding the cured film forming composition of this embodiment, the polymer of the component (D) can be used in the form of a powder or in the form of a solution in which the purified powder is redissolved in the solvent described below.

本發明之硬化膜形成組成物中之(D)成分的含有量對於(A)成分之聚合物及(B)成分的交聯劑之合計量100質量份而言,以400質量份以下為佳,較佳為10質量份~380質量份,更佳為40質量份~360質量份。(D)成分之含有量過大時,液晶配向性容易降低,過小時密著性容易降低。 The content of component (D) in the cured film forming composition of the present invention is preferably 400 parts by mass or less based on 100 parts by mass of the total amount of the polymer of component (A) and the crosslinking agent of component (B) , Preferably 10 parts by mass to 380 parts by mass, more preferably 40 parts by mass to 360 parts by mass. When the content of the component (D) is too large, the liquid crystal alignment tends to decrease, and when it is too small, the adhesion tends to decrease.

又,對於本實施的形態之硬化膜形成組成物,(D)成分亦可為作為(D)成分所例示的聚合物之複數種混合物。 In addition, in the cured film forming composition of the present embodiment, the component (D) may be a mixture of plural kinds of polymers exemplified as the component (D).

<(E)成分> <(E) Ingredient>

本發明之硬化膜形成組成物除前述(A)成分、(B)成分、(C)成分及/或(D)成分以外,可進一步含有作為(E)成分之交聯觸媒。 In addition to the aforementioned (A) component, (B) component, (C) component and/or (D) component, the cured film forming composition of the present invention may further contain a crosslinking catalyst as the (E) component.

作為(E)成分的交聯觸媒,例如可適用酸或熱酸產生劑。該(E)成分對於促進本發明之硬化膜形成組成物的熱硬化反應為有效。 As the crosslinking catalyst of the component (E), for example, an acid or a thermal acid generator can be applied. The (E) component is effective for promoting the thermal curing reaction of the cured film forming composition of the present invention.

(E)成分具體例子中,作為上述酸可舉出含有磺酸基之化合物、鹽酸或其鹽。作為上述熱酸產生劑,僅為於加熱處理時經熱分解而產生酸的化合物,即在溫度80℃至250℃下進行熱分解而產生酸的化合物即可,並無特別限定。 (E) In specific examples of the component, examples of the acid include a compound containing a sulfonic acid group, hydrochloric acid or a salt thereof. As the above-mentioned thermal acid generator, only a compound that generates an acid by thermal decomposition during heat treatment, that is, a compound that generates an acid by thermal decomposition at a temperature of 80°C to 250°C, is not particularly limited.

作為上述酸之具體例子,例如可舉出鹽酸或其鹽;甲磺酸、乙磺酸、丙烷磺酸、丁烷磺酸、戊烷磺酸、辛烷磺酸、苯磺酸、p-甲苯磺酸、樟腦磺酸、三氟甲磺酸、p-酚磺酸、2-萘磺酸、三甲苯磺酸、p-二甲苯-2-磺酸、m-二甲苯-2-磺酸、4-乙基苯磺酸、1H,1H,2H,2H-全氟辛烷磺酸、全氟(2-乙氧基乙烷)磺酸、五氟乙磺酸、九氟丁烷-1-磺酸、十二烷基苯磺酸等磺酸基含有化合物或其水合物或鹽等。 As specific examples of the above acid, for example, hydrochloric acid or its salt; methanesulfonic acid, ethanesulfonic acid, propanesulfonic acid, butanesulfonic acid, pentanesulfonic acid, octanesulfonic acid, benzenesulfonic acid, p-toluene Sulfonic acid, camphorsulfonic acid, trifluoromethanesulfonic acid, p-phenolsulfonic acid, 2-naphthalenesulfonic acid, tritoluenesulfonic acid, p-xylene-2-sulfonic acid, m-xylene-2-sulfonic acid, 4-ethylbenzenesulfonic acid, 1H,1H,2H,2H-perfluorooctanesulfonic acid, perfluoro(2-ethoxyethane)sulfonic acid, pentafluoroethanesulfonic acid, nonafluorobutane-1- Sulfonic acid group-containing compounds such as sulfonic acid and dodecylbenzenesulfonic acid, or hydrates or salts thereof.

又作為藉由熱產生酸的化合物,例如可舉出雙(甲苯黃醯氧基)乙烷、雙(甲苯黃醯氧基)丙烷、雙(甲苯黃醯氧基)丁烷、p-硝基苯甲基甲苯磺酸酯、o-硝基苯甲基甲苯磺酸酯、1,2,3-伸苯基參(甲基磺酸鹽)、p-甲苯磺酸吡啶鎓鹽、p-甲苯磺酸嗎啉鎓鹽、p-甲苯磺酸乙基酯、p-甲苯磺酸丙基酯、p-甲苯磺酸丁基酯、p-甲苯磺酸異丁基酯、p-甲苯磺酸甲基酯、p-甲苯磺酸苯乙基酯、氰基甲基p-甲苯磺酸鹽、2,2,2-三氟乙基p-甲苯磺酸鹽、2-羥基丁基p-甲苯磺酸鹽、N-乙基-p-甲苯磺醯亞胺以及下述式所示化合物: Further, as a compound that generates an acid by heat, for example, bis(toluene xanthoxy) ethane, bis(toluene xanthoxy) propane, bis(toluene xanthoxy) butane, p-nitro Benzyl toluene sulfonate, o-nitrobenzyl toluene sulfonate, 1,2,3-phenyl ginseng (methyl sulfonate), p-pyridinium toluene sulfonate, p-toluene Morpholinium sulfonate, p-ethyl toluenesulfonate, p-propyl toluenesulfonate, p-butyl toluenesulfonate, p-isobutyl toluenesulfonate, p-methyl toluenesulfonate Base ester, p-phenethyl p-toluenesulfonate, cyanomethyl p-toluenesulfonate, 2,2,2-trifluoroethyl p-toluenesulfonate, 2-hydroxybutyl p-toluenesulfonate Acid salt, N-ethyl-p-toluenesulfonimide and the compound represented by the following formula:

Figure 109112027-A0101-12-0057-13
Figure 109112027-A0101-12-0057-13

Figure 109112027-A0101-12-0057-14
Figure 109112027-A0101-12-0057-14

Figure 109112027-A0101-12-0058-15
Figure 109112027-A0101-12-0058-15

Figure 109112027-A0101-12-0058-16
Figure 109112027-A0101-12-0058-16

Figure 109112027-A0101-12-0058-17
Figure 109112027-A0101-12-0058-17

Figure 109112027-A0101-12-0059-18
等。
Figure 109112027-A0101-12-0059-18
Wait.

本發明之硬化膜形成組成物中之(E)成分的含有量對於(A)成分之聚合物及(B)成分的交聯劑之合計量100質量份,以0.01質量份~20質量份為佳,較佳為0.1質量份~15質量份,更佳為0.5質量份~10質量份。(E)成分的含有量若在0.01質量份以上時,無法賦予充分熱硬化性及溶劑耐性。然而,若超過20質量份時,組成物的保存安定性會有降低之情況產生。 The content of the (E) component in the cured film forming composition of the present invention is 0.01 to 20 parts by mass relative to 100 parts by mass of the total amount of the polymer of the component (A) and the crosslinking agent of the component (B) Preferably, it is preferably 0.1 parts by mass to 15 parts by mass, more preferably 0.5 parts by mass to 10 parts by mass. (E) When the content of the component is 0.01 parts by mass or more, sufficient thermosetting properties and solvent resistance cannot be imparted. However, if it exceeds 20 parts by mass, the storage stability of the composition may decrease.

<溶劑> <Solvent>

本發明之硬化膜形成組成物主要為在溶解於溶劑之溶液狀態下使用。此時所使用的溶劑僅可溶解(A)成分、(B)成分、(C)成分及/或(D)成分、依所需的(E)成分及/或後述之其他添加劑者即可,可為任意種類及結構等並無特別限 定。 The cured film forming composition of the present invention is mainly used in a solution state dissolved in a solvent. The solvent used at this time can only dissolve (A) component, (B) component, (C) component and/or (D) component, as required (E) component and/or other additives described later, It can be of any type and structure, and there is no particular limitation set.

作為溶劑之具體例子,例如可舉出甲醇、乙醇、n-丙醇、異丙醇、n-丁醇、異丁醇、2-甲基-1-丁醇、n-戊醇、乙二醇單甲基醚、乙二醇單乙基醚、甲基溶纖劑乙酸酯、乙基溶纖劑乙酸酯、二乙二醇、二乙二醇單甲基醚、二乙二醇單乙基醚、丙二醇、丙二醇單甲基醚、丙二醇單甲基醚乙酸酯、丙二醇單乙基醚、丙二醇丙基醚、丙二醇丙基醚乙酸酯、甲苯、二甲苯、甲基乙基酮、異丁基甲基酮、環戊酮、環己酮、2-丁酮、3-甲基-2-戊酮、2-戊酮、2-庚酮、γ-丁內酯、2-羥基丙酸乙酯、2-羥基-2-甲基丙酸乙酯、乙氧基乙酸乙酯、羥基乙酸乙酯、2-羥基-3-甲基丁烷酸甲酯、3-甲氧基丙酸甲酯、3-甲氧基丙酸乙酯、3-乙氧基丙酸甲酯、3-乙氧基丙酸乙酯、丙酮酸甲酯、丙酮酸乙酯、乙酸乙酯、乙酸丁酯、乳酸乙酯、乳酸丁酯、環戊基甲基醚、N,N-二甲基甲醯胺、N,N-二甲基乙醯胺、及N-甲基-2-吡咯啶酮等。 As specific examples of solvents, for example, methanol, ethanol, n-propanol, isopropanol, n-butanol, isobutanol, 2-methyl-1-butanol, n-pentanol, ethylene glycol Monomethyl ether, ethylene glycol monoethyl ether, methyl cellosolve acetate, ethyl cellosolve acetate, diethylene glycol, diethylene glycol monomethyl ether, diethylene glycol mono Ethyl ether, propylene glycol, propylene glycol monomethyl ether, propylene glycol monomethyl ether acetate, propylene glycol monoethyl ether, propylene glycol propyl ether, propylene glycol propyl ether acetate, toluene, xylene, methyl ethyl ketone , Isobutyl methyl ketone, cyclopentanone, cyclohexanone, 2-butanone, 3-methyl-2-pentanone, 2-pentanone, 2-heptanone, γ-butyrolactone, 2-hydroxypropionic acid Ethyl ester, ethyl 2-hydroxy-2-methylpropionate, ethyl ethoxy acetate, ethyl hydroxyacetate, methyl 2-hydroxy-3-methylbutanoate, methyl 3-methoxypropionate Ester, ethyl 3-methoxypropionate, methyl 3-ethoxypropionate, ethyl 3-ethoxypropionate, methyl pyruvate, ethyl pyruvate, ethyl acetate, butyl acetate, Ethyl lactate, butyl lactate, cyclopentyl methyl ether, N,N-dimethylformamide, N,N-dimethylacetamide, and N-methyl-2-pyrrolidone, etc.

使用本發明之硬化膜形成組成物,於樹脂薄膜上形成硬化膜製造配向材時,甲醇、乙醇、n-丙醇、異丙醇、n-丁醇、2-甲基-1-丁醇、2-庚酮、異丁基甲基酮、二乙二醇、丙二醇、丙二醇單甲基醚、丙二醇單甲基醚乙酸酯等係為對樹脂薄膜顯示耐性的溶劑之觀點來看為佳。 When using the cured film forming composition of the present invention to form a cured film on a resin film to produce an alignment material, methanol, ethanol, n-propanol, isopropanol, n-butanol, 2-methyl-1-butanol, It is preferable that 2-heptanone, isobutyl methyl ketone, diethylene glycol, propylene glycol, propylene glycol monomethyl ether, propylene glycol monomethyl ether acetate, etc. are solvents showing resistance to the resin film.

這些溶劑可1種單獨或組合2種以上使用。 These solvents can be used individually by 1 type or in combination of 2 or more types.

<其他添加劑> <Other additives>

且,本發明之硬化膜形成組成物以不損害本發明效果之範圍下,視必要可含有密著提升劑、矽烷偶合劑、界面活性劑、流變調整劑、顏料、染料、保存安定劑、消泡劑、抗氧化劑等。 In addition, the cured film forming composition of the present invention may contain adhesion promoters, silane coupling agents, surfactants, rheology modifiers, pigments, dyes, storage stabilizers, Defoamer, antioxidant, etc.

<硬化膜形成組成物之調製> <Preparation of cured film forming composition>

本發明之硬化膜形成組成物含有(A)成分之聚合物、(B)成分之交聯劑及(C)成分之密著促進劑及/或(D)成分之具有熱交聯性基的聚合物,依所需含有(E)成分之交聯觸媒,且進一步不損害本發明之效果的範圍下,可含有其他添加劑的組成物。而一般為將這些溶解於溶劑之溶液形態下使用。 The cured film forming composition of the present invention contains the polymer of component (A), the crosslinking agent of component (B), the adhesion promoter of component (C), and/or the thermally crosslinkable group of component (D) The polymer may contain the cross-linking catalyst of the component (E) as required, and the composition of other additives may be contained within the range that does not further impair the effect of the present invention. Generally, these are used in the form of a solution dissolved in a solvent.

本發明之硬化膜形成組成物的較佳例子,如以下所示。 Preferred examples of the cured film forming composition of the present invention are shown below.

[1]:一種硬化膜形成組成物,其為含有(A)成分、以(A)成分100質量份為基準之1質量份~300質量份的(B)成分、以及對於(A)成分之聚合物及(B)成分的交聯劑之合計量100質量份為0.1質量份~100質量份之(C)成分及1質量份~400質量份之(D)成分的至少一方者。 [1]: A cured film forming composition containing (A) component, 1 part by mass to 300 parts by mass of (B) component based on 100 parts by mass of (A) component, and relative to (A) component The total amount of the crosslinking agent of the polymer and (B) component 100 parts by mass is at least one of 0.1 part by mass to 100 parts by mass of the (C) component and 1 part by mass to 400 parts by mass of the (D) component.

[2]:一種硬化膜形成組成物,其為含有(A)成分、以(A)成分100質量份為基準之1質量份~300質量份的(B)成分、對於(A)成分之聚合物及(B)成分的交聯劑之合計量100質量份而言為0.1質量份~100質量份之(C)成分及1質量份~400質量份之(D)成分的至少一方、以及溶劑。 [2]: A cured film forming composition containing (A) component, 1 part by mass to 300 parts by mass of (A) component based on 100 parts by mass of (A) component, for polymerization of (A) component The total amount of the crosslinking agent of the component (B) and 100 parts by mass is at least one of 0.1 parts by mass to 100 parts by mass of the (C) component and 1 part by mass to 400 parts by mass of the (D) component, and a solvent .

[3]:一種硬化膜形成組成物,其為含有(A)成分、以(A)成分100質量份為準之1質量份~300質量份的(B)成分、對於(A)成分之聚合物及(B)成分的交聯劑之合計量100質量份而言為0.1質量份~100質量份之(C)成分及1質量份~400質量份之(D)成分的至少一方、對於(A)成分之聚合物及(B)成分之交聯劑的合計量100質量份而言為0.01質量份~20質量份之(E)成分、溶劑。 [3]: A cured film forming composition containing (A) component, 1 part by mass to 300 parts by mass of (A) component based on 100 parts by mass of (A) component, for polymerization of (A) component The total amount of the crosslinking agent of component (B) and 100 parts by mass is at least one of 0.1 parts by mass to 100 parts by mass of (C) component and 1 part by mass to 400 parts by mass of (D) component, for ( The total amount of the polymer of the component A) and the crosslinking agent of the component (B) is 0.01 parts by mass to 20 parts by mass of the (E) component and the solvent for 100 parts by mass.

[4]:一種硬化膜形成組成物,其為含有(A)成分、以(A)成分100質量份為基準之1質量份~300質量份的(B)成分、對於(A)成分之聚合物及(B)成分的交聯劑之合計量100質量份而言為0.1質量份~100質量份的(C)成分、對於(A)成分之聚合物及(B)成分的交聯劑之合計量100質量份而言為1~400質量份之(D)成分、對於(A)成分之聚合物及(B)成分的交聯劑之合計量100質量份而言為0.01質量份~20質量份之(E)成分、以及溶劑。 [4]: A cured film forming composition containing (A) component, 1 part by mass to 300 parts by mass of (A) component based on 100 parts by mass of (A) component, for polymerization of (A) component The total amount of the crosslinking agent of component and (B) component is 0.1 to 100 parts by mass of component (C) for 100 parts by mass, for the polymer of component (A) and the crosslinking agent of component (B) The total amount of 100 parts by mass is 1 to 400 parts by mass of component (D), and the total amount of the polymer of (A) component and the crosslinking agent of (B) component is 0.01 to 20 parts by mass for 100 parts by mass. Parts by mass of (E) component and solvent.

將本發明之硬化膜形成組成物作為溶液使用時的配合比例、調製方法等如以下詳述。 The mixing ratio and preparation method when using the cured film forming composition of the present invention as a solution will be described in detail below.

本發明之硬化膜形成組成物中之固體成分的比例僅可均勻地溶解各成分的溶劑即可,並無特別限定,但為1質量%~60質量%,以2質量%~50質量%為佳,較佳為2質量%~20質量%。其中,所謂固體成分表示自硬化膜形成組成物之全成分除去溶劑者。 The ratio of the solid content in the cured film forming composition of the present invention is only required to uniformly dissolve each component in the solvent, and is not particularly limited, but it is 1% by mass to 60% by mass, and 2% by mass to 50% by mass is used as More preferably, it is preferably 2% by mass to 20% by mass. Here, the term "solid content" means that the solvent is removed from all components of the cured film forming composition.

本發明之硬化膜形成組成物的調製方法,並無特別限定。作為調製法,例如於溶解在溶劑的(A)成分 之溶液中以所定比例混合(B)成分、(C)成分及/或(D)成分、進一步為(E)成分等,成為均勻溶液之方法、或者在該調製法之適當階段,視必要進一步添加並混合其他添加劑的方法。 The method of preparing the cured film forming composition of the present invention is not particularly limited. As a preparation method, for example, component (A) dissolved in a solvent (B) component, (C) component and/or (D) component, further to (E) component, etc. are mixed in the solution in a predetermined ratio to form a uniform solution, or at the appropriate stage of the preparation method, if necessary The method of adding and mixing other additives.

對於本發明之硬化膜形成組成物的調製,可直接使用將藉由溶劑中之聚合反應所得的特定共聚物(聚合物)之溶液。此時,例如於(A)成分的溶液中放入與前述相同的(B)成分、(C)成分、(D)成分、進一步為(E)成分等成為均勻溶液。此時,將濃度調整作為目的,可進一步追加投入溶劑。此時,在(A)成分之生成過程中所使用的溶劑與使用於硬化膜形成組成物之濃度調整的溶劑可為相同或相異。 For the preparation of the cured film forming composition of the present invention, a solution of a specific copolymer (polymer) obtained by a polymerization reaction in a solvent can be used as it is. At this time, for example, the same (B) component, (C) component, (D) component, and further (E) component and the like as described above are put into the solution of (A) component to form a uniform solution. At this time, for the purpose of concentration adjustment, a solvent can be further added. At this time, the solvent used in the production process of the component (A) and the solvent used for the concentration adjustment of the cured film forming composition may be the same or different.

又,所調製之硬化膜形成組成物的溶液為使用孔徑為0.2μm程度之濾器進行過濾後再使用為佳。 In addition, the prepared solution of the cured film forming composition is preferably filtered with a filter having a pore size of about 0.2 μm before use.

<硬化膜、配向材及相位差材> <Cured film, alignment material and retardation material>

將本發明之硬化膜形成組成物的溶液於基板(例如矽/二氧化矽被覆基板、氮化矽基板、金屬、例如以鋁、鉬、鉻等包覆之基板、玻璃基板、石英基板、ITO基板等)或薄膜基板(例如三乙醯纖維素(TAC)薄膜、聚碳酸酯(PC)薄膜、環烯烴聚合物(COP)薄膜、環烯烴共聚物(COC)薄膜、聚乙烯對苯二甲酸乙二醇酯(PET)薄膜、丙烯酸薄膜、聚乙烯薄膜等樹脂薄膜)等上,藉由棒塗佈、轉動塗佈、流動塗佈、輥塗佈、狹縫塗佈、狹縫後繼續進行轉動 塗佈、噴墨塗佈、印刷等進行塗佈後形成塗膜,其後以加熱板或烤箱等進行加熱乾燥後,可形成硬化膜。該硬化膜可直接作為配向材使用。 Apply the solution of the cured film forming composition of the present invention to a substrate (e.g., silicon/silicon dioxide coated substrate, silicon nitride substrate, metal, such as a substrate coated with aluminum, molybdenum, chromium, etc., glass substrate, quartz substrate, ITO Substrate, etc.) or film substrate (e.g. triacetyl cellulose (TAC) film, polycarbonate (PC) film, cycloolefin polymer (COP) film, cycloolefin copolymer (COC) film, polyethylene terephthalic acid Ethylene glycol ester (PET) film, acrylic film, polyethylene film and other resin films), etc., by bar coating, rotary coating, flow coating, roll coating, slit coating, and slit coating. Rotate Coating, inkjet coating, printing, etc. are applied to form a coating film, and then heated and dried with a hot plate or oven, etc., to form a cured film. The hardened film can be used directly as an alignment material.

作為加熱乾燥之條件,硬化膜(配向材)的成分在於其上經塗佈的聚合性液晶溶液不溶離之程度下,僅藉由交聯劑進行交聯反應即可,例如採用溫度60℃~200℃,時間0.4分鐘~60分鐘之範圍中適宜地選擇的加熱溫度及加熱時間。加熱溫度及加熱時間較佳為70℃~160℃、0.5分鐘~10分鐘。 As the conditions for heating and drying, the composition of the cured film (alignment material) is such that the polymerizable liquid crystal solution coated on it does not dissociate, and the crosslinking reaction can be carried out only by the crosslinking agent. For example, the temperature is 60°C~ 200°C, the heating temperature and heating time are appropriately selected in the range of 0.4 minutes to 60 minutes. The heating temperature and heating time are preferably 70°C to 160°C, 0.5 minutes to 10 minutes.

使用本發明之硬化性組成物所形成的硬化膜(配向材)之膜厚,例如為0.05μm~5μm,可考慮到所使用之基板的段差或光學、電性質而做適宜選擇。 The thickness of the cured film (alignment material) formed by using the curable composition of the present invention is, for example, 0.05 μm to 5 μm, which can be appropriately selected in consideration of the step difference or optical and electrical properties of the substrate used.

由本發明之硬化膜組成物所形成的配向材因具有耐溶劑性及耐熱性,於該配向材上塗佈具有垂直配向性之聚合性液晶溶液等相位差材料,可在配向材上進行配向。而藉由將成為配向狀態之相位差材料直接硬化,作為具有光學異方性之層可形成相位差材。而形成配向材之基板若為薄膜時,作為相位差薄膜為有用。 Since the alignment material formed by the cured film composition of the present invention has solvent resistance and heat resistance, it can be aligned on the alignment material by coating the alignment material with a phase difference material such as a polymerizable liquid crystal solution with vertical alignment. By directly hardening the phase difference material in the aligned state, the phase difference material can be formed as a layer with optical anisotropy. If the substrate on which the alignment material is formed is a thin film, it is useful as a retardation film.

又,使用如上述所形成的具有本發明之配向材的2片基板,介著間隔物使兩基板上的配向材可彼此相對面而貼合後,於這些基板之間注入液晶,可成為液晶經配向的液晶顯示元件。 In addition, using the two substrates with the alignment material of the present invention formed as described above, the alignment materials on the two substrates can face each other through the spacers, and then the liquid crystal is injected between these substrates to become liquid crystal Aligned liquid crystal display element.

如此本發明之硬化膜形成組成物可適用於各種相位差材(相位差薄膜)或液晶顯示元件等製造。 In this way, the cured film forming composition of the present invention can be applied to the production of various retardation materials (retardation films), liquid crystal display elements, and the like.

[實施例] [Example]

以下舉出例子,更詳細說明本發明,但本發明並未限定於此等實施例。 Examples are given below to explain the present invention in more detail, but the present invention is not limited to these embodiments.

[在實施例使用的簡稱] [Abbreviation used in the examples]

在以下實施例所使用的簡稱之意思如以下所示。 The meanings of the abbreviations used in the following examples are as follows.

<聚合物原料> <Polymer Raw Material>

LAA:月桂基丙烯酸酯 LAA: Lauryl Acrylate

PAA:十六烷丙烯酸酯 PAA: hexadecyl acrylate

LAMA:月桂基甲基丙烯酸酯 LAMA: Lauryl Methacrylate

HEMA:2-羥基乙基甲基丙烯酸酯 HEMA: 2-hydroxyethyl methacrylate

MMA:甲基甲基丙烯酸酯 MMA: Methmethacrylate

BzMA:苯甲基甲基丙烯酸酯 BzMA: Benzyl methacrylate

BMAA:N-丁氧基甲基丙烯醯基 BMAA: N-butoxymethacryloyl

GMA:縮水甘油基甲基丙烯酸酯 GMA: Glycidyl methacrylate

AIBN:α,α’-偶氮二異丁腈 AIBN: α,α’-Azobisisobutyronitrile

A1:2-(((4-(4’-戊基-[1,1’-雙(環己烷)]-4-基)苯氧基)羰基胺基)乙基甲基丙烯酸酯 A1: 2-(((4-(4'-pentyl-[1,1'-bis(cyclohexane)]-4-yl)phenoxy)carbonylamino)ethyl methacrylate

Figure 109112027-A0101-12-0066-19
Figure 109112027-A0101-12-0066-19

A2:6-(4-(4-庚基環己基)苯氧基)己基甲基丙烯酸酯 A2: 6-(4-(4-heptylcyclohexyl)phenoxy)hexyl methacrylate

Figure 109112027-A0101-12-0066-20
Figure 109112027-A0101-12-0066-20

<(B)成分> <(B) Ingredient>

HMM:下述結構式所示三聚氰胺交聯劑[Cymel(CYMEL)(註冊商標)303(Mitsui Cytec(股)製)] HMM: Melamine crosslinking agent represented by the following structural formula [Cymel (CYMEL) (registered trademark) 303 (manufactured by Mitsui Cytec Co., Ltd.)]

Figure 109112027-A0101-12-0066-21
Figure 109112027-A0101-12-0066-21

<(C)成分> <(C) Ingredient>

BMAA:N-丁氧基甲基丙烯醯基 BMAA: N-butoxymethacryloyl

DM-1: DM-1:

Figure 109112027-A0101-12-0067-22
Figure 109112027-A0101-12-0067-22

<(D)成分> <(D) Ingredients>

PUA:聚胺基甲酸酯接枝丙烯酸聚合物[ACRIT(註冊商標)8UA-146(大成Fine化學(股)製)] PUA: Polyurethane grafted acrylic polymer [ACRIT (registered trademark) 8UA-146 (manufactured by Dacheng Fine Chemical Co., Ltd.)]

PCDO:聚碳酸酯二醇[C-590((股)Kuraray製)] PCDO: Polycarbonate diol [C-590 (manufactured by Kuraray)]

PEPO:聚酯多元醇聚合物(具有下述結構單位之己二酸/二乙二醇共聚物。分子量4,800)。 PEPO: Polyester polyol polymer (adipic acid/diethylene glycol copolymer with the following structural unit. Molecular weight 4,800).

Figure 109112027-A0101-12-0067-23
Figure 109112027-A0101-12-0067-23

(上述式中,R表示伸烷基)。 (In the above formula, R represents an alkylene group).

<(E)成分> <(E) Ingredient>

PTSA:p-甲苯磺酸‧一水合物 PTSA: p-toluenesulfonic acid‧monohydrate

<溶劑> <Solvent>

PM:丙二醇單甲基醚 PM: Propylene glycol monomethyl ether

BA:乙酸丁酯 BA: Butyl acetate

MEK:甲基乙基酮 MEK: Methyl ethyl ketone

CPME:環戊基甲基醚 CPME: Cyclopentyl methyl ether

依據以下合成例所得之丙烯酸共聚物的數平均分子量及重量平均分子量為使用日本分光(股)製GPC裝置(Shodex(註冊商標)管柱KF803L及KF804L),將溶離溶劑四氫呋喃以流量1mL/分流入於管柱中(管柱溫度40℃)並使其溶離的條件下進行測定。且下述數平均分子量(以下稱為Mn)及重量平均分子量(以下稱為Mw)表示聚苯乙烯換算值。 The number-average molecular weight and weight-average molecular weight of the acrylic copolymer obtained according to the following synthesis example are GPC equipment (Shodex (registered trademark) column KF803L and KF804L) manufactured by Japan Branch The measurement is carried out under the conditions of dissociating in the column (column temperature 40°C). In addition, the following number average molecular weight (hereinafter referred to as Mn) and weight average molecular weight (hereinafter referred to as Mw) represent values in terms of polystyrene.

<(A)成分之合成(1)> <Synthesis of component (A) (1)>

<合成例1> <Synthesis Example 1>

溶解LAA 4.0g、MMA 12.0g、HEMA 4.0g、作為聚合觸媒之AIBN 0.3g於PM 60.9g,藉由在80℃進行20小時反應後得到丙烯酸共聚物溶液(固體成分濃度25質量%)(PA1)。所得之丙烯酸共聚物的Mn為12,000,Mw為26,000。 Dissolve 4.0 g of LAA, 12.0 g of MMA, 4.0 g of HEMA, 0.3 g of AIBN as a polymerization catalyst in 60.9 g of PM, and react at 80°C for 20 hours to obtain an acrylic copolymer solution (solid content 25% by mass) ( PA1). The Mn of the obtained acrylic copolymer was 12,000 and the Mw was 26,000.

<合成例2> <Synthesis example 2>

將PAA 4.0g、MMA 12.0g、HEMA 4.0g、作為聚合觸媒的AIBN 0.3g溶解於PM 60.9g,藉由在80℃進行20小時反應後得到丙烯酸共聚物溶液(固體成分濃度25質量%)(PA2)。所得之丙烯酸共聚物的Mn為6,000,Mw為 12,000。 4.0 g of PAA, 12.0 g of MMA, 4.0 g of HEMA, and 0.3 g of AIBN as a polymerization catalyst were dissolved in 60.9 g of PM and reacted at 80°C for 20 hours to obtain an acrylic copolymer solution (solid content concentration 25% by mass) (PA2). The Mn of the obtained acrylic copolymer is 6,000, and the Mw is 12,000.

<合成例3> <Synthesis Example 3>

將LAMA 4.0g、MMA 12.0g、HEMA 4.0g、作為聚合觸媒的AIBN 0.3g溶解於PM 60.9g,藉由在80℃進行20小時反應後得到丙烯酸共聚物溶液(固體成分濃度25質量%)(PA3)。所得之丙烯酸共聚物的Mn為14,000,Mw為31,000。 4.0 g of LAMA, 12.0 g of MMA, 4.0 g of HEMA, and 0.3 g of AIBN as a polymerization catalyst were dissolved in 60.9 g of PM, and reacted at 80°C for 20 hours to obtain an acrylic copolymer solution (solid content concentration 25% by mass) (PA3). The Mn of the obtained acrylic copolymer was 14,000 and the Mw was 31,000.

<合成例4> <Synthesis Example 4>

將LAA 4.0g、BzMA 12.0g、HEMA 4.0g、作為聚合觸媒的AIBN 0.3g溶解於PM 60.9g,藉由在80℃進行20小時反應後得到丙烯酸共聚物溶液(固體成分濃度25質量%)(PA4)。所得之丙烯酸共聚物的Mn為10,000,Mw為24,000。 4.0 g of LAA, 12.0 g of BzMA, 4.0 g of HEMA, and 0.3 g of AIBN as a polymerization catalyst were dissolved in 60.9 g of PM, and reacted at 80°C for 20 hours to obtain an acrylic copolymer solution (solid content concentration 25% by mass) (PA4). The Mn of the obtained acrylic copolymer was 10,000 and the Mw was 24,000.

<合成例5> <Synthesis Example 5>

將LAA 2.0g、MMA 14.0g、HEMA 4.0g、作為聚合觸媒的AIBN 0.3g溶解於PM 60.9g,藉由在80℃進行20小時反應後得到丙烯酸共聚物溶液(固體成分濃度25質量%)(PA5)。所得之丙烯酸共聚物的Mn為12,000,Mw為27,000。 LAA 2.0g, MMA 14.0g, HEMA 4.0g, and AIBN 0.3g as a polymerization catalyst were dissolved in PM 60.9g, and reacted at 80°C for 20 hours to obtain an acrylic copolymer solution (solid content concentration 25% by mass) (PA5). The Mn of the obtained acrylic copolymer was 12,000 and the Mw was 27,000.

<合成例6> <Synthesis Example 6>

將LAA 6.0g、MMA 10.0g、HEMA 4.0g、作為聚合觸媒的AIBN 0.3g溶解於PM 60.9g,藉由在80℃進行20小時反應後得到丙烯酸共聚物溶液(固體成分濃度25質量%)(PA6)。所得之丙烯酸共聚物的Mn為14,000,Mw為31,000。 6.0 g of LAA, 10.0 g of MMA, 4.0 g of HEMA, and 0.3 g of AIBN as a polymerization catalyst were dissolved in 60.9 g of PM, and the reaction was carried out at 80°C for 20 hours to obtain an acrylic copolymer solution (solid content concentration 25% by mass) (PA6). The Mn of the obtained acrylic copolymer was 14,000 and the Mw was 31,000.

<(B)成分之合成> <(B) Synthesis of ingredients>

<合成例7> <Synthesis Example 7>

將BMAA 100.0g、作為聚合觸媒的AIBN 4.2g溶解於PM 193.5g,藉由在90℃進行20小時反應後得到丙烯酸聚合物溶液(固體成分濃度35質量%)(PB1)。所得之丙烯酸共聚物的Mn為2,700,Mw為3,900。 100.0 g of BMAA and 4.2 g of AIBN as a polymerization catalyst were dissolved in 193.5 g of PM and reacted at 90° C. for 20 hours to obtain an acrylic polymer solution (solid content concentration 35% by mass) (PB1). The Mn of the obtained acrylic copolymer was 2,700 and the Mw was 3,900.

<(C)成分之合成> <(C) Synthesis of ingredients>

<合成例8> <Synthesis Example 8>

將BMAA32.0g、GMA8.0g、作為聚合觸媒的AIBN 0.8g溶解於四氫呋喃204.0g,藉由在60℃進行20小時反應後得到丙烯酸共聚物溶液。將丙烯酸共聚物溶液徐徐滴入於己烷1000.0g後析出固體,經過濾及減壓乾燥後得到丙烯酸共聚物(PC1)。所得之丙烯酸共聚物的Mn為7,000,Mw為18,000。 32.0 g of BMAA, 8.0 g of GMA, and 0.8 g of AIBN as a polymerization catalyst were dissolved in 204.0 g of tetrahydrofuran and reacted at 60° C. for 20 hours to obtain an acrylic copolymer solution. The acrylic copolymer solution was slowly dropped into 1000.0 g of hexane, and a solid was precipitated. After filtration and drying under reduced pressure, an acrylic copolymer (PC1) was obtained. The Mn of the obtained acrylic copolymer was 7,000, and the Mw was 18,000.

<合成例9> <Synthesis Example 9>

將在合成例8所得之丙烯酸共聚物(PC1)10.0g、丙烯 酸2.2g、二丁基羥基甲苯0.2g、作為反應觸媒的苯甲基三乙基銨氯化物10mg溶解於PM60g,在90℃進行20小時反應。將該溶液徐徐滴入於己烷500g中並析出固體,藉由經過濾及減壓乾燥後,得到具有丙烯醯基之丙烯酸共聚物(PC2)。進行1H-NMR分析後確認丙烯酸共聚物(PC2)為具有丙烯醯基者。 10.0 g of the acrylic copolymer (PC1) obtained in Synthesis Example 8, 2.2 g of acrylic acid, 0.2 g of dibutylhydroxytoluene, and 10 mg of benzyltriethylammonium chloride as a reaction catalyst were dissolved in 60 g of PM and heated at 90°C The reaction was carried out for 20 hours. This solution was slowly dropped into 500 g of hexane to precipitate a solid, which was filtered and dried under reduced pressure to obtain an acrylic copolymer (PC2) having an acryl group. After 1 H-NMR analysis, it was confirmed that the acrylic copolymer (PC2) had an acryl group.

且,PC2亦可作為本發明中之B成分而作用。 In addition, PC2 can also function as the B component in the present invention.

<化合物合成例1>化合物[DM-1]之合成 <Compound Synthesis Example 1> Synthesis of Compound [DM-1]

Figure 109112027-A0101-12-0071-24
Figure 109112027-A0101-12-0071-24

在氮氣流下中,於2L四口燒瓶中將乙酸乙酯500g、1,6-已二醇35.5g(0.300mol)、1,8-二氮雜雙環[5.4.0]-7-十一碳烯(DBU)1.80g(11.8mmol)、2,6-二-第三丁基-對-甲酚(BHT)0.45g(2.04mmol)在室溫下裝入,在磁力攪拌器攪拌下升溫至55℃。對反應液滴入2-異氰酸根乙基丙烯酸酯95.9g(0.679mol),經2小時攪拌後將反應液以高速液體層析法進行分析,當中間體的面積百分率成為1%以下時,使反應結束。加入己烷328g,冷卻至室溫後,將析出的固體以己烷229g進行2次洗淨,得到經乾燥之化合物[A-a](104g、0.260mol、產率86.7%)。 Under nitrogen flow, in a 2L four-necked flask, 500 g of ethyl acetate, 35.5 g (0.300 mol) of 1,6-hexanediol, 1,8-diazabicyclo[5.4.0]-7-undecane Ene (DBU) 1.80g (11.8mmol), 2,6-di-tert-butyl-p-cresol (BHT) 0.45g (2.04mmol) were charged at room temperature, and heated to 55°C. 95.9 g (0.679 mol) of 2-isocyanatoethyl acrylate was dropped into the reaction liquid, and after 2 hours of stirring, the reaction liquid was analyzed by high-speed liquid chromatography. When the area percentage of the intermediate became less than 1%, End the reaction. After adding 328 g of hexane and cooling to room temperature, the precipitated solid was washed twice with 229 g of hexane to obtain a dried compound [A-a] (104 g, 0.260 mol, yield 86.7%).

Figure 109112027-A0101-12-0072-25
Figure 109112027-A0101-12-0072-25

在氮氣流下中,於2L四口燒瓶中裝入二氯甲烷1330g、化合物[A-a]100g(0.250mol)、對甲醛22.5g(0.749mol),冰浴中滴入三甲基矽基氯化物122g(1.12mol)。2小時攪拌後滴入三乙基胺63.2g(0.625mol)與甲醇240g之混合液。30分攪拌後移至5L分液漏斗,加入水1500g後進行分液操作。將所得之有機層以硫酸鎂乾燥,將硫酸鎂藉由過濾除去所得之濾液經濃縮、乾燥後得到化合物[DM-1](110g、0.226mol、產率90.3%)。化合物[DM-1]的結構可藉由1H-NMR分析確認得到以下光譜數據。 In a nitrogen stream, a 2L four-necked flask was charged with 1330g of methylene chloride, 100g (0.250mol) of compound [Aa], 22.5g (0.749mol) of p-formaldehyde, and 122g of trimethylsilyl chloride was dropped into an ice bath. (1.12mol). After stirring for 2 hours, a mixture of 63.2 g (0.625 mol) of triethylamine and 240 g of methanol was added dropwise. After stirring for 30 minutes, transfer to a 5L separatory funnel, add 1500 g of water, and perform liquid separation operation. The obtained organic layer was dried with magnesium sulfate, and the magnesium sulfate was removed by filtration. The resulting filtrate was concentrated and dried to obtain compound [DM-1] (110 g, 0.226 mol, yield 90.3%). The structure of compound [DM-1] can be confirmed by 1 H-NMR analysis to obtain the following spectral data.

1H-NMR(CDCl3):δ6.42(d,2H J=17.2),6.17-6.08(m,2H),5.86(d,2H J=10.0),4.77(d,4H J=19.6),4.30(m,4H),4.12(t,4H J=6.4),3.61(m,4H),3.30(d,6H J=12.8),1.67(m,4H),1.40(m,4H)。 1 H-NMR(CDCl 3 ): δ6.42(d,2H J=17.2), 6.17-6.08(m,2H), 5.86(d,2H J=10.0), 4.77(d,4H J=19.6), 4.30 (m, 4H), 4.12 (t, 4H J=6.4), 3.61 (m, 4H), 3.30 (d, 6H J=12.8), 1.67 (m, 4H), 1.40 (m, 4H).

<(D)成分之合成> <(D) Synthesis of ingredients>

<合成例10> <Synthesis Example 10>

將MMA 100.0g、HEMA11.1g、作為聚合觸媒的AIBN 5.6g溶解於PM 450.0g,藉由在80℃進行20小時反應後得到丙烯酸共聚物溶液(固體成分濃度20質量%)(PD1)。所得之丙烯酸共聚物的Mn為4,200,Mw為7,600。 100.0 g of MMA, 11.1 g of HEMA, and 5.6 g of AIBN as a polymerization catalyst were dissolved in 450.0 g of PM and reacted at 80° C. for 20 hours to obtain an acrylic copolymer solution (solid content concentration 20% by mass) (PD1). The Mn of the obtained acrylic copolymer was 4,200, and the Mw was 7,600.

<(A)成分之合成(2)> <(A) Synthesis of component (2)>

<合成例11> <Synthesis Example 11>

將A1 4.0g、MMA 12.0g、HEMA 4.0g、作為聚合觸媒的AIBN 0.3g溶解於PM 60.9g,藉由在80℃進行20小時反應後得到丙烯酸共聚物溶液(固體成分濃度25質量%)(PA7)。所得之丙烯酸共聚物的Mn為12,000,Mw為23,000。 4.0 g of A1, 12.0 g of MMA, 4.0 g of HEMA, and 0.3 g of AIBN as a polymerization catalyst were dissolved in 60.9 g of PM and reacted at 80°C for 20 hours to obtain an acrylic copolymer solution (solid content concentration 25% by mass) (PA7). The Mn of the obtained acrylic copolymer was 12,000 and the Mw was 23,000.

<合成例12> <Synthesis Example 12>

將A2 4.0g、MMA 12.0g、HEMA 4.0g、作為聚合觸媒的AIBN 0.3g溶解於PM 60.9g,藉由在80℃進行20小時反應後得到丙烯酸共聚物溶液(固體成分濃度25質量%)(PA8)。所得之丙烯酸共聚物的Mn為15,000,Mw為29,000。 A2 4.0g, MMA 12.0g, HEMA 4.0g, and AIBN 0.3g as a polymerization catalyst were dissolved in PM 60.9g, and reacted at 80°C for 20 hours to obtain an acrylic copolymer solution (solid content concentration 25% by mass) (PA8). The Mn of the obtained acrylic copolymer was 15,000 and the Mw was 29,000.

<合成例13> <Synthesis Example 13>

將MAA 13.8g、LAA 14.1g、HEMA 7.2g、作為聚合觸媒的AIBN 0.68g溶解於PM 107.0g,藉由在80℃進行 16小時反應後得到丙烯酸共聚物溶液(固體成分濃度25質量%)(PA9)。所得之丙烯酸共聚物的Mn為13,300,Mw為27,800。 Dissolve 13.8g of MAA, 14.1g of LAA, 7.2g of HEMA, and 0.68g of AIBN as a polymerization catalyst in PM 107.0g, After 16 hours of reaction, an acrylic copolymer solution (solid content concentration 25% by mass) (PA9) was obtained. The Mn of the obtained acrylic copolymer was 13,300 and the Mw was 27,800.

<基材薄膜之作成> <Making of Base Film>

作為基材所使用的丙烯酸薄膜,例如可藉由以下方法作成。即,由將甲基甲基丙烯酸酯作為主成分的共聚物等所成的原料顆粒在250℃以押出機進行熔融,並通過T-噴嘴,經由流延輥及乾燥輥等可做成厚度40μm之丙烯酸薄膜。 The acrylic film used as the base material can be produced by the following method, for example. That is, raw material pellets made of copolymers containing methacrylate as the main component are melted at 250°C in an extruder, and passed through a T-nozzle, and can be made into a thickness of 40μm through a casting roll, a drying roll, etc. The acrylic film.

<實施例、比較例> <Examples, Comparative Examples>

於表1所示組成中調製實施例及比較例之各硬化膜形成組成物。且,表1中之(A)~(E)成分的配合量為全固體成分換算(於調製時作為溶液得到時,除去溶劑者)。其次使用各相位差材形成組成物形成硬化膜,對於所得之各硬化膜,評估其垂直配向性及密著性。 In the composition shown in Table 1, each cured film forming composition of the example and the comparative example was prepared. In addition, the blending amounts of the components (A) to (E) in Table 1 are in terms of total solid content (when obtained as a solution at the time of preparation, the solvent is removed). Next, each retardation material forming composition was used to form a cured film, and the vertical alignment and adhesion of the obtained cured film were evaluated.

Figure 109112027-A0101-12-0075-28
Figure 109112027-A0101-12-0075-28

[垂直配向性之評估] [Evaluation of vertical alignment]

<實施例1、比較例1> <Example 1, Comparative Example 1>

使用Techno Vision製UV臭氧處理裝置(UV-312),於表2所示基材表面上施予5分鐘UV臭氧處理。於該基 材上將實施例1及比較例1之各硬化膜形成組成物,使用棒塗佈塗佈至Wet膜厚4μm。其後,在該溫度110℃下進行60秒的在熱循環式烤箱中之加熱乾燥,於基材上形成各硬化膜。 Using a UV ozone treatment device (UV-312) manufactured by Techno Vision, UV ozone treatment was applied to the surface of the substrate shown in Table 2 for 5 minutes. Yu Gaiji Each cured film forming composition of Example 1 and Comparative Example 1 was applied on the material to a Wet film thickness of 4 μm using bar coating. Thereafter, heating and drying in a thermal cycle oven at the temperature of 110°C for 60 seconds were performed to form each cured film on the substrate.

於該硬化膜上將默克(股)製之垂直配向用聚合性液晶溶液RMS03-015使用棒塗佈,塗佈至Wet膜厚6μm。將該基材上之塗膜以600mJ/cm2進行曝光,製作出相位差材。 On the cured film, a vertical alignment polymerizable liquid crystal solution RMS03-015 manufactured by Merck (Stocks) was applied using a bar to a Wet film thickness of 6 μm. The coating film on the substrate was exposed at 600 mJ/cm 2 to produce a retardation material.

將製作的這些相位差材使用大塚電子(股)製相位差測定裝置RETS100,測定面內相位差之入射角度依存性。在入射角度0度之面內相位差值為0,在入射角度±50度之面內相位差為38±5nm之範圍者判斷為垂直配向者。評估結果歸納為後面之表2的「垂直配向性」。 These produced retardation materials were measured using a retardation measuring device RETS100 manufactured by Otsuka Electronics Co., Ltd., to measure the incident angle dependence of the in-plane retardation. The in-plane phase difference value is 0 at the incident angle of 0 degrees, and the in-plane phase difference is within the range of 38±5 nm at the incident angle of ±50 degrees. It is judged as a vertical alignment. The evaluation results are summarized as "Vertical Orientation" in Table 2 below.

<實施例2~18、比較例2~5> <Examples 2 to 18, Comparative Examples 2 to 5>

除不進行UV臭氧處理以外,實施與上述實施例1相同條件下的評估。將實施例2~17及比較例2及3之評估結果表示於表2之「垂直配向性」,將實施例18及比較例4及比較例5的評估結果表示於表3。 Except that the UV ozone treatment was not performed, the evaluation was performed under the same conditions as in Example 1 above. The evaluation results of Examples 2 to 17 and Comparative Examples 2 and 3 are shown in "Vertical Orientation" in Table 2, and the evaluation results of Example 18, Comparative Example 4 and Comparative Example 5 are shown in Table 3.

[密著性之評估] [Assessment of Adhesion]

<實施例1、比較例1> <Example 1, Comparative Example 1>

使用Techno Vision製UV臭氧處理裝置(UV-312),如表2所示於基材表面施予5分鐘UV臭氧處理。於該基 材上將實施例及比較例之各硬化膜形成組成物,使用棒塗佈塗佈至Wet膜厚4μm。其後,在各溫度110℃下進行60秒在熱循環式烤箱中之加熱乾燥,於基材上形成各硬化膜。 Using a UV ozone treatment device (UV-312) manufactured by Techno Vision, as shown in Table 2, UV ozone treatment was applied to the surface of the substrate for 5 minutes. Yu Gaiji Each cured film forming composition of the Examples and Comparative Examples was applied on the material to a Wet film thickness of 4 μm using bar coating. After that, heating and drying in a thermal cycle oven at each temperature of 110°C for 60 seconds were performed to form each cured film on the substrate.

於該硬化膜上將默克(股)製之垂直配向用聚合性液晶溶液RMS03-015使用棒塗佈塗佈至Wet膜厚6μm。將該基材上之塗膜以600mJ/cm2進行曝光,製作出相位差材。 On the cured film, a polymerizable liquid crystal solution RMS03-015 for vertical alignment manufactured by Merck (Stocks) was applied to a Wet film thickness of 6 μm using bar coating. The coating film on the substrate was exposed at 600 mJ/cm 2 to produce a retardation material.

於該相位差材以縱橫1mm間隔以切割刀切成5×5mass。於該切口上使用Scotch膠帶進行透明膠帶剝離試驗。評估係將25mass中皆無剝落者評估為○,若僅1mass剝落則評估為×。評估結果歸納於如後之表2的「密著性」。 The phase difference material was cut into 5×5 mass with a dicing knife at an interval of 1 mm in the vertical and horizontal directions. Scotch tape was used on the cut to perform a scotch tape peel test. In the evaluation system, those without peeling in 25 masses are evaluated as ○, and those with only 1 mass peeling are evaluated as ×. The evaluation results are summarized in "Adhesion" in Table 2 below.

<實施例2~17、比較例2~3> <Examples 2 to 17, Comparative Examples 2 to 3>

除未經過UV臭氧處理以外,在與上述實施例1之相同條件下實施評估。評估結果歸納為如後之表2的「密著性」。 The evaluation was carried out under the same conditions as in Example 1 above except that it was not subjected to UV ozone treatment. The evaluation results are summarized as "adhesion" in Table 2 below.

Figure 109112027-A0101-12-0078-29
Figure 109112027-A0101-12-0078-29

Figure 109112027-A0101-12-0078-30
Figure 109112027-A0101-12-0078-30

如表2所示,使用實施例1~17的硬化膜形成組成物所得之配向材與使用比較例1~3的硬化膜形成 組成物所得之配向材同樣地顯示良好垂直配向性。又,如表3所示,使用實施例18的硬化膜形成組成物所得之配向材與使用比較例4及5的硬化膜形成組成物所得之配向材做比較,對於種種基材顯示良好垂直配向性。 As shown in Table 2, the alignment material obtained by using the cured film forming composition of Examples 1 to 17 and the cured film formed of Comparative Examples 1 to 3 The alignment material obtained from the composition also shows good vertical alignment. In addition, as shown in Table 3, the alignment material obtained by using the cured film forming composition of Example 18 compared with the alignment material obtained by using the cured film forming composition of Comparative Examples 4 and 5 showed good vertical alignment for various substrates. Sex.

又,使用實施例1~17的硬化膜形成組成物所得之硬化膜顯示優良密著性。相對於此,使用比較例1~3的硬化膜形成組成物所得之硬化膜難得到密著性。 In addition, the cured films obtained by using the cured film forming compositions of Examples 1 to 17 showed excellent adhesion. In contrast, the cured films obtained using the cured film forming compositions of Comparative Examples 1 to 3 are difficult to obtain adhesion.

[產業上可利用性] [Industrial availability]

本發明的硬化膜形成組成物非常適合作為形成液晶顯示元件的液晶配向膜之材料、或於液晶顯示元件形成設置於內部或外部的光學異方性薄膜時所用的配向材之材料,特別適合作為IPS-LCD的使用於光學補償薄膜的材料。 The cured film forming composition of the present invention is very suitable as a material for forming a liquid crystal alignment film of a liquid crystal display element, or as a material for an alignment material used when a liquid crystal display element forms an optically anisotropic thin film installed inside or outside, and is particularly suitable as IPS-LCD is used as a material for optical compensation films.

Claims (9)

一種硬化膜形成組成物,其特徵為含有 A cured film forming composition characterized by containing (A)具有垂直配向性基與可進行熱交聯之官能基的聚合物、 (A) Polymers with vertical alignment groups and functional groups that can be thermally crosslinked, (B)交聯劑,以及 (B) Crosslinking agent, and (C)密著促進劑及(D)具有熱交聯性基的聚合物中任一方或雙方 Either or both of (C) adhesion promoter and (D) polymer with thermally crosslinkable group 的硬化膜形成組成物, The cured film forming composition, 前述垂直配向性基為下述式[1]所示基; The aforementioned vertical alignment group is a group represented by the following formula [1];
Figure 109112027-A0101-13-0001-27
Figure 109112027-A0101-13-0001-27
式[1]中,*表示鍵結位置,Y1至Y4皆表示單鍵,n為2至3,Y5表示選自苯環及環己烷環的基,Y6表示碳原子數1~18的烷基。 In formula [1], * represents the bonding position, Y 1 to Y 4 all represent single bonds, n is 2 to 3, Y 5 represents a group selected from a benzene ring and a cyclohexane ring, and Y 6 represents the number of carbon atoms 1. ~18 alkyl group.
如請求項1之硬化膜形成組成物,其中(A)成分的可進行熱交聯的官能基為羥基、羧基、胺基或烷氧基矽基。 According to the cured film forming composition of claim 1, wherein the thermally crosslinkable functional group of the component (A) is a hydroxyl group, a carboxyl group, an amino group or an alkoxysilyl group. 如請求項1或請求項2之硬化膜形成組成物,其中(B)成分的交聯劑為具有羥甲基或烷氧基甲基的交聯劑。 The cured film forming composition of claim 1 or claim 2, wherein the crosslinking agent of the component (B) is a crosslinking agent having a methylol group or an alkoxymethyl group. 如請求項1或請求項2之硬化膜形成組成物,其中進一步含有(E)交聯觸媒。 The cured film forming composition of claim 1 or claim 2, which further contains (E) a crosslinking catalyst. 如請求項1或請求項2之硬化膜形成組成物,其中以(A)成分100質量份為基準,含有1質量份 ~300質量份的(B)成分。 Such as the cured film forming composition of claim 1 or claim 2, which contains 1 part by mass based on 100 parts by mass of component (A) ~300 parts by mass of (B) component. 如請求項1或請求項2之硬化膜形成組成物,其中含有對於(A)成分之聚合物及(B)成分的交聯劑之合計量100質量份而言為0.1質量份~100量部的(C)之成分及1質量份~400質量份的(D)成分中任一方或雙方者。 For example, the cured film forming composition of claim 1 or claim 2, which contains 0.1 parts by mass to 100 parts by mass for 100 parts by mass of the polymer of component (A) and crosslinking agent of component (B) Either or both of the (C) component and 1 to 400 parts by mass of the (D) component. 如請求項4之硬化膜形成組成物,其中含有對於(A)成分之聚合物及(B)成分的交聯劑之合計量100質量份而言為0.01質量份~20質量份的(E)成分。 The cured film forming composition of claim 4, which contains 0.01 to 20 parts by mass relative to 100 parts by mass of the polymer of component (A) and crosslinking agent of component (B) (E) ingredient. 一種配向材,其特徵為將如請求項1至7中任一項之硬化膜形成組成物經硬化後所得者。 An alignment material characterized by hardening the cured film-forming composition of any one of claims 1 to 7. 一種相位差材,其特徵為使用由如請求項1至7中任一項之硬化膜形成組成物所得的硬化膜而形成者。 A retardation material characterized by being formed by using a cured film obtained from the cured film forming composition of any one of claims 1 to 7.
TW109112027A 2014-08-28 2015-08-28 Cured film forming composition, alignment material and retardation material TWI724860B (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
JP2014174284 2014-08-28
JP2014-174284 2014-08-28
JP2015-024750 2015-02-10
JP2015024750 2015-02-10
JP2015024752 2015-02-10
JP2015-024752 2015-02-10

Publications (2)

Publication Number Publication Date
TW202030263A TW202030263A (en) 2020-08-16
TWI724860B true TWI724860B (en) 2021-04-11

Family

ID=55399801

Family Applications (2)

Application Number Title Priority Date Filing Date
TW104128399A TWI723961B (en) 2014-08-28 2015-08-28 Cured film forming composition, alignment material and retardation material
TW109112027A TWI724860B (en) 2014-08-28 2015-08-28 Cured film forming composition, alignment material and retardation material

Family Applications Before (1)

Application Number Title Priority Date Filing Date
TW104128399A TWI723961B (en) 2014-08-28 2015-08-28 Cured film forming composition, alignment material and retardation material

Country Status (5)

Country Link
JP (1) JP6706010B2 (en)
KR (1) KR102481772B1 (en)
CN (2) CN111240102B (en)
TW (2) TWI723961B (en)
WO (1) WO2016031917A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102662074B1 (en) * 2017-01-13 2024-05-02 닛산 가가쿠 가부시키가이샤 Cured film forming composition, orientation material and phase difference material
KR20230062899A (en) * 2017-02-22 2023-05-09 닛산 가가쿠 가부시키가이샤 Cured film-forming composition, alignment material, and phase difference material
US20220204697A1 (en) * 2020-12-31 2022-06-30 Industrial Technology Research Institute Polymer and resin composition thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0641496A (en) * 1992-07-21 1994-02-15 Kansai Paint Co Ltd Coating composition, method for forming coating film, and coated article
TW201414784A (en) * 2012-06-20 2014-04-16 Nissan Chemical Ind Ltd Cured film forming composition, alignment material and retardation material
WO2014073658A1 (en) * 2012-11-08 2014-05-15 日産化学工業株式会社 Film having cured film formed thereon, aligning material, and retardation material

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56138718A (en) * 1980-04-01 1981-10-29 Nec Corp Liquid crystal cell
JP2857889B2 (en) 1988-11-04 1999-02-17 富士写真フイルム株式会社 Liquid crystal display
JPH0385521A (en) * 1989-08-30 1991-04-10 Matsushita Electric Ind Co Ltd Liquid crystal panel
JP3099099B2 (en) * 1992-04-20 2000-10-16 関西ペイント株式会社 Paint composition and coating method
JP2923125B2 (en) * 1992-05-26 1999-07-26 関西ペイント株式会社 Paint composition
JP3204182B2 (en) 1997-10-24 2001-09-04 日本電気株式会社 In-plane switching LCD
JP2001281669A (en) * 2000-03-30 2001-10-10 Matsushita Electric Ind Co Ltd Liquid crystal alignment layer, its manufacturing method and liquid crystal display device and its manufacturing method
KR100677050B1 (en) 2003-10-22 2007-01-31 주식회사 엘지화학 In-plane switching liquid crystal display comprising compensation film for angular field of view using +a-plate and +c-plate
CN102317847B (en) * 2008-12-26 2015-08-26 日产化学工业株式会社 Aligning agent for liquid crystal, liquid crystal orientation film and liquid crystal display cells
JP5459520B2 (en) * 2009-06-23 2014-04-02 日産化学工業株式会社 Thermosetting film forming composition having photo-alignment property
EP2457964B1 (en) * 2009-07-21 2015-09-09 Nissan Chemical Industries, Ltd. Composition forming thermoset film having photo alignment
WO2011142393A1 (en) * 2010-05-13 2011-11-17 日産化学工業株式会社 Thermosetting resin composition and display device
KR101824283B1 (en) * 2010-07-13 2018-01-31 닛산 가가쿠 고교 가부시키 가이샤 Liquid crystal aligning agent, liquid crystal alignment film, and liquid crystal display element
JP5790156B2 (en) * 2010-07-15 2015-10-07 Jsr株式会社 Liquid crystal aligning agent for retardation film, liquid crystal aligning film for retardation film, retardation film and method for producing the same
CN103052680B (en) * 2010-08-05 2016-05-25 日产化学工业株式会社 Resin combination, liquid crystal aligning material and phase difference material
EP2767562A4 (en) * 2011-10-11 2015-08-12 Nissan Chemical Ind Ltd Cured film formation composition, orientation material, and phase difference material
WO2015019962A1 (en) * 2013-08-09 2015-02-12 日産化学工業株式会社 Cured film-forming composition, alignment material, and phase difference material
KR102333902B1 (en) * 2013-10-17 2021-12-02 닛산 가가쿠 가부시키가이샤 Composition for forming cured film, alignment material, and retardation material

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0641496A (en) * 1992-07-21 1994-02-15 Kansai Paint Co Ltd Coating composition, method for forming coating film, and coated article
TW201414784A (en) * 2012-06-20 2014-04-16 Nissan Chemical Ind Ltd Cured film forming composition, alignment material and retardation material
WO2014073658A1 (en) * 2012-11-08 2014-05-15 日産化学工業株式会社 Film having cured film formed thereon, aligning material, and retardation material

Also Published As

Publication number Publication date
WO2016031917A1 (en) 2016-03-03
CN106604973B (en) 2020-04-17
KR20170046647A (en) 2017-05-02
TWI723961B (en) 2021-04-11
CN111240102B (en) 2022-11-15
TW202030263A (en) 2020-08-16
TW201620998A (en) 2016-06-16
JP6706010B2 (en) 2020-06-03
CN106604973A (en) 2017-04-26
CN111240102A (en) 2020-06-05
KR102481772B1 (en) 2022-12-27
JPWO2016031917A1 (en) 2017-06-15

Similar Documents

Publication Publication Date Title
TWI673290B (en) Cured film forming composition, alignment material and retardation material
TWI650356B (en) Hardened film forming composition, alignment material, and phase difference material
TWI644961B (en) Cured film forming composition, alignment material and retardation material
JP6700609B2 (en) Cured film forming composition, aligning material and retardation material
JPWO2016002722A1 (en) Cured film forming composition, alignment material and retardation material
TWI724860B (en) Cured film forming composition, alignment material and retardation material
JPWO2018181364A1 (en) Cured film forming composition, alignment material and retardation material
JPWO2018131682A1 (en) Cured film forming composition, alignment material and retardation material
TWI693251B (en) Cured film forming composition, alignment material and retardation material
JP2018070733A (en) Cured film forming composition, orientation material and retardance material